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1 Summary 
 
The optimization studies of coupling-isomerization reactions (CIR) of electron poor 
(hetero)aryl halides with propargyl alcohols using microwave heating allowed the synthesis of 
chalcones in only 8-25 minutes in high yields, using reduced amounts of base (Scheme 1). 
 
OH
R2 R1
O
R2
R1-Hal +
1 2
    2% PdCl2(PPh3)2
1% CuI, 5 eq. of base
4
THF, 120-150 °C
        MW
      8-25 min
62 - 96 %R1 = EWG-pi- R2 = Aryl, Alkyl
 
 
Scheme 1 Microwave accelerated CIR of electron withdrawing (hetero)aryl halides with 
propargyl alcohols. 
 
Moreover the microwave-assisted coupling-isomerization reaction (MACIR) was 
successfully extended to electron rich aryl halides that commonly did not undergo CIR when 
conventional literature conditions were used (Scheme 2). 
 
OH
R2 R1
O
R2
R1-Hal +
1 2
    2% Pd(PPh3)2Cl2
1% CuI, 2 eq. of base
4
    MW,
   30 min
70 - 92 %R1 = EDG-pi- R2 = Aryl
 
 
Scheme 2 Microwave assisted CIR of electron donating aryl halides with propargyl alcohols. 
 
These transformations required the use of stronger bases like DBU (pKB ~ 1.1). 
However, only 2 equivalents were sufficient for the completion of CIR for a large variety of 
substrates. 
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The versatility of 1,3-di(hetero)aryl enones as 3-carbon building blocks was exploited in 
one-pot polysubstituted pyridine 10 synthesis starting from readily available aryl halides 1 
and propargyl alcohols 2, using a CIR-enamine addition-cyclocondensation sequence 
(Scheme 3). 
 
HalAr1
OH
Ar2
N
O
R1
R2
Ar2
Ar1
N
R2
R1
N OR2 R1
Ar1
Ar2
O
H
 
+
2% PdCl2(Ph3P)2, 
1% CuI,
NEt3, ∆
1 2
5
then:
10
, ∆
 NH4Cl (9)  
acetic acid, ∆
6
41 - 68 %
 
 
Scheme 3 One-pot four-component synthesis of pyridine derivatives 10. 
 
The mechanism of the enamine addition to chalcone is supported by the isolation of the 
Diels-Alder cycloadduct 6. The formation of the intermediate 6 was in agreement with 
molecular modeling studies. 
Following the same CIR-enamine addition-cyclocondensation sequence and using 
appropriate enaminones 11, different dihydropyridines 12 and pyridine derivatives 13 could 
be synthesized in moderate yields (Scheme 4). 
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NH2 O
OEt
Ar1
N
EtO2C
Ph
Ar1
N
EtO2C
Ph
H
+
2% PdCl2(Ph3P)2, 1% CuI
NEt3 or HNEt2, ∆
1 2a
11
then:
acetic acid, ∆, under N2
1312
or
37 - 45 % 26 - 50 %
 
 
Scheme 4 One-pot three-component synthesis of dihydropyridines 12 and pyridines 13. 
 
Similar to chalcones, the 1,3-di(hetero)aryl enimines were used as key intermediates in 
one-pot pyridine derivatives synthesis, in this case as 2-carbon-1-nitrogen synthons. The 
enimines underwent inverse Diels-Alder reactions with electron demand when reacted with 
electron rich ketene diethyl acetal or with even more electron rich N,S cyclic ketene acetals 
(Scheme 5). 
 
Ar1 Hal
NH
Ar2
Tos N
Ar1 Ar2
Tos
 
OEt
OEt
Ar1 N
Ar2
OEt
Ar2
Ar1
N N
CH3
n
 
N
CH3
n
 
H3CS
+
2 % PdCl2(PPh3)2,
      1 % CuI
THF/NEt3, ∆
1 18 19
20
21
25 - 65 %
25
27
n = 1, 2, 3
31 - 66 %
 
 
Scheme 5 One-pot three-component synthesis of pyridines 21 and 27. 
 
Whereas multicomponent syntheses with β-enamino crotonates under conductive 
heating led to the formation of pyridines and dihydropyridines in low to moderate yields, by a 
CIR-enamine addition-cyclocondensation sequence, the microwave assisted multicomponent 
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syntheses gave rise to the unexpected formation of cyclohexadienes 31 or cyclohexenones 32, 
in good yields.  These products can be interpreted as the results of a MACIR-enamine 
addition-aldol condensation sequence (Scheme 6). 
 
OH
Ar2
Ar1
O
Ar2
 
O NHR2
R1
Ar1
Ar2
O
R1
NHR2CH3COOH
Ar1
Ar2
O
R1
O
R1=Alkyl
O NHR2
R1
R1=NMe2
CH3COOH
Ar1 Hal
Ar1
Ar2
O
R1
NHR2
 
+
1
2
4 
30,
31, 30 - 74 %
  MW, 
10 min
     MW
 15-20 min
32, 48 - 70 %
30, 31
hydrolysis
PdCl2(PPh3)2
      CuI
  MW, 
10 min
 
 
Scheme 6 One-pot MW-assisted multicomponent synthesis of cyclohexadienes 31 and 
cycohexanones 32. 
 
A direct application of MACIR allowed the one-pot synthesis of quinoline derivatives 
41, in good to excellent yields (40 – 92 %). Based upon this methodology, naturally occuring 
chimanine alkaloids were synthesized starting from the readily available o-amino aryl halides 
1 and propargyl alcohols 2, in 30 minutes (Scheme 7). 
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R
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R
OH
Ar2
NH2
R
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R
 
+
-H2O
1 2 38
41
2 % mol Pd(PPh3)2Cl2, 
      1 % mol CuI
  2eq. of DBU, THF
120-150 °C, 30 min,
       Microwave
39
40 - 92 %
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Scheme 7 One-pot microwave-assisted quinoline 41 synthesis. 
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2 Zusammenfassung 
 
Die Studien zur Optimierung der Kupplung−Isomerisierungs−Reaktion (KIR) von 
elektronenarmen (Hetero)Arylhalogeniden 1 mit Propargylalkoholen 2 unter Mikrowellen-
bestrahlung führten zu Chalkonsynthesen mit sehr kurzen Reaktionszeiten. Zudem konnte der 
Verbrauch an Base reduziert werden (Schema 1). 
 
 
OH
R2 R1
O
R2
R1-Hal +
1 2
    2% PdCl2(PPh3)2
1% CuI, 5 eq. Base
4
THF, 120-150 °C
        MW
      8-25 min
62 - 96 %R1 = EWG-pi- R2 = Aryl, Alkyl
 
 
 
Schema 1 MUKIR von elektronenarmen Arylhalogeniden mit Propargylalkoholen zu 
Chalkonen 4. 
 
Des weiteren konnte die mikrowellenunterstützte Kupplung−Isomerisierungs- 
Reaktion (MUKIR) bei leicht abgewandelten Reaktionsbedingungen erfolgreich auf 
elektronenreiche Arylhalogenide ausgeweitet werden.  
 
 
OH
R2 R1
O
R2
R1-Hal +
1 2
    2% Pd(PPh3)2Cl2
1% CuI, 2 eq. Base
4
    MW,
   30 min
70 - 92 %R1 = EDG-pi- R2 = Aryl
 
 
 
Schema 2 MUKIR von elektronereichen Arylhalogeniden mit Propargylalkoholen zu 
Chalkonen 4. 
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Bei diesen Transformationen kamen stärkere Basen wie zum Beispiel DBU zum 
Einsatz. Hierdurch konnte aber auch die für die Reaktion benötigte Basenmenge in den 
meisten Fällen auf zwei Äquivalente abgesenkt werden.  
1,3-Di(hetero)arylenonen sind als C3-Bausteine für Ein-Topf-Reaktion zur 
Darstellung von Pyridinen 10 ausgezeichnet geeignet. Ausgangsverbindungen stellten 
wiederum die verfügbaren Arylhalogenide 1 und die Propargylalkohole 2 dar (Schema 3). 
 
 
HalAr1
OH
Ar2
N
O
R1
R2
Ar2
Ar1
N
R2
R1
N OR2 R1
Ar1
Ar2
O
H
 
+
2% PdCl2(Ph3P)2, 
1% CuI,
NEt3, ∆
1 2
5
dann:
10
, ∆
 NH4Cl (9)  
CH3COOH, ∆
6
41 - 68 %
 
 
 
Schema 3 Ein-Topf-Vier-Komponenten-Synthese von Pyridinen 10. 
 
Aufgrund der Isolierung des Diels-Alder-Cycloadduktes 6 konnte der mechanistische 
Verlauf der Enaminaddition gestützt werden. Die Bildung dieses Intermediates stimmt mit 
den berechneten Strukturvorhersagen überein. Bei Nutzung geeigneter Enaminone 11 konnten 
unter Befolgung der gleichen Reaktionswege verschiedene Dihydropyridine 12 und 
Pyridinderivative 13 synthetisiert werden (Schema 4). 
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NH2 O
OEt
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N
EtO2C
Ph
Ar1
N
EtO2C
Ph
H
+
2% PdCl2(Ph3P)2, 1% CuI
NEt3 oder HNEt2, ∆
1 2a
11
dann:
CH3COOH, ∆, unter N2
1312
oder
37 - 45 % 26 - 50 %
 
 
 
Schema 4 Ein-Topf-Drei-Komponenten-Synthese von Dihydropyridinen 12 und 
Pyridinen 13. 
 
Analog den Chalkonen 4 wurden die 1,3-Di(hetero)arylenimine 19 als Schlüsselinter-
mediate – in diesem Fall als C2N-Synthone – für eine Ein-Topf-Pyridinsynthese genutzt. Die 
Enimine 19 durchlaufen bei der Reaktion mit elektronenreichen Ketendiethylacetalen 20 oder 
noch nucleophileren cyclischen N,S-Ketenacetalen 25  Diels-Alder Reaktionen mit inversem 
Elektronenbedarf (Schema 5). 
 
Ar1 Hal
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Ar2
Tos N
Ar1 Ar2
Tos
 
OEt
OEt
Ar1 N
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OEt
Ar2
Ar1
N N
CH3
n
 
N
CH3
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H3CS
+
2 % PdCl2(PPh3)2,
      1 % CuI
THF/NEt3, ∆
1 18 19
20
21
25 - 65 %
25
27
n = 1, 2, 3
31 - 66 %
 
 
Schema 5 Ein-Topf-Drei-Komponenten-Synthese der Pyridine 21 and 27. 
 
Während bei konventionellem Erhitzen die Multikomponentensynthese mit β-
Enaminocrotonaten 30 zur Bildung von Pyridinen und Dihydropyridinen in niedrigen oder 
moderaten Ausbeute führt, kommt es beim Erhitzen durch Mikrowellen zur unerwarteten 
Bildung von Cyclohexadienen 31 oder Cyclohexenonen 32 mit guten Ausbeuten. Diese 
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Produkte können als Ergebnis einer MUKIR-Enamin-Additions-Aldolkondensations-Sequenz 
interpretiert werden (Schema 6).  
 
OH
Ar2
Ar1
O
Ar2
 
O NHR2
R1
Ar1
Ar2
O
R1
NHR2CH3COOH
Ar1
Ar2
O
R1
O
R1=Alkyl
O NHR2
R1
R1=NMe2
CH3COOH
Ar1 Hal
Ar1
Ar2
O
R1
NHR2
 
+
1
2
4 
30,
31, 30 - 74 %
  MW, 
10 min
     MW
 15-20 min
32, 48 - 70 %
30, 31
Hydrolyse
PdCl2(PPh3)2
      CuI
  MW, 
10 min
 
 
Schema 6: Mikrowellenunterstützte Mehrkomponentensynthese von Cyclohexadienen 31 und 
Cycohexanonen 32. 
 
Einen direkten Anwendungsbezug der MACIR ermöglicht die Ein-Topf-Synthese von 
Chinolinderivaten 41 anhand der Reaktion von o-Aminoarylhalogeniden 1 mit Propargyl-
alkoholen 2. Basierend auf dieser Methode wurden die in der Natur vorkommenden 
Chimanine Alkaloiden in guten bis exzellenten Ausbeuten dargestellt (Schema 7).  
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Hal OH
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R
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Schema 7 Mikrowellenunterstützte Ein-Topf-Chinolinsynthese. 
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3 Introduction 
 
One-pot multicomponent processes address very fundamental principles of synthetic 
efficiency and reaction design, and therefore have gained a considerable and steadily 
increasing academic, economic, and ecological interest.1,2 They are diversity oriented 
syntheses3 that can be often developed into combinatorial and solid-phase strategies,2d,4 
promising manifold opportunities for generating novel structures of pharmaceuticals, 
catalysts, and even novel molecule based materials. 
The combination of one-pot multicomponent reactions and microwave irradiation might 
be one of the most straightforward steps in the development of multicomponent processes 
since the microwave heating is able to speed up reactions, reduce side reactions, increase 
yields and improve reproducibility. For instance, the formation of heterocycles, well-known 
constituents of many natural and biologically active compounds, by cyclocondensation 
reactions is typically a well-suited process for microwave acceleration. Many of these 
condensation reactions require high temperatures and conventional reaction conditions very 
often involve heating the reactants in an oil or sand bath for many hours or even days.  
Similarly, the rate of the transition metal-catalyzed carbon-carbon and carbon-
heteroatom bond-forming reactions that typically need hours or days to reach completion with 
conventional conductive heating under reflux conditions, can be enhanced significantly by 
employing microwave heating under sealed vessel conditions. The use of metal catalysts in 
conjunction with microwaves may have great advantages since the inverted temperature 
gradients under microwave conditions may lead to an increased lifetime of the catalyst and 
the elimination of wall effects.  
Numerous reports on microwave-assisted transition metal-catalyzed reactions and one-
pot multicomponent reactions have been published, therefore, only a few recent examples 
were selected for detailed description. 
Liu et al.5 reported a microwave-assisted one-pot total synthesis of several 
quinazolinone alkaloids as deoxyvasicinone, mackinazolinone, isaindigotone and their 
derivatives that exhibit anti-inflammatory, antimicrobial and antidepressant activities 
(Scheme 8). 
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(
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Scheme 8 One-pot total synthesis of quinazolinone alkaloids promoted by microwave 
irradiation. 
 
A plausible mechanism for the formation of the quinazolinone core involves a transannular 
cyclization of the intermediate cyclic diamide (Scheme 9). The cyclic diamide may be 
prepared via ring expansion of the intermediate benzoxazinone, which could be accessed in 
situ from boc-protected benzoxazinone, which in turn should be generated in situ from the 
readily available anthranilic acid and boc-protected amino acids. In addition, the 
isaindigotone could be synthesized through a condensation reaction of quinazolinone with the 
appropriate aldehyde via a three-component one-pot reaction process. 
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R R
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Scheme 9 Mechanistic rationale of the quinazolinone derivatives synthesis. 
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Microwave synthesis has been frequently criticized because of the typically high 
reaction temperatures that invariably would lead to reduced selectivities. This is perhaps the 
reason why comparatively few enantioselective processes driven by microwave heating have 
been reported in the literature. In 2000 the research groups of Moberg, Hallberg, and Larhed 
reported on microwave-mediated palladium-6 and molybdenum-catalyzed7 asymmetric allylic 
alkylation reactions involving neutral carbon, nitrogen, and oxygen nucleophiles. Both 
processes were carried out under non-inert conditions and yielded the desired products in high 
chemical yield and with typical ee values of over 98 %. 
More recently, Trost and Andersen have applied this concept in their approach to the 
orally bioavailable HIV inhibitor tipranavir8 (Scheme 10). Synthesis of the key chiral 
intermediate was achieved by asymmetric allylic alkylation starting from a carbonate 
derivative. A 94 % yield of the product was achieved by employing 10 mol% of the 
molybdenum precatalyst and 15 mol% of a chiral ligand with 2.0 equivalents of sodium 
dimethylmalonate as the additive. The reaction was carried out by sealed-vessel microwave 
heating at 180 °C for 20 minutes. Thermal heating under reflux conditions (67 °C) required 
24 h and produced the same chemical yield of the key intermediate, though higher 
enantiomeric purity (96 % ee) could be reached 
 
BocO
NO2
O O
OMeMeO
MeO2C
MeO2C
NO2
N
SNH
O O
OH
OO
CF3
Ph
Na
+
+
[Mo(CO)3(C7H8)], Ligand
              THF
MW, 180 °C, 20 min
tipranavir
94 %(ee 94 %)
 
 
Scheme 10 MW-assisted molybdenum-catalyzed asymmetric allylic alkylation in the total 
synthesis of the HIV inhibitor tipranavir. 
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Thus, the microwave irradiation has proven its significant benefit and general 
applicability in organic synthesis.  
A challenging and unexplored concept that combines synergetically the advantages of 
the metal-catalyzed reactions with multicomponent process and microwave technique can be 
envisioned. Thus, the implementation of the Sonogashira coupling-isomerization as a mild 
and efficient route to chalcones or enimines into microwave-assisted multicomponent 
methodologies for the synthesis of biologically active heterocycles and new scaffolds 
represents an interesting and challenging goal. (Scheme 11). 
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Scheme 11 General concept. 
 
Therefore, the goals of this thesis were: 
 
1) The optimization of the reaction parameters for an efficient, rapid and general 
coupling-isomerization reaction of electron poor as well as electron rich (hetero)aryl 
halides with propargyl alcohols, 
2) To perform coupling-isomerization reactions of aryl halides with propargyl alcohols or 
propargyl amines and transform the intermediate chalcones or enimines directly 
without isolation in a one-pot fashion into biologically active pyridines, 
tetrahydroquinolines, naphthyridines, quinolines, 
3) To investigate the microwave effects on multicomponent synthesis versus  
conventional heated multicomponent synthesis, and   
4) To extend this general coupling-isomerization reaction to the synthesis of selected 
natural products.
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4 General Part − Results and Discussion 
 
4.1 Chalcones − Natural and Synthetic Compounds, Versatile Synthons 
for Cycloaddition Reactions 
 
4.1.1 Chalcones − Literature Review 
 
Flavonoids, a group of ~ 5000 naturally occurring compounds, have long been known to 
function as defence compounds in protecting the seeds and the roots of plants from insects, 
bacteria, fungi and alien plants.9 1,3-diaryl-2-propen-1-ones, constitute a class of  naturally 
occurring and synthetic compounds belonging to the flavonoid family. They are often referred 
as “chalcones”, the term being first coined by Kostanecki10 who did pioneering work in the 
synthesis of natural colouring compounds. 
 Chalcones possess a broad spectrum of biological activity. Not many structural 
templates can claim association with such a diverse range of pharmacological activities, 
among which cyctotoxicity,11 antitumour,12 anti-inflammatory,13 antiplasmodial,14 
antioxidant15 properties are widely cited. Dimmock and coworkers gave an insightful review 
of the biological properties of chalcones in 1999.16  
Two naturally occurring chalcones, Isoliquiritigenin and Licochalcone A (Fig. 1) 
extracted from licorice plant (glycyrrhiza glabra), one of the oldest known botanicals in 
Chinese medicine, may account for many of its beneficial activities (anti-inflammation, 
antiulcer, antiallergy, and anticarcinogenesis).17  
 
O
OH
OH
OH
O
OH
OH
OMe
 
            isoliquiritigenin                                                           licochalcone A  
                                                                                                                    IC50 (Leish.) = 4.0 µM        
                                                                                                                    IC50 (Tuberc.) = 5-10 µM        
 
Fig. 1 Naturally occurring chalcones extracted from Chinese licorice. 
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Additionally, Zhai et al.18 have found that Licochalcone A alters the ultrastructure of the 
parasite mitochondria and inhibits their function, having a strong antileishmanial activity. 
Similarly to Licochalcone A, other synthetic oxygenated chalcones exhibit a strong 
antileishmanial activity both in vitro and in vivo (Fig. 2). 
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                              IC50 (Leish.) = 4.0 µM                                                   IC50 (Leish.) = 5.7 µM 
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O
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                              IC50 (Leish.) = 5.8 µM                                                   IC50 (Leish.) = 4.5 µM 
 
Fig. 2  Synthetic oxygenated chalcones with antileishmanial activity. 
 
Leishmaniasis is a major and increasing health problem, particularly in Africa, Asia and 
Latin America. In Europe, the disease is endemic in many southern countries, and imported 
leishmaniasis is a growing problem, and the emergence of AIDS-related leishmaniasis has 
added a new dimension to the problem.  
Recently, Simoneau et al.19 have identified the flavokawains (Fig. 3), from kawa 
extracts that have been commonly used by South Pacific Islanders for thousands of years, as 
anticarcinogen agents and apoptosis inducers.  
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Fig. 3  Flavokains, naturally occurring chalcones extracted from Kawa. 
 
 Apoptosis is considered as a physiological process to extinguish DNA-damaged cells 
with minimal damage to surrounding normal cells or tissue. Novel apoptosis inducers, 
therefore, would provide more effective therapy and prevention against cancer. 
Comprehensive accounts of the effects of structure on activity are given by Liu and 
Dhar.11,12 Generally, due to the α,β-unsaturated ketone moiety, chalcones have a preferential 
reactivity toward soft nucleophiles as thiols, rather than hard nucleophiles like amino and 
hydroxy groups19 (Scheme 12). Therefore, chalcones are less likely to interact with nucleic 
acids and then avoid the problems of mutagenicity and carcinogenity associated with certain 
alkylating agents in cancer chemotherapy.16 In addition, chalcones which are typical Michael 
acceptors, can bind to particular receptors and lead to the induction of phase II enzymes 
against carcinogens.20 
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Scheme 12 Reaction of a representative chalcone (Michael acceptor) and a nucleophilic thiol 
(RSH). 
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For antimitotic activity, the presence of methoxy substituents, α-methylation of enone 
moiety and the presence of 2’ oxygenated substituents are favourable features. 
Conformational restraint of the chalcone template generally leads to a decrease in cytotoxic 
activity. Chemoprotection by chalcones may be a consequence of their antioxidant properties, 
mediated via inhibition or induction of metabolic enzymes, by anti-invasive effect or a 
reduction in nitric oxide production. Hydroxy and prenyl substituents are generally associated 
with antioxidant properties.21 
 
 
4.1.2 Chalcone Synthesis – Literature Review 
 
Chalcones are the first isolable compounds of the flavonoid biosynthesis in plants, but 
do not necessarily accumulate to any appreciable degree unless the enzyme chalcone 
isomerase, which catalyses the cyclization of chalcone to flavone, is absent.22 Chalcones are 
readily synthesized in the laboratory and in the literature there are numerous references to 
structural modifications of the chalcone template. Some examples are introducing different 
substituents on the phenyl rings A and B, (Fig. 4) replacing the phenyl rings with heterocyclic 
and polyaromatic rings, and cyclization of the chalcone gives rise to the formation of 
conformationally restricted analogues. 
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Fig. 4 Substituting sites on chalcone template. 
 
Most synthetic methods are based on the base-catalysed Claisen-Schmidt condensation 
of aldehydes and appropriate acetophenones in polar solvents (Scheme 13). 
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Scheme 13 Synthesis of chalcones by base-catalyzed Claisen-Schmidt condensation of 
ketones and aldehydes. 
 
The method is versatile and convenient, although yields may be variable, ranging from 5 
% to 90 %. Many investigators have sought to improve yields using alternative catalysts, 
other than the widely employed alkaline bases like NaOH and KOH. Among different 
catalysts used were sodium phosphate doped with sodium nitrate23 and hydrated aluminium-
magnesium hydroxides.24 
In an effort to encourage “green chemistry”, some solvent-free Claisen-Schmidt 
methods have been developed. Fringuelli et al. used a polymer-supported TBD (1,5,7-
triazabicyclo[4.4.0]dec-5-ene) catalyst, obtaining good results, although the same reactions 
performed under solvent-free conditions by using non-supported base (TBD) gave closely 
comparable results both in terms of the reaction time and isolated yields.25  
Ultrasound and microwave-assisted methods reduced reaction times and facilitated 
work-up for the synthesis of chalcones.26 Claisen-Schmidt condensation in the presence of 
pulverised KOH or KF supported alumina, under ultrasound gave good yields under milder 
conditions and at shorter reaction times.27  
The utility of microwave-assisted synthesis was investigated for 2’-hydroxy chalcones 
that are generally impeded by cyclization to flavonones. Unfortunately, protecting the 2’ 
hydroxy group for minimising the cyclization reaction is not a viable option due to the ortho 
position of the group. Stoyanov and coworkers28 noted that microwave irradiation of the 
reactants in 20 % KOH/ethanol in a closed pressure vial gave excellent yields of 2’-hydroxy 
chalcones with no trace of side products. When the reaction was repeated in an oil bath at the 
same temperature (~ 130 °C) identical yields were obtained. Thus, a high temperature and 
short heating time are important conditions for ensuring good yields of 2’-hydroxy chalcones. 
Despite its versatility and generality, the aldol condensation is not a suitable method for 
multistep-synthesis due to the required drastic conditions such as strong alkaline base, or 
strong Lewis acids that are not compatible with further transformations of chalcones. 
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New methodologies for synthesis of chalcones have also been described in the literature. 
A general method, based on the Suzuki reaction, between benzoyl chloride and styrylboronic 
acid gave chalcones in nearly quantitative yields29 (Scheme 14). This reaction is not affected 
by substituents (electron-donating, electron withdrawing) on the acid chloride or 
styrylboronic acid.  
 
X
O B
OH
OH O
+
Palladium catalyst
benzoyl chloride
(X=Cl)
styrylboronic acid
 
 
Scheme 14 Chalcone synthesis by Suzuki coupling between activated benzoic acids and 
styrylboronic acids. 
 
On the other hand, coupling cinnamoyl chloride and phenylboronic acid in presence of 
palladium catalyst gave a complex mixture of products. 
Xu et al30 have examined the acid-catalysed coupling reaction of aromatic alkynes with 
aldehydes in ionic liquids (Scheme 15). They found out that aromatic aldehydes with 
electron-donating and electron-withdrawing groups including those bearing an alkoxy, chloro, 
bromo or nitro substituents were able to undergo the corresponding coupling reaction and 
displayed high conversion to chalcones, although with aliphatic alkynes, as starting material,  
no reaction occurred even after prolonged reaction times. 
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Scheme 15 Chalcone synthesis via ionic-liquid-promoted coupling of alkynes with aldehydes. 
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4.1.3 Reactions of Chalcones 
 
The α,β-unsaturated ketone moiety is an extremely common feature of many organic 
compounds. As such, it serves as a very useful site for syntheses and transformations. 
Numerous reactions have been extensively developed over the years: e.g., Michael additions; 
β-cuprate additions; α-alkylations or arylations by reductive trapping or oxidative couplings; 
carbonyl refunctionalizations by addition, oxidation, reduction, and alkylidenations and α-
oxidations by halogen-dehalogenation (Scheme 16). 
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Scheme 16 Chalcone transformation reactions. 
 
Besides the refunctionalization reactions of the “ene” and “one” functionalities, 
chalcones have proven to be useful synthons for the preparation of various heterocycles such 
as, pyridine,31 pyrimidine,32 furans,33d pyrroles, pyrazolines, 34  spiroadducts,35 α-tetralones,36 
pyrindines, tetrahydroquinolines33f and heterazepines,33b,c (Scheme 17). Furthermore, the 
chalcones potency as building blocks was successfully exploited in various one-pot 
multicomponent heterocycle syntheses.33 
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Scheme 17 Heterocycle syntheses using chalcone as building block. 
 
Since chalcones possess two electrophilic centers, the reactions with nucleophiles 
(Michael addition) and binucleophiles (cyclocondensation) are the most important 
transformations for heterocycle synthesis (Scheme 18). 
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Scheme 18 The electrophilic centers of chalcone. 
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Although not so numerous, some transformations involving the nucleophilic center of 
chalcone have also been reported, such as tandem Michael addition-Robbinson reactions with 
the formation carbocyclic rings.37 
 
4.1.4 Synthesis of Chalcones via Sonogashira Coupling-Isomerization Reaction  
 
Transition metal mediated croos-couplings have proven to be powerful reactions for 
mild, highly efficient carbon-carbon bond formations. Among these processes, the bimetallic, 
catalytic Sonogashira coupling has turned out to be a versatile and mild alkyne-to-alkyne 
transformation, i.e. a powerful tool for transforming a terminal alkyne into an internal one as a 
consequence of a sp-sp2-CC-bond forming reaction.38 Besides mild reaction conditions, an 
excellent compatibility with fragile functional groups dispenses with tedious protection-
deprotection operations, and since hydrogen halide (scavenged by weak bases such as amines) 
is formed as the sole by-product, the Sonogashira coupling displays a high degree of atom 
economy.  
Our group has recently discovered and developed an unusual mode of alkyne activation 
by a detouring outcome of the Sonogashira coupling, i.e. a coupling-isomerization reaction.39  
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Scheme 19 The coupling-isomerization-reaction as a peculiar mode of alkyne activation by 
cross-coupling. 
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Conceptually, the cross-coupling reaction of an electron deficient halide with a terminal 
alkyne not only activates the newly formed internal triple bond towards Michael-type 
additions but also at the propargyl position, e.g. towards an alkyne-allene isomerization 
(Scheme 19). 
In particular, the Sonogashira coupling of electron poor halides with 1-(hetero)aryl 
propargyl alcohols furnishes chalcones in good to excellent yields (Scheme 20). 
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Scheme 20 Chalcones synthesized by CIR. 
 
 
The mild conditions of CIR allow to apply chalcones as in-situ generated Michael 
acceptors in multicomponent syntheses of a large variety of heterocycles in one-pot fashion 
(Scheme 17). Besides exploiting the Michael reactivity for the multicomponent reactions 
(MCR) heterocyclizations, the synergism between palladium-copper catalyst system and the 
generated electron-deficiency at the α-(hetero)aryl substituent became the key to conceive 
and further devise sequential Pd-catalyzed reactions such as additional Sonogashira, Heck, 
Suzuki, or coupling isomerization40 (Scheme 21). 
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Scheme 21 Exploiting gradual reactivity differences for coupling-isomerization sequence. 
 
 Although the Sonogashira coupling-isomerization has found many applications, CIR 
lacks generality. The substitution pattern of pi-system halide is limited to electron deficient 
halides and aromatic propargylic alcohols are generally preferred over the alkyl-propargylic 
alcohols. Another drawback of CIR is the required large excess of base, both for the coupling 
and for the isomerization step (Scheme 22). 
 
 
 
Scheme 22 Mechanistic rationale of CIR. 
 
The large excess of base does not necessarily favours the compability of CIR with the 
multistep methodologies, especially in the case of the acid catalyzed subsequent steps. Trying 
to overcome these main drawbacks a new microwave–assisted CIR was conceived. 
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4.1.5 Microwave Assisted Coupling–Isomerization Reaction (MACIR) – Towards a 
General CIR 
 
4.1.5.1 Literature Overview on Microwave Acceleration of Transition Metal Catalysis 
 
The number of publications on microwave assisted organic synthesis has been 
increasing exponentially since the first report on the use of microwave heating to accelerate 
organic chemical transformations by the groups of Gedye, Giguere and Majetich in 1986.41 
Microwave heating is not only able to reduce reaction times from hours to minutes, but it is 
also known to reduce side reactions, increase yields, and improve reproducibility. Therefore, 
many academic and industrial research groups are already using microwave as a forefront 
technology. Also a large number of review articles42 and several monographs43 provide an 
extensive coverage of the subject. 
Homogenous transition metal-catalyzed reactions have attracted considerable interest in 
microwave assisted organic synthesis, representing one of the most important and best studied 
reaction types in this field.44 Transition metal catalyzed carbon-carbon and carbon-heteroatom 
bond-forming reactions typically need hours or days to reach completion by conventional 
heating under reflux conditions.  
The use of metal catalysis in conjunction with dielectric microwave heating may have 
significant advantages over traditional conductive heating methods, since the inverted 
temperature gradients under microwave conditions may lead to an increased lifetime of the 
catalyst through elimination of wall effects45 (Fig. 5), together with a controlled heating at 
“molecular level”.46 The microwave irradiation raises the temperature of the whole reaction 
volume simultaneously (bulk heating) whereas in the oil-heated tube, the reaction mixture in 
contact with the vessel wall is heated first. 
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Fig. 5 Inverted temperature gradients in microwave versus oil-bath heating: difference in the 
temperature profiles (finite element modelling) after 1 min of microwave irradiation (left) and 
treatment in oil bath (right). 
 
Sonogashira reaction enjoys remarkable popularity as a reliable and general method for 
the preparation of unsymmetrical alkynes. Numerous elegant synthetic transformations based 
on C-C bond forming Sonogashira reactions have been developed both in classical organic 
synthesis and natural product chemistry.47 General protocols for microwave–assisted 
Sonogashira reactions under controlled conditions were first reported in 2001 by Erdelyi and 
Gogoll.48 Typical reaction conditions for the coupling of aryl iodides, bromides, chlorides and 
triflates involve DMF as solvent, diethyl amine as the base in large excess, PdCl2(PPh3)2 (2-5 
mol %) and CuI (5 mol %) as catalysts.  
Although there are many reports on MW-assisted Sonogashira reaction in the literature, 
MW-assisted Sonogashira coupling-isomerization reaction (MACIR) (Scheme 23) has not 
been reported to date.  
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Scheme 23 Sonogashira coupling-isomerization reaction. 
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4.1.5.2 The General MACIR 
 
Attempts to optimize Sonogashira coupling-isomerization under microwave irradiation 
would have to address some of CIR limitations observed under conventional heating 
conditions:  
- the limited choice of the reaction medium,  
- large excess of base, 
- long reaction times, 16-24 h, 
- the demand for a reactive arene derivative. 
First optimisation studies of Sonogashira coupling-isomerization under microwave 
irradiation were focused on reducing the reaction time (under conventional condition, reaction 
times are over 16 h) and the amount of base in order to enhance the enones reactivity as 
dienes, i.e. under Lewis acid catalyzed Diels-Alder reaction conditions. Therefore, different 
electron poor aryl-halides 1 and propargyl alcohols 2 were subjected to CIR (Scheme 24) 
screening various parameters such as, base, temperature, reaction time, concentration of the 
substrate and solvent. 
 
OH
R2 R1
O
R2
R1-Hal R1
R2
OH
+
1 2 3
2% PdCl2(PPh3)2
       1% CuI
Base conditions, MW
+
4
4a,  R1 = p-NCC6H4-, R2 = Ph
4b,  R1 = 2-pyrimidyl, R2 = Ph
4c,  R1 = 2-pyridyl, R2 = Ph
4d,  R1 = p-F3CC6H4-, R2 = Ph
4e,  R1 = p-EtO2CC6H4-, R2 = Ph
4f,   R1 = p-O2NC6H4-, R2 = Ph
4g,  R1 = p-H2NO2SC6H4-, R2 = Ph
4h,  R1 = p-NCC6H4-, R2 = 2-thienyl
4i,   R1 = p-NCC6H4-, R2 = 3-thienyl
4j,   R1= p-NCC6H4-, R2 = n-propyl
4l,   R1 = Ph, R2 = Ph
4m, R1 = p-H3CC6H4-, R2 = Ph
4n,  R1 = p-MeOC6H4-, R2 = Ph
4o,  R1 = m-H2NC6H4-, R2 = Ph
 
3a,  R1 = p-NCC6H4-, R2 = Ph
3e,  R1 = p-EtO2CC6H4-, R2 =Ph
3k,  R1 = p-NCC6H4-, R2 = Me
3l,   R1 = Ph, R2 = Ph,
3m, R1 = p-H3CC6H4-, R2 = Ph
3n,  R1 = p- MeOC6H4-, R2 = Ph
3o,  R1 = m-H2NC6H4-, R2 = Ph
 
Scheme 24 MACIR of (hetero)aryl halides 1 with propargylic alcohols 2. 
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The amount of base was varied between 1.05 – 10 eq., the optimum being achieved for 5 
equivalents of NEt3 and THF as a solvent, with a conversion of 100% and 84% yield of the 
desired chalcone 4a (entry 15, Table 1). Obviously, acetonitrile and dimethylformamide are 
not suitable solvents for CIR. Side-reactions such as Michael additions, Diels-Alder reactions 
may occur, and consequently the yields are lower, i.e. 67 % using acetonitrile (entry 10), and 
73 % for dimethylformamide (entry 12, Table 1). 
 
Table 1 Optimization MACIR experiments for the reaction of 1a (R1 = p-NCC6H4-) and 2a 
(R2 = Ph) using NEt3 as a base. 
NCR1 = 
  
R2 =
 
No. Equivalents 
of NEt3 Solvent 
Solvent 
[mL] 
Ratio 
Solvent/Base 
[mL] 
Time 
[min] Temp. [°C] Yield, 4a [%] 
1 3.0 CH3CN 2.0 6.67 : 1 60 120 63 
2 3.0 CH3CN 2.0 6.67 : 1 100 120 61 
3 3.0 CH3CN 0.7 2.33 : 1 60 120 61 
4 5.0 CH3CN 3.0 5.00 : 1 60 120 66 
5 5.0 CH3CN 2.0 3.33 : 1 60 150 52 
6 5.0 CH3CN 2.0 3.33 : 1 20 150 58 
7 5.0 CH3CN 1.3 2.17 : 1 60 150 44 
8 5.0 CH3CN 2.0 3.33 : 1 20 120 50 
9 5.0 CH3CN 2.0 3.33 : 1 40 120 52 
10 10.0 CH3CN 3.0 2.14 : 1 60 120 67 
11 10.0 CH3CN 3.0 2.14 : 1 60 180 54 
12 10.0 DMF 0.5 0.64 : 1 20 120 73 
13 10.0 DMF 0.5 0.64 : 1 10 120 70 
14 2.5 THF 1.0 4.89 : 1 30 150 62 
15 5.0 THF 1.0 2.44 : 1 30 150 84 
16 6.0 THF 1.0 2.04 : 1 30 150 76 
17 7.0 THF 1.0 1.75 : 1 30 150 80 
18 10.0 THF 1.0 1.22 : 1 30 150 52 
19 10.0 THF 2.0 2.44 : 1 30 150 84 
20 5.0 THF 2.0 4.89 : 1 30 150 72 
21 5.0 THF 0.5 1.22 : 1 30 150 56 
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Within the optimization scope, the reaction temperature was varied between 100 and 
180 °C, with an optimal reaction enhancement at 150 °C. At higher temperatures fast 
decomposition of the palladium catalyst together with the product decomposition were 
observed (entry 11). 
Using triphenylphosphane as additive, the yields of the desired chalcones were 
improved by over 10 %, entry 4 and 9 (Table 2). The role of this additive is not well 
established. It might increase the catalyst’s solubility or the catalyst’s stability at higher 
temperatures49 and it also facilitates the reduction of Pd2+ to Pd0. 
 
Table 2 Optimization MACIR experiments for the reaction of 1a (R1 = p-NCC6H4-) and 2a 
(R2 = Ph) using PPh3 as additive. 
No. 
Solvent/ 
Additive 
Solvent 
[ml]/  
Additive 
[eq] 
Ratio 
Solvent/ 
Base 
[molar] 
Ratio 
Solvent/ 
Base [mL] 
Time 
[min] 
Temp. 
[°C] 
Yield, 
4a [%] 
1 THF/PPh3 1.0/0.2 2.44 : 1 1.67 : 1 45 150 79 
2 THF/PPh3 1.0/0.2 2.44 : 1 1.67 : 1 30 150 88 
3 THF/PPh3 1.0/0.2 2.44 : 1 1.67 : 1 20 150 92 
4 THF/PPh3 1.0/0.2 2.44 : 1 1.67 : 1 15 150 96 
5 THF/PPh3 1.0/0.2 3.06 : 1 2.00 : 1 15 150 73 
6 DMF/PPh3 1.0/0.2 2.58 : 1 1.67 : 1 60 150 79 
7 DMF/PPh3 1.0/0.2 2.56 : 1 1.67 : 1 20 150 78 
8 DMF/PPh3 1.0/0.2 2.58 : 1 1.67 : 1 10 150 87 
9 DMF/PPh3 1.0/0.2 2.58 : 1 1.67 : 1 5 150 87 
10 DMF/PPh3 1.0/0.2 2.58 : 1 1.67 : 1 10 120 76 
11 DMF/PPh3 0.5/0.2 0.64 : 1 0.36 : 1 10 120 84 
 
 
The reaction time was varied between 5 to 100 minutes. Surprisingly, the reaction 
showed full completion after 5 min using DMF as solvent, 0.2 eq of PPh3 and 5 eq of NEt3, 
yield 87 % (entry 9). Longer reaction times did not improve the yields (entries 6-8), and they 
might lead to side reactions together with product decomposition.  
Using THF as solvent, the yield of the desired chalcone was almost quantitative, but the 
reaction needed longer time, 15 minutes (entry 4). Similarly, longer reaction times did not 
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improve the yields. Optimal concersion was achieved after 15 min, whereas prolonging the 
reaction time  to 20-35 min the yield significantly decreased (Fig. 6). 
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Fig. 6 Reaction time - yield dependence for MACIR using THF as solvent 
 
Reaction rates strongly depend on the substrate concentrations. Optimal rates were 
found for 0.25 M. At higher concentrations, the probability of explosions increases as Pd and 
Cu catalysts are very strong microwave absorbers and higher concentration of the catalysts 
might be critical. 
The optimal results were found for 5 eq of triethylamine, less amounts of base gave 
lower yields of the chalcone 4a (entry 14, Table 1 and entry 5, Table 2). In order to decrease 
the amount of base, alternative stronger bases, for instance DBU (pKb ~1.1), were tested. The 
chalcone 4a (85%) was obtained in 5 minutes using only 1.05 eq of DBU, entry 1 (Table 3). 
Neither longer reaction time, entry 2, nor higher temperature, entry 4 (Table 3) improved the 
product formation. 
 
Table 3 Optimization MACIR experiments for the reaction of 1a (R1 = p-NCC6H4-) and 2a 
(R2 = Ph) using DBU as base, in presence of PPh3, in THF. 
No. base [eq] Solvent [mL]/ Additive [eq] 
Solvent [mL]/ 
Base [mL] 
Time 
[min] 
Temp. 
[°C] 
Yield, 4a 
[%] 
1 DBU 1.05 1.0/0.2 10 : 1 5 150 85 
2 DBU 1.05 1.0/0.2 10 : 1 10 150 82 
3 DBU 1.05 1.0/0.2 10 : 1 2.5 150 65 
4 DBU 1.05 1.0/0.2 10 : 1 5 160 73 
5 DBU 1.05 1.5/0.2 15 : 1 5 120 70 
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MACIR method was optimized for a large variety of electron poor aryl halides 1 with 
1-phenylprop-2-yn-1-ol 2 (Table 4─Table 6). 
 
Table 4 Temperature and time optimization for the reaction of 1b (R1 =2-pyrimidyl) and 2a 
(R2 = Ph) using NEt3 as base, in the presence of PPh3, in THF. 
N
N
R1 = 
  
R2 =
 
No. Equivalents 
of base Solvent [mL] Time [min] Temp. [°C] Yield, 4b [%] 
1 5.0 1.0 10 150 70 
2 5.0 1.0 15 150 80 
3 5.0 1.0 20 150 69 
4 5.0 1.0 15 170 25 
5 5.0 1.0 15 120 84 
6 5.0 1.0 15 100 52 
 
Table 5 Optimization experiments for the reaction of 1c (R1 = 2-pyridyl) and 2a (R2 =Ph) 
using NEt3 as base, in the presence of PPh3, in THF. 
N
R1 = 
  
R2 =
 
No. 
Equivalents  
of base 
Solvent [mL] Time [min] Temp. [°C] Yield, 4c [%] 
1 5.0 1.0 15 150 78 
2 5.0 1.0 15 150 76 
 
Table 6 Optimization experiments for the reaction of 1d (R1 = p-F3CC6H4-) and 2a (R2 =Ph) 
using NEt3 as base, in the presence of PPh3, in THF. 
F3CR1 = 
  
R2 =
 
No. Equivalents 
of base Solvent [mL] Time [min] Temp. [°C] Yield, 4d [%] 
1 5.0 1.0 15 150 53 
2 5.0 1.0 25 150 47 
3 5.0 1.0 15 170 65 
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Table 7 Optimization experiments for the reaction of 1e (R1 = p-EtO2CC6H4-) and 2a 
(R2 = Ph) using NEt3 as base, in the presence of PPh3, in THF. 
 
EtO2CR1 = 
 
R2 =
 
No. 
Equivalents 
 of base 
Solvent [mL] Time [min] Temp. [°C] Yield, 4e [%] 
1 5.0 1.0 15 150 not complete 
2 5.0 1.0 20 150 49 
3 5.0 1.0 30 150 62 
4 5.0 1.0 45 150 61 
 
For the chalcone formation high temperatures and short reaction times are generally 
more favourable. Good to excellent yields (57–96 %) were obtained in 8–30 minutes (Table 
8). Various substituents, such as sulfonamide, 2 or 3-thienyl substituents, well-known motifs 
in pharmacophor molecules, were inserted into the chalcone template (entries 8–10, Table 8). 
Aryl acetylenes are generally more reactive than alkyl acetylenes, due to the increasing 
acidity of the acetylenic hydrogen.48 In order to increase the MACIR rate for the alkyl 
propargyl alcohols, aryl iodides were used instead of corresponding less reactive aryl 
bromides. However, MACIR using 1-hexyn-3-ol (2d) and p-iodobenzonitrile (1h) furnished 
the corresponding chalcone 4j in a moderate yield, 62 % (entry 11). In the case of 1-butyn-3-
ol (2e) available as 0.5 M aqueous solution, the only isolated product was the unisomerized 
alkyne 3k (entry 13). The exclusive formation of 3k might be explained by the higher stability 
of the alcohol in an aqueous solution. 
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Table 8 MACIR for different electron poor aryl halides 1 and propargyl alcohols 2. 
No. Aryl-hal, 1 
 
Propargyl 
alcohol, 2 
 
Product Base 
Yield, 
Conventional 
cond. 
(~80 °C, 16-
24h) 
Yield, 
MW irra-
diation 
(conditions) 
1 
BrNC
 
1a 
OH
 
2a 
NC
O
 
4a 
NEt3 95 % 
96 % 
(150 °C, 15 
min., 5 eq. 
of base) 
2 1a 2a 4a DBU 80 % 
85 % 
(150 °C, 15 
min., 5 eq. 
of base) 
 
3 
N
N
Br
 
1b 
2a N
N
O
 
4b 
NEt3 91 % 
84 % 
(120 °C, 15 
min., 5 eq 
base) 
4 
N
Br
 
1c 
2a 
N
O
 
4c 
NEt3 79 % 
78 % 
(150 °C, 15 
min, 5 eq. of 
base) 
5 
BrF3C
 
1d 
 
2a F3C
O
 
4d 
NEt3 75 % 
65 % 
(170 °C, 15 
min., 5 eq. 
of base) 
6 
BrEtO2C
 
1e 
2a 
O
EtO2C
 
4e 
NEt3 59% 
62 % 
(150 °C, 30 
min., 5 eq. 
of base) 
7 
BrO2N
 
1f 
2a 
O
O2N
 
4f 
NEt3 82% 63 % 
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Table 8 continued 
8 
BrH2NO2S
 
1g 
2a 
O
H2NO2S
 
4g 
NEt3 31% 62 % 
9 1a 
OH
S
 
2b 
NC
O
S
 
4h 
NEt3 - 87 % 
10 1a 
OH
S
 
2c 
NC
O
S
 
4i 
NEt3 - 70 % 
11 
INC
 
1h 
OH
 
2d 
NC
O
 
4j 
DBU - 62 % 
12 1h 
OH
 
2e 
NC
OH
 
3k 
DBU - 92 % 
 
The remarkably short reaction times for microwave-assisted CIR achieved through these 
optimization studies raised the question of whether the reaction might have been affected by 
any kind of special rate enhancing microwave effect. Such non-thermal effects were discussed 
for a long time in the literature.50 Therefore, the coupling-isomerization reactions were carried 
out at exactly similar conditions using both conventional conductive and dielectric heating. 
The chosen model was the CIR of p-bromobenzonitrile (1a) with 1-phenylprop-2-yn-1-ol 
(2a), which furnished excellent results under microwave irradiation, entry 1 (Table 8). As 
expected, the conventional CIR (method B, Scheme 25) furnished lower yields of the desired 
chalcone, with over 30 %. The significant difference of the isolated yields can be reduced to 
the entirely thermal microwave effect51 as a consequence of more efficient heating, so called 
“molecular heating”. 
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OH
Ph
BrNC
OH
Ph
NC NC
O
Ph
THF/NEt3 (2:1), 15 min
2 % PdCl2(PPh3)2
1 % CuI
20 % PPh3
+
80 °C (oil bath) 65 % 5 %
150 °C (oil bath) 12 % 61 %
microwave, 150 °C 0 % 96 %
+
A
B
C
 
 
Scheme 25 Evidence experiments for MW effects. 
 
In order to scout the scope and the generality of MACIR procedure, also electron rich 
aryl halides, substrates that commonly do not participate in the CIR fashion were examined. 
All reports on CIR sustained the necessity for strong acceptor halides, the main limiting 
condition for the propargyl alcohol-enone isomerization. Thus CIR of electron neutral aryl 
halides stopped after Sonogashira coupling without further isomerization (Scheme 26). 
 
OH
Ph
I
OH
PhTHF, NEt3 ,
(Ph3P)2PdCl2, CuI
+
∆
 
 
Scheme 26 CIR Experiments of an electron neutral aryl halide. 
 
 
As the isomerization is a base-catalyzed process, different type of bases of various pKb 
were tested (Table 9) to find out the optimal conditions for the CIR of electron rich aryl 
halides. The MACIR of iodobenzene 1i and 1-phenylprop-2-yn-1-ol 2a (Scheme 27) was 
chosen as model reaction. 
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+ +
1i 2a 3l 4l
 
 
Scheme 27 MACIR experiments of iodobenzene 1i with 1-phenylprop-2-yn-1-ol 2a. 
 
Table 9 MACIR experiments using different type of bases. 
Entry 
Base 
Solvent THF (1.5 mL) 
Conditions 
Coupling Product 
(3m) 
Chalcone (4l) 
1 
NEt3 (5 eq) 
pKb ~ 3.35 
microwave, 
100 °C, 30 min 
0 % 35 % 
2 NEt3 (5 eq) 
microwave, 
120 °C, 20 min 
30 % 0 % 
3 
piperidine (5 eq) 
pKb ~ 3.2 
microwave, 100 °C, 
30 min 
80 % 0 % 
4 piperidine (5 eq) 
microwave, 150 °C, 
30 min 
9 % 0% 
5 
DBU (1.05 eq) 
pKb ~ 1.1 
microwave, 100 °C, 
60 min 
70 % 8 % 
6 DBU (2 eq) 
microwave, 100 °C, 
30 min 
0 % 92 % 
7 DBU 
100 °C (oil bath), 30 
min 
0 % 71 % 
 
Using triethylamine (pKb ~3.35) the isolated yields were poor both for the coupling 
product 3l and the coupling-isomerization product 4l (entry 1 and 2). In case of piperidine 
(pKb ~3.2), a slightly stronger base than triethylamine, the coupling product 3l is formed at 
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100 °C in higher yields (80 %, entry 3). At higher temperature, the chalcone can undergo 
either a conjugate addition or a Mannich reaction and consequently only 9 % of the coupling 
product 3l and 0 % of the chalcone 4l were obtained, entry 4 (Table 9). Using only 1.05 eq. 
DBU, as much stronger organic base (pKb ~1.1), the reaction furnished 70 % of 3l and 8 % of 
chalcone 4l (entry 5). This promising result encouraged me to investigate the CIR using 
higher amount of DBU. As expected, higher yields were obtained using 2 eq. of DBU, the 
coupling product was completely isomerized to the corresponding chalcone 4l (30 min, at 
100 °C, 92 %, entry 6). For the same parameters, but under conventional heating condition, 
the reaction furnished only 71 % of chalcone 4l (entry 7).  The large difference of the isolated 
yields, over 20 %, can be accounted for microwave effects, since all other parameters had the 
same values in both cases. 
The conditions for the productive CIR of p-iodobenzene under microwave irradiation 
were applied to further substrates. The electron rich p-iodotoluene and the even more electron 
rich p-iodoanisol and 3-iodoaniline were successfully subjected to MACIR, although to 
complete the isomerization, slightly higher temperatures were needed, 120 °C (entries 2, 5, 8, 
Table 10). 
In summary, a new, general, rapid and efficient microwave-assisted Sonogashira 
coupling-isomerization reaction (MACIR) was developed. It was applied to the coupling of 
various electron poor and electron rich (hetero)aryl halides,  with propargyl-aryl(alkyl) 
alcohols using a reduced amount of  base (1.05−5 eq). Good to excellent yields (52–96 %) 
were obtained within a few minutes (8−30 min.). The generality and the efficiency of this 
method were also proven by new CIR examples of electron rich aryl halides that gave 
excellent results (73−92 %), as compared to conventional literature conditions, when no 
product formation was detected. 
 
 
 
 
 
 
 
 
 
 
4 General Part – Results and Discussion  41 
Table 10 MACIR experiments with electron rich electron aryl halides. 
Entry 
Aryl halide 
(1) 
Base 
Conditions (Solvent 
THF, 1.5 mL) 
Coupling Product 
(3) 
Chalcone (4) 
1 
I
 
1j 
DBU  
(2 eq) 
microwave, 
100 °C, 30 min 
OH
 
3m, 46 % 
O
 
4m, 46 % 
2 1j 
DBU  
(2 eq) 
microwave, 
120 °C, 20 min 
3m, 0 % 4m, 92 % 
3 1j 
DBU 
(2 eq) 
microwave 
100 °C, 30 min 
3m, 0 % 4m, 70 % 
4 
IO
 
1k 
DBU 
(2 eq) 
microwave, 
100 °C, 30 min 
OH
O
3n, 44 % 
O
O
4n, 46 % 
5 1k 
DBU 
(2 eq) 
microwave, 
120 °C, 30 min 
3n, 0 % 4n, 85 % 
6 1k 
DBU 
(2 eq) 
Conventional heating, 
120°C, 30 min. 
3n, 0 % 4n, 60% 
7 
I
NH2
 
1l 
DBU 
(2 eq) 
microwave, 
100 °C, 60 min 
OH
NH2
 
3o, 40 % 
ONH2
 
4o, 44 % 
8 1l 
DBU 
(2 eq) 
Microwave, 
120 °C, 30 min 
3o, 0 % 4o, 73 % 
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Spectroscopic Data 
 
Most characteristically in 1H NMR, and as an indication for the successful CIR, are the 
resonances of the (E)-olefinic protons of the chalcones. They appear as doublets, in the range 
of δ 7.05–7.92, with large trans coupling constants J = 15.5–18.9 Hz. In some cases, (4a and 
4e) variable mixtures of Z/E-configurated chalcones (up to 1:4) could be observed, wherein 
the lower coupling constants, J = 12.5–12.8 Hz, were assigned to the Z-configurated 
chalcones. Due to the electron withdrawal effect of the ring B (Fig. 4) in the chalcones 4a−j 
or the electron donating effect of the ring B in the chalcones 4l−o, the signals of the olefinic 
protons are accordingly shifted to lower fields (up to δ 7.92 in the case of chalcone 4f) or to 
higher fields respectively (up to δ  7.05 in the case of chalcone 4n). However, the conjugation 
through the chalcone shifts the signals of the olefinic protons from the usual values to lower 
field. The aromatic protons display typical chemical shifts in the range of δ 6.70–8.77. The 
lowest field, δ 8.77, was found for the pyrimidine protons of chalcone 4b, and the most 
upfield shift for the protons ortho positioned to the methoxy group of chalcone 4n, δ 6.70. 
The signals of the ethoxy protons of chalcone 4e are detected as a triplet at δ 1.41 and a 
quartet at δ  4.39 with a coupling constant of 6.9 Hz.  
13C NMR resonances appear for α,β-unsaturated ketones between  δ 188.4 and 190.7, 
where the signals at lower field, δ 190.7, are for 4m and 4o. The carbon nucleus of the ester 
group in 4e resonates, as expected, at higher field, δ 165.7. 
The carbon nuclei of the nitrile groups for 4a, 4h, 4i and 4j resonate in the range 
of δ  118.3−122.1. The other signals for the aromatic carbon nuclei are detected between δ 
112.9−166.3.  
The mass spectra of all the obtained compounds display the molecular peaks. The 
fragmentation mode leads to the loss of the NH2, CH3, OCH3 and OC2H5 groups for the 
chalcones 4e, 4g, 4m, 4n and 4o respectively.  
For all chalcones, α-fragmentation at the carbonyl group, a characteristic feature of 
ketones, could be examined. The C-C bonds are lightly to break on both sites leading to the 
typical fragments (Table 11). 
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Table 11  The Fragmentation of selected chalcones 4 (EI, 70 eV) 
Compound Fragment m/z 
(%) 
Fragment m/z 
(%) 
4a 
O+
NC
 
156 (33) O+
 
105 (38) 
4c 
N
O+
 
132 (42) O+
 
105 (8) 
4h 
O+
NC
 
156 (40) 
S O+
 
111 (100) 
4j 
O+
NC
 
156 (39) O
+
 
71 (11) 
4l 
O+
 
131 (45) O+
 
105 (28) 
 
The α-fragments lose the CO group (M+ - 28) leading to the corresponding peaks of 
significantly lower intensity, however still detectable.  
The stretching vibrations of carbonyl groups for α,β-unsaturated ketones  4 give rise to a 
strong and distinctive IR absorbtion in the range of 1675−1656 cm-1. Another characteristic 
band at 2223−2230 cm-1 can be assigned to the nitrile groups, even if the vibration is slightly 
downshifted due to the conjugation with the aromatic ring. 
In addition, the absorptions of highly polarized double bonds in the IR spectra of α,β-
unsaturated ketones, 4 are detected at 1589−1568 cm-1.  
Moreover, the structure of 4b is unambiguously supported by an X-ray analysis (Fig. 7).  
The chalcone structure is almost planar, with a dihedral angle of 16.39 ° between the aromatic 
rings. The dihedral angle of the α,β-unsaturated ketone moiety is 5.19 °. 
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Fig. 7 ORTEP plot of compound 4b. 
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4.2 [3+2+1] Pyridine Derivatives Synthesis Based upon CIR 
 
4.2.1 Pyridines – Literature Review 
 
Among six membered aromatic heterocycles the pyridyl core52 adopts a central role. In 
nature, pyridine is the constituting structural unit in the coenzyme vitamin B6 family 
(pyridoxal, pyridoxol, pyridoxamine) and an important subunit in numerous alkaloids53 (Fig. 
8). 
 
N
CONH2
N
CH2OH
CH2OHOH
Me
N
O NHNH2
N N
H
SO2
      niacin
(nicotinamide) pyridoxine (vitamin B6)
          isoniazide
(antituberculosis agent)
    sulfapyridine
(antibacterial agent)
 
 
Fig. 8 Naturally occurring pyridine derivatives. 
 
Many relatively simple 3-alkylpyridines alkaloids extracted from marine organisms 
have already been used or tested for their biological activity. For example, the antileukemic 
and antineoplastic theonelladins C and D were isolated from Okinawan marine sponge 
theonella swinhoei.54 The antileukemic niphatesines C and D and the cytotoxic and 
antimicrobial niphatesine G have been obtained from the Okinawan marine sponge niphates 
sp.55 The cytotoxic ikimines A-C have been isolated from a Micronesian sponge.56 The 
antimicrobial xestamine C comes from a Caribbean sponge xestospongia wiedenmayeri, 
whilethe antimicrobial xestamines D-H have been extracted from a Bahamian sponge calyx 
podatypa57 (Fig. 9). 
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N
R1
Y
R2 R3
R4
X
( )
n
 
 R1 R2 R3 R4 n X, Y 
theonelladin C - H H H 9 H, NH2 
theonelladin D - H H H 9 H, NHMe 
niphatesine C - H H Me 8 H, NH2 
niphatesine D - H Me H 8 H, NH2 
niphatesine G - H H Me 9 =NOMe 
ikimine A - H H Me 8 =NOMe 
ikimine B - H Me H 8 =NOMe 
ikimine C - H H H 9 H, NHOMe 
xestamine C - Me H H 10 H, NMe(Ome) 
xestamine D - H H H 10 H, NMe(Ome) 
xestamine E - H H H 11 H, NMe(Ome) 
xestamine G Me+ H H H 10 H, NMe(Ome) 
xestamine H Me+ H H H 11 H, NMe(Ome) 
 
Fig. 9 Some naturally occuring pyridine alkaloids 
 
In pharmaceutical chemistry, also highly substituted58 and annealed59 pyridines, like 6,7-
dihydro-5H-[1]pyrindines and 5,6,7,8-tetrahydroquinolines, have recently gained considerable 
interest as antiarteriosclerotics since they efficiently inhibit HMG-CoA reductase and 
cholesterol transport proteins. Besides, the classes of pyrindine, tetrahydroquinoline and 
naphthyridine derivatives additionally display antimycobacterial,60 fungicidal and 
bactericidal,61 antiulcer,62 antivertigo,63 antiviral,64 and anti-inflammatory activities.65  
The pyridines also find broad applications as versatile building blocks in the syntheses 
of natural products and as ligands in supramolecular coordination chemistry. In the past few 
decades luminescent metal complexes based on polypyridine ligands, have already been used 
in various fields such as solar energy conversion,66 information storage,67 photocleavage of 
DNA,68 and oxygen sensors69 due to to their long-lived metal-to-ligand charge-transfer 
(MLCT) excited states. 
Although many methods have been reported for the synthesis of the pyridine 
heterocyles, due to their great importance, the development of novel and efficient synthetic 
methods remains an active research area.  
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A literature overview reveals the large number of preparation approaches proposed for 
ring-pyridine construction that include (a)  [5+1] type ring annulations from a nitrogen 
derivative and a five-carbon fragment, usually a 1,5-diketone,70 (b)  [2+2+2] type reactions of 
substituted acetylenes and nitriles, (c) [3+3] cyclizations of chalcones and 
iminophosphoranes,71 Bohlmann-Rathtz pyridine synthesis from β-amino-crotonates and 
alkynones and cyclocondensation of 1,3-diketones with enaminones,72 (d) [4+2] reactions of 
unsaturated imines with enolates and intramolecular 6pi-electrocyclization of  aza-unsaturated 
compounds,73 (e) [3+2+1] reaction of α-benzotriazolyl ketones with α,β-unsaturated 
ketones,74 (f) [2+2+1+1] Hantzsch dihydropyridine synthesis followed by subsequent 
oxidation. Besides the condensation and cycloaddition approaches, there are exceptions, such 
as ring expansion from 5-membered rings, but these methods are generally low-yielding and 
narrow in applicability. 
A straightforward protocol is the transition metal mediated cycloaddition of alkynes and 
nitriles, method (b). Although a variety of stoichiometric methods have been described,75 
catalytic systems are restricted to Fe, Rh, Co, Ni and Ru complexes.76 Both Fe and Rh 
systems need elevated temperatures and afford more arene byproducts than the desired 
pyridine.77 Cobalt catalyzed methods are versatile, but suffer from a main drawback: except 
for symmetrical alkynes or reaction yielding fused pyridines, regioisomers are produced 
(Scheme 28). 
 
NR1 X
R1
NR1
R1
X
NR1 X
R1
NR1
R1
X NR
1
R2
XNR2
R1
X
NR1 X
R2
NR2 X
R1
R1
R2
N X
CoI catalyst
4 homopyridines 4 heteropyridines
 
 
Scheme 28 Two different terminal alkynes react with one nitrile to afford eight different 
pyridines. 
 
For symmetrical alkynes, the substitution pattern is limited to either the 2,4,6- or the 
2,5,6-trisubstituted pyridines78 (Scheme 29). 
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∆
+
 
 
Scheme 29 Addition of a nitrile to three possible cobaltacyclopentadienes furnishing only 
2,4,6- and 2,5,6-pyridine isomers. 
 
In general, milder conditions are employed with Ru catalysts. Nevertheless, substrates 
are currently limited to activated nitriles (e.g., cyanides).79 Complete regioselectivity was 
observed using a Ni catalyst for both intramolecular (Scheme 30) and intermolecular 
reactions,76c although the substitution pattern is also limited. 
 
E
E
N
Me
N
Me
E
ETMS
5 mol% Ni(COD)2
60 °C, 30 min
      58%
TMS
+
 
 
Scheme 30 Nickel catalyzed cycloaddition of alkynes and nitrile. 
 
Among [3+3] approaches (method c) one of the most important is Bohlmann-Rahtz 
synthesis (Scheme 31). 
 
R2O2C
R1 NH2 O R3
R2O2C
R1
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O
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R2O2C
R1 R3
+
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50 °C
120-160 °C
 
 
 
Scheme 31 Bohlmann-Rahtz synthesis 
 
Elevated temperatures in the dehydration step can be avoided by performing the 
condensation under acidic conditions (Scheme 32). However, poor yields were obtained for 
aromatic substituents, R4.80 
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Scheme 32 Improved conditions for Bohlmann-Rahtz pyridine synthesis. 
 
The Bohlmann-Rahtz procedure served as key step in the synthesis of the thiopeptide 
promothiocin A, an antibiotic,81 and for dimethyl sulfocinamate, an important synthon for 
sulfomycin antibiotics.82 
The most straightforward [4+2] cycloaddtion approach to pyridines (method d) involves 
a Diels-Alder reaction of 1-azadienes with alkene or alkyne followed by subsequent 
oxidation. However, this route is rarely used, as the Diels-Alder reaction is disfavoured on 
electronic, conformational and thermodynamic grounds. A method modification consists in 
the introduction of an electron donating group on nitrogen, which is subsequently eliminated 
(Scheme 33). 
 
Me
N
NMe2
CO2MeMeO2C
N CO2Me
CO2MeMe
neat, 50 °C, ultrasound, 50h;
 CHCl3, reflux, 2h, air, 60 %
 
 
 
Scheme 33 Diels-Alder reaction of 1-azadiene. 
 
This methodology was used by Boger in his approach to the rubrolone aglycon, an 
alkaloid isolated from streptomyces enchinoruber, by an intramolcular hetero-Diels-Alder 
cycloaddition83 (Scheme 34). 
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Scheme 34 Key-step in rubrolone synthesis. 
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Due to the intransigence of 1-azadienes [4+2] cycloadditions, the use of a variety of 
heterocyclic azadiene in an inverse demand Diels-Alder reaction, followed by either the 
extrusion of  a part of the resulting bicycle in a retro-[4+2] reaction or the scission of the 
resulting bridge, has become a favoured method for constructing pyridine rings.84 Despite of 
the use of a large excess of electron rich dienophile, the yields are moderate. 
Using  [3+2+1] type of reaction (method e) Katritzky et al. have recently reported the 
reaction of  α,β-unsaturated ketones and α-benzotriazolyl ketones that furnish the 
2,4,6 trisubstituted pyridines in quite good yields, but the synthesis of  α-benzotriazolyl 
ketones decreases the overall yields of this procedure.85 
The most important [2+2+1+1] approach (method f) is the classical Hantzsch 
multicomponent dihydropyridine synthesis followed by oxidation. This route suffers of 
several limitations with respect of substitution patterns. The products incorporate acyl or 
carbonyl groups in the 3 and 5-positions. 
Among the numerous synthetic approaches to highly substituted pyridines, the novel 
multicomponent strategies, comparable to the powerful, classical Hantzsch dihydropyridine 
synthesis,86 remain particularly challenging. 
 
4.2.2 One-Pot Four-Component CIR-Enamine Addition-Cyclocondensation Pyridine 
Synthesis 
 
Facile accesses to unsymmetrical pyridines by cocondensation of Michael acceptors 
with enols, enamines or stabilized ylids and ammonia87 represent an intriguing starting point 
for the development of a novel multicomponent reaction, in particular, with respect to the 
generation of combinatorial libraries. From this point of view, a four-component reaction is 
most attractive, as it allows, by individual variations of the components, to generate large 
diversity of products. 
In previous chapters it was shown that CIR is the most elegant and atom-economic way 
of transforming aryl halides into chalcones, highly reactive Michael acceptors, that readily 
react with all kinds of mono- and bidentate nucleophiles. Therefore, chalcones have directly 
been subjected, in a one-pot fashion, to the reaction with enamines and ammonium chloride 
providing access to substituted and annelated pyridines. 
 Hence, a novel four-component pyridine synthesis based upon a CIR, followed by a 
consecutive enamine cycloaddition and a concluding cyclocondensation with ammonium 
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chloride was developed. The retrosynthetic scheme for the pyridine synthesis via a coupling-
isomerization sequence provides aryl bromides, propargyl alcohols and ammonium chloride 
as  readily available starting materials (Scheme 35). 
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     [4+2]
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Scheme 35 Retrosynthetic concept of consecutive one-pot four-component pyridine synthesis. 
 
Product analysis suggests that the intermediate is either a keto enamine or a 
cycloadduct, as a consequence of a Michael addition or a Diels-Alder reaction with inverse 
electron demand88 between an enamine and a chalcone. The aqueous work-up of the 
intermediate does not help in the structure elucidation of the intermediate, since the hydrolysis 
product in both cases is a 1,5-diketone (Scheme 36). 
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Scheme 36 Hydrolitic formation of 1,5-diketones. 
 
Therefore, in order to elucidate the reaction pathway, according to Katritzky,89 after CIR 
of 1a and 2a furnishing the chalcone 4a, and after subsequent addition of enamine 5c 
followed by reaction at room temperature for 72 h, suitable single crystals of the cycloadduct 
6 were isolated by careful crystallization of the crude product from petroleum ether (Scheme 
37, Fig. 10). 
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6
 
 
Scheme 37 Coupling-isomerization-cycloaddition sequence. 
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Fig. 10 ORTEP plot of cycloadduct 6 
 
The proton NMR spectrum of the isolated product shows the appearance of a signal at δ 
5.25 and unambiguously indicates the formation of a vinyl ether that can be attributed to a 
cycloadduct. Formally, the formation of the endo-product 6 is the result of a concerted or 
stepwise [4+2] cycloaddition. The intermediacy of 6 in the CI-enamine addition reaction is 
also in full agreement with the observed stereochemistry in the diketone, which can be 
considered to be the hydrolysis product of the cyclic aminal 6. 
Molecular modeling of alternative reaction pathways (Fig. 11), i.e. concerted and 
stepwise [4+2] cycloaddition and ene reaction, respectively, was performed on the PM3 level 
of theory,90 both in gas phase and water.91 The results of the computations reveal that, 
although the heat of formation of the ene product, i.e. the enamino ketone 7, is 
thermodynamically slightly favoured over the cycloadduct 6, under kinetic control a stepwise 
[4+2] cycloaddition occurs most likely. In particular, in polar solvents the formation of the 
dipolar iminium enolate 8 as an intermediate in the rate determining step most likely 
concludes to the 1,6-dipolar cyclization of the zwitter ion 8 to give the experimentally 
observed reaction product 6. 
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Fig. 11 Calculated PM3 energies [kcalmol-1] of the addition of an enamine to a chalcone in 
solution and in the gas phase (in parentheses). Imaginary frequencies that verify transition 
states: [a]i473.2 cm-1, [b]i735.1 cm-1, [c]i100.9 cm-1, [d]i947.2 cm-1, [e]i487.4 cm-1. 
 
After the coupling-isomerization reaction and the subsequent enamine cycloaddition, the 
final step of this new one-pot four-component reaction begins with the protonation of the 
cycloadduct with acetic acid to give a reactive electrophilic iminium ion that now initiates the 
concluding cyclocondensation step with ammonium chloride or benzyl amine.  
 
Thus, applying electron poor (hetero)aryl halides 1 and aryl propynols 2 to the 
conditions of the CIR, and after complete conversion to the corresponding chalcones, adding 
(hetero)cyclic and a cyclic morpholino enamines 5 to the reaction mixture and, finally, adding 
ammonium chloride 9 in the presence of acetic acid tetrahydro-[1,6]naphthyridines 10a-d, 
pyrindines 10e-h, tetrahydroquinolines 10i-k, tri(hetero)aryl pyridines 10l-o were formed in 
moderate to good yields as colourless crystals (Scheme 38, Table 12). 
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Scheme 38 Four-component synthesis of annealed and substituted pyridines 10 based upon a 
CIR-enamine addition-cyclocondensation sequence. 
 
Conformationally fixed enamines like N-morpholino cyclopentene, cyclohexene or 
tetrahydropyridine, or enamines of acetophenone derivatives smoothly react in the enamine 
addition step, and finally lead to the formation of annealed or substituted pyridines (Table 12). 
Acyclic disubstituted enamines rather give a mixture of products and were, therefore, not 
considered for further investigation. 
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Table 12 One-pot synthesis of annealed and substituted pyridines 10. 
Entry Aryl halide 
1 
Propargyl 
alcohol 2 
Enamine 5 Pyridines 10 (Yield) 
1[a,b] Ar1 = p-C6H4CN 
(1a) 
Ar2 = Ph 
(2a) 
R1, R2 = 
(CH2)2N(CO2Et)CH2, 
(5a) 
N
CN
NEtO2C
 
10a (61 %)  
 
2[a,b] Ar1 = 
2-pyrimidyl (1b) 
2a 5a 
NN
N
N
EtO2C
 
10b (57 %)  
 
3[a,b] Ar1 = 2-pyridyl 
(1c) 
2a 5a 
N
N
N
EtO2C
 
10c (41 %) 
 
4[a,b] Ar1 = p-C6H4CF3 
(1d) 
2a 5a 
N
CF3
N
EtO2C
 
10d (58 %)  
 
5[b,c] 1b 2a R1, R2 =(CH2)3 (5b) 
N
NN
 
10e (59 %) 
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Table 12 continued 
6[b,c] 1c 2a 5b 
N
N
 
10f (62 %) 
 
7[c,d] 1d 2a 5b 
N
CF3
 
10g (54 %)  
 
8[b,c] Ar1 = 
p-C6H4CO2Et 
(1e) 
2a 5b 
N
CO2Et
 
10h (42 %) 
 
9[a] 1a 2a R1,R2 = (CH2)4 (5c) 
N
CN
 
10i (70 %) 
 
10[b,c] 1b 2a 5c 
N
NN
 
10j (50 %) 
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Table 12 continued  
11[c,d] 1c 2a 5c 
N
N
 
10k (64 %) 
 
12[a,b] 1a 2a R1 = p-C6H4OMe, R2 = 
H (5d) 
N
CN
MeO
 
10l (54 %) 
 
13[a,b] 1a 2a R1 = 2-thienyl, R2 = H 
(5e) 
N
CN
S
 
10m (46 %) 
 
14[b,c] 1b 2a R1 = Ph, R2 = H (5f) 
NN
N
 
10n (68 %) 
 
15[a,b] 1b 2a 5d 
NN
N
MeO
 
10o (39 %)  
 
[a]Reaction time of the CIR 16 h. [b]In NEt3. [c]Reaction time of the CIR 12 h. [d]In HNEt2. 
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Spectroscopic Data 
 
The structure of the pyridine derivatives 10 is unambiguously supported by the expected 
appearance of the characteristic proton and carbon resonances and multiplicities. In particular, 
in the 1H NMR spectra of 10 the diagnostic singlets for the pyridine methine signals, 
appearing between δ 7.5 and 8.5, are applied for the assignments of the ortho phenyl or 
phenylene doublets by 2D NOESY spectra, indicating clear cross-peaks as a consequence of 
spatial proximity. Likewise, the structure of naphthyridines 10a−d can be established by 
thorough inspection of 2D NOESY correlations between the methylene groups in the 
saturated ring appearing as singlets at δ 4.5−4.9 and the proximal methine resonances steming 
from the electron poor (hetero)aryl substituent. The signals for the ethyl protons for 10a−d are 
detected as a multiplet in the range of δ 1.18–1.26, with an intensity of 3 protons and a quartet 
in the range of δ 4.05–4.12, with coupling constants of J 7.0–7.1 Hz.  
Characteristically for the dihydropyrindines 10e−h are the downfieldshifted signals of 
the methylene protons that appear as triplets in the range of δ 3.01−3.38, with coupling 
constants of J 7.3−7.8 Hz. Similarly, the methylene protons of the tetrahydronaphthyridines 
10i−k, are detected as triplets, in the range of δ 2.59−3.11, with coupling constants of 
6.4−6.6 Hz.  
The mass spectra of all obtained compounds show the molecular peaks. The usual 
fragmentation mode for all pyridine derivatives leads to the loss of phenyl fragments. For 
10a−d the loss of ethyl and carboethoxy groups were detected. 
The vibrations of CN group in 10a, 10i and 10l were identified at 2224−2227 cm-1 in 
the IR spectra.  
Furthermore, the structures of pyrindines, tetrahydroquinolines, and naphthyridines 10 
were corroborated by X-ray crystal structure analyses of compounds 10a, 10f, 10g, 10j, 10k 
and 10n (Fig. 12−Fig. 17). 
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Fig. 12 ORTEP plot of compound 10a. 
 
 
 
 
Fig. 13 ORTEP plot of compound 10f. 
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Fig. 14 ORTEP plot of compound 10g. 
 
 
 
Fig. 15 ORTEP plot of compound 10j. 
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Fig. 16 ORTEP plot of compound 10k. 
 
 
 
Fig. 17 ORTEP plot of compound 10n. 
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4.3  [3+3] Dihydropyridine and Pyridine Syntheses Based upon CIR  
 
4.3.1 Dihydropyridines – Literature Review 
 
 
First mentioned by Hantzsch92 almost one century ago, dialkyl 1,4-dihydro-2,6-
dimethylpyridine-3,5-dicarboxylates (1,4-DHP) have now been recognized as vital drugs in 
the treatment of angina and hypertension. Some of them (amlodipine, felodipine, isradipine, 
lacidipine, nicardipine, nifedipine, Fig. 18) have been commercialized and it has been proven 
that their therapeutic success is related to their efficacy to bind to calcium channels, and 
consequently to decrease the passage of the transmembrane calcium current, associated in 
smooth muscle with a long lasting relaxation and in cardiac muscles with a reduction of 
contractility throughout the heart.93 
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Fig. 18 Calcium channel blocker pyridines. 
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The usefulness of the calcium antagonists has led to the development of novel synthetic 
strategies94 to improve the classical Hantzsch dihydropyridine synthesis, (Scheme 39) and 
microwave activation stands among the alternative routes proposed the past decade.95  
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Scheme 39 Hantzsch Synthesis. 
 
 
Recently, Santander et al.96 reported a modified Hantzsch 1,4-dihydropyridines 
synthesis, starting with the condensation of nitrobenzaldehyde with α,β-ketoesters and 
subsequent cyclocondensation with alkyl 3-amino crotonates (Scheme 40). 
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Scheme 40 Modified Hantzsch dihydropyridine synthesis. 
 
Aromatization of 1,4-DHP has also attracted considerable attention in recent years as 
Böcker97 has demonstrated that metabolism of those drugs involves a cytochrome P-450 
catalyzed oxidation in the liver. The so-obtained pyridines are devoid of the pharmacological 
activity of the parent heterocycles and are further transformed by additional chemical 
modifications. Due to the biological importance of the oxidation step of 1,4-DHP, the reaction 
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has been the subject of a large number of studies and a plethora of reagents has been utilized 
to mimic the in vivo transformation.98  
Jacobson et al.99 showed that both the dihydropyridine and the corresponding pyridine 
derivatives are good antagonist for A3 adenosine receptor and, therefore, potential 
antiinflamatory, antihismatic and antiischemic agents. They also found defined common 
pharmacophore elements for pyridine and dihydropyridine structures, e.g., ester group and 6-
phenyl group using molecular modelling based on the steric and electrostatic alignment 
(SEAL) method. Moreover, a relationship between affinity and hydrophobicity was examined 
for the pyridines. 
 
4.3.2 One-Pot Three-Component CIR-Enamine Addition-Cyclocondensation 
Dihydropyridine and Pyridine Syntheses 
 
The great importance of 1,4-dihydropyridines and their corresponding pyridine 
derivatives prompted us to develop a new one-pot, three-components synthesis, using 
coupling-isomerization, enamine addition, cyclocondensation sequence, in one-pot fashion. 
Thus, upon performing the CIR with the aryl halides 1 and the propargyl alcohol 2a followed 
by the addition of ethyl 3-amino crotonate 11 as a suitable enamine in the presence of acetic 
acid and under nitrogen, in a few cases the expected dihydropyridines 12 could be isolated 
(Scheme 41).  
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Scheme 41 Three-component synthesis of functionalized dihydropyridines 12 and pyridines 
13 based upon a CIR-enamine addition-cyclocondensation sequence. 
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Table 13 One-pot synthesis of dihydropyridines 13 and pyridines 14. 
Entry Aryl halide 
1 
Propargyl 
alcohol 2 
Enamine 11 Dihydropyridines 12 / Pyridines 
13 (Yield) 
1[a] Ar1 = p-
C6H4CN (1a) 
Ar2 = Ph 
(2a) 
 
NH2 O
OEt
 
11 
N
CN
EtO2C
 
 12a (45 %)  
2[a] Ar1 = p-
C6H4CF3 (1c) 
2a 11 
N
CF3
EtO2C
 
12b (37 %) 
3[b] Ar1 = p-
C6H4CN (1a) 
2a 11  
N
CN
EtO2C
 
13a (40 %) 
4[a] Ar1 = 2-
pyrimidyl 
(1b) 
2a 11  
NN
N
EtO2C
 
13b (50 %) 
5[a] Ar1 = 2-
thiazolyl (1a) 
2a 11   
N
EtO2C
S
 
13c (26 %) 
6[a] Ar1 = 2-
pyridyl 
(1c) 
2a 11  
N
N
EtO2C
 
13d (26 %) 
[a]All reaction steps were performed under nitrogen. [b]After CIR the reaction was performed under air. 
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However, either under aerobic (compound 13a) or anaerobic conditions in most cases 
the aromatization readily furnishes the ethyl nicotinoate derivatives 13 in moderate yields.  
 
Again, in this three-component pyridine synthesis as before in the four-component 
sequence, the oxidative aromatization of the actual dihydropyridine intermediate readily 
occurs under the reaction conditions assisted by the presence of the palladium and copper 
species that obviously catalyze this final step in the sequence. A moderate substituent effect in 
this dehydrogenating aromatization can be attributed to the fact that only for slightly weaker 
acceptors such as cyano and trifluoromethyl groups give rise to the isolation of the 
dihydropyridine intermediate. Although, the three-component pyridine synthesis opens an 
entry to further functionalized pyridines such as ethyl nicotinoate derivatives 13, the yields of 
the four-component sequence are consistently higher. 
 
 
Spectroscopic data 
 
The formation of the dihydropyridines 12 and pyridines 13 is unequivocally supported 
by the appearance of the characteristic methine proton resonances in the 1H NMR spectra as 
multiplets at δ 5.0 for dihydropyridines 12 and as singlets between δ 7.5 and 8.5 for ethyl 
nicotinoate derivatives 13. The ethyl proton resonances for all dihydropyridines 12 and 
pyridines 13, are detected as triplets in the range of δ 1.01−1.27 with a coupling constant of J 
7.0 Hz, and quintets in the range of δ 3.86−4.36 with a coupling constant of J 7.0 Hz. The 
methyl protons of all dihydropyridine and pyridine derivatives resonate in the range of 
δ 2.3−2.90, as singlets. 
The mass spectra of all obtained compounds show the molecular peaks. The usual 
fragmentation mode for all dihydropyridines and pyridines leads to the loss of ethyl and 
carboxyethyl fragments.  
Besides the mass spectrometric, IR spectroscopic, and combustion analytical data are in 
agreement with the suggested molecular structure of the dihydropyridines 12 and ethyl 
nicotinoate derivatives 13. Additionally, the structures of the nicotinoates 13 were 
corroborated by X-ray crystal structure analyses of compounds 13a, 13b, and 13c (Fig. 
19−Fig. 21). 
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Fig. 19 ORTEP plot of compound 13a. 
 
 
 
 
Fig. 20 ORTEP plot of compound 13b. 
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Fig. 21 ORTEP plot of compound 13c. 
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4.4  [4+2] 2-Ethoxy Pyridine Synthesis Based upon CIR  
 
4.4.1 Synthesis of N-Propargyl Tosyl Amides 
 
The azomethine 16 were synthesized according to the standard literature procedure,100 from 
the corresponding aromatic aldehydes, 14, and tosylamine, 17 (Scheme 42). The acid 
catalyzed reaction is performed in toluene using the Dean-Stark water-trap. 
 
 
Scheme 42 Synthesis of azomethine 16. 
 
The azomethines 16 were reacted with ethynylmagmesium bromide, 17, according to 
Brandsma,101 to furnish the desired propargyl tosylamine 18 in excellent yields (Scheme 43). 
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Scheme 43 Synthesis of N-propargyl tosyl amide 18. 
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4.4.2 Enimine Synthesis Based upon CIR 
 
Recently we have reported an extension of the CIR to N-propargyl tosyl amide 
substrates that opens a new and efficient access to N-tosyl-enimines (Scheme 44). 102 
 
Ar1 Hal
NH
(Het)Aryl
Tos N
Ar1 (Het)Aryl
Tos
+
2 % PdCl2(PPh3)2, 1 % CuI
THF/NEt3 ∆
1 18 19
 
Scheme 44 CIR access to N-tosyl enimines 19 from propargyl N-tosyl amides 18. 
 
 
Although the electron deficient 1-azadienes do not easily participate in [4+2] 
cycloadditions, N-tosyl-enimines are more suitable for Diels-Alder reactions with inverse 
electron demand due to the tosyl group with an excellent leaving group propensity. Therefore, 
their increased reactivity towards cycloadditions, with the formation of new heterocycle 
derivatives, motivated us to synthesize a series of new N-tosyl-enimines with a diversified 
substitution pattern. 
Thus, electron deficient aromatic and heteroaromatic halides 1 and N-[1-(hetero)aryl-
prop-2-ynyl] tosyl amides 18 were submitted to the reaction conditions of the CIR in a boiling 
mixture of triethylamine and THF to give after trituration of the crude products in ethanol the  
N-tosyl enimines 19a-e in excellent yields (Table 14). However, it should be mentioned that, 
due to the hydrolytic sensitivity of enamine functionality, column chromatography often led 
to the isolation of the corresponding chalcones. Therefore, purification of the crude enimines 
is most efficiently achieved by recristallization from ethanol, or ethyl acetate/hexane 
mixtures.  
 
 
 
 
 
 
 
 
4 General Part – Results and Discussion  72 
Table 14 CIR synthesis of enimines 19a−e. 
No. (Hetero)Aryl1-Hal, 1 N-Propargyl tosyl amide, 19 N-tosyl enimines 20 Yield 
1 
BrNC
 
1a 
N
H
Tos
O
 
18a 
NC
N Tos
O
 
19a 
96 % 
 
2 
N
N
Br
 
1b 
18a N
N
N Tos
O
 
19b 
~100 % 
3 
N
Br
 
1c 
18a 
N
N Tos
O
 
19c 
~100 % 
4 
BrF3C
 
1d 
18a 
F3C
N Tos
O
 
19d 
~ 100 % 
5 1a 
N
H
Tos
O
 
18b 
N Tos
O
NC
 
19e 
94 % 
 
 
 
 
 
 
 
 
 
4 General Part – Results and Discussion  73 
4.4.3 One-Pot Three-Component CIR-Ketene Acetal-Cycloaddition Syntheses  of 
2-Ethoxy Pyridines  
 
The aza Diels-Alder reaction has become an important synthetic route to pyridines and 
several recent reviews discuss the scope and limitation of this versatile methodology.103  
The electron rich 1-azabutadienes are well known to undergo facile HOMO-diene 
controlled [4+2] cycloadditions,104 but the 4pi-participation of the electron deficient 
1-azadiene is reported105 to suffer from low conversion, competitive [2+2] addition, and low 
reactivity due to an unfavorable s-cis/s-trans equilibrium, tautomerism of γ-alkyl substituted 
1-azadienes to enamines precluding [4+2] addition and instability of endocyclic enamine 
products. In the last decade some successful methods have been proposed for the 
4pi-participation of electron deficient 1-azabutadienes in LUMO-diene controlled hetero-
Diels-Alder reactions, among these the use of N-sulfonyl84b-d substituents is particularly 
notable, although the aromatization of the corresponding cycloadducts, does not take place 
unless strong bases or oxidation agents are added. Nevertheless the electron-poor 1-aza-
dienes, despite their potential as heterodienes in Diels-Alder reactions, have received much 
less attention. 
Ar1 Hal
NH
(Het)Aryl
Tos
N
Ar1 (Het)Aryl
Tos
 
OEt
OEt
Ar1 N
OMe
OEt
+
2 % PdCl2(PPh3)2, 1 % CuI]
THF/NEt3 ∆
1 18 19
20
21a-e
21a Ar1 = p-C6H4CN, 57 %
21b Ar1 = 2-pyrimidyl, 46 %
21c Ar1 = 2-pyridyl, 65 %
21d Ar1 = p-C6H4CF3, 30 %
21e Ar1 = p-C6H4CO2Et, 25 %
 
 
Scheme 45 Three-component synthesis of 2-ethoxy pyridines 21. 
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As shown previously, the N-tosyl enimines (19), readily available by CIR of (hetero)aryl 
halides (1) with N-propargyl tosyl amides (18), offer the advantage compared to other 
electron deficient 1-azadienes, of a good leaving group that facilitates their participation to the 
[4+2] cycloadditions. These properties were exploited in one-pot multcomponent pyridine 
syntheses based upon CIR-ketene acetal-cycloaddition sequence (Scheme 45, Table 15). 
 
Thus, after performing the CIR with the aryl halides 1 and the N-propargyl tosyl amides 
18 the electron rich diethyl ketene acetal 20 was added to the reaction mixture. After reaction 
times of 24-48 h, the 2-ethoxy pyridines 21 were isolated in moderate to good yields as 
colorless to yellow crystals or as light yellow oil. 
 
Mechanistically, the formation of 2-ethoxypyridines 21 can be rationalized by either a 
concerted or stepwise [4+2] cycloaddition of the transient N-tosyl enimine 19 to furnish a 
tetrahydropyridine intermediate. However, the excellent leaving group propensity of the 
N-tosyl group could lead to a base induced elimination giving rise to a dihydropyridine that 
rapidly eliminates ethanol with concomitant aromatization, thereby, concluding the formation 
of the aromatic pyridine core.  
 
In conclusion, we have demonstrated that the CIR can successfully be extended to the 
synthesis of N-tosyl enimines starting from propargyl N-tosyl amides. These electron deficient 
heterodienes are perfectly suited as reaction partners in Diels-Alder reactions with inverse 
electron demand. Therefore, we designed a one-pot three-component synthesis of 2-ethoxy 
pyridines by CIR-cyclocondensation sequence. This novel consecutive pyridine synthesis not 
only enhances molecular and structural diversity in a combinatorial sense and potentially in 
solid phase applications, but also allows a rapid construction of complex multicore 
heterocyclic arrays. 
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Table 15 Three-component synthesis of 2-ethoxy pyridine synthesis 21. 
No. (Hetero)Aryl1-Hal, 1 N-Propargyl tosyl amide, 18 2-Ethoxy pyridine, 22 Yield 
1 
BrNC
 
1a 
N
H
Tos
O
 
18a 
N
OMe
OEt
NC
 
21a 
57 % 
 
2 
N
N
Br
 
1b 
18a 
N
OMe
OEt
N
N
 
21b 
46 % 
3 
N
Br
 
1c 
18a 
N
OMe
OEt
N
 
21c 
65 % 
4 
BrF3C
 
1d 
18a 
N
OMe
OEt
F3C
 
21d 
30 % 
5 
BrEtO2C
 
1e 
18a 
N
OMe
OEt
EtO2C
 
21e 
25 % 
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Spectroscopic data 
 
The structure of the 2-ethoxy-6-(p-anisyl)pyridines 21 is unambiguously supported by 
the expected appearance of the characteristic proton and carbon resonances and multiplicities. 
In particular, in the 1H-NMR spectra of 21 the diagnostic triplets for the ethoxy methyl proton 
signals at δ 1.35−1.46 (J 7.1 Hz) and the quartets for the ethoxy methylene protons at 
δ 4.39−4.53 (J 7.1 Hz) are applied for the assignments of the 3-methine doublets of the newly 
formed pyridyl core at δ 6.73−7.05 (J 1.3 Hz) by NOESY spectra, indicating clear 
cross-peaks as a consequence of spatial proximity (Fig. 22). 
 
MeO
N
Ar1
O
H
H
H
H NOESY
6.73 - 6.77
4.39 - 4.53
a
b c
7.41 - 8.49
d
e
6.85 - 6.98
7.96 - 8.15
3.73 - 3.86
1.35 - 1.46
c
 
 
Fig. 22 Assignment of the chemical shifts in 1H NMR for pyridine 21. 
 
The signals of the methoxy protons are detected as singlets, in the range of δ 3.73−3.86. 
Additionally, the mass spectrometric, IR spectroscopic, and combustion analytical data 
are in full agreement with the suggested molecular structure of the 2-ethoxy pyridines 21. The 
mass spectra of all obtained compounds show the molecular peaks. The usual fragmentation 
mode for all pyridines leads to the loss of ethyl, methyl and carboxymethyl fragments. 
Furthermore, the structure of 21 is corroborated by an X-ray crystal structure analysis of 
compound 21e (Fig. 23). 
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Fig. 23 ORTEP plot of compound 21e. 
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4.5  [4+2] Synthesis of Annelated 2-Amino Pyridines Based upon CIR  
 
4.5.1 Annelated 2-Amino Pyridines – Literature Review 
 
Annelated 2-amino pyridines where the amino group is an endo constituent of the 
annelated saturated ring are pharmaceutically intriguing structures. In particular, 
pyrrolo[2,3-b]pyridines or 7-azaindolines,106 [1,8]naphthyridines,107 and 
pyrido[2,3-b]azepines,108 have received considerable interest as a consequence of their broad 
pharmacological activities among which anti-inflammatory, antibacterial, antitumour, 
cardiotonic and anticonvulsivant properties. 
 Recently, Hartman et al.,107e have identified the 5,6,7,8-tetrahydro[1,8]naphthyridine 
(THN) moiety as a lipofilic, moderately basic N-terminus that provides molecules with 
excellent potency and selectivity for the integrin receptor αvβ3, therefore good 
antiosteoporosis agents (Fig. 24). 
 
N
H
N
O
N
H
CO2H
H NHSO2Ph
 
IC50 3 nM  
(inhibition of rat osteoclast-mediated  
bone resorption in vivo)  
 
 
Fig. 24 THN-derivative - inhibitor of bone resorption. 
 
For a convenient access to new potential biologically active 2-amino annelated 
pyridines, it is essential that reliable, flexible and general synthetic methods to be readily 
available. However, the various synthetic routes towards these compounds are limited with 
respect to yields and scope. 
As a recent example, Zard et al.,109 reported a synthetic route involving a tin free-
radical-mediated cyclization onto the pyridine ring as the key step (Scheme 46). 
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N ClCl N NHCl
NH2
Cl
O
N N
O
Cl
R S
S
O
O
S
S
R
Cl
EtO
N N
R
O
Cl
( )
n
( )
n
( )n
( )
n
( ) n
87-100 % 88-97 %
51-97%
43-74 %
DLP, ClPh
 
 
Scheme 46 Free radical mediated synthesis of 7-azaindolines and 
tetrahydro[1,8]naphthyridines. 
 
 Despite its flexibility towards 5 to 7-membered annelated ring (n = 1−3), the method 
furnished the desired compounds only in poor overall yields (15−57 %). 
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4.5.2 Synthesis of Ketene N,S-Acetals as Electron Rich Dienophiles for [4+2] 
Cycloadditions 
 
Ketene N,S-acetals are widely used as electron rich dienophiles110 for [4+2] 
cycloaddition reactions. They were synthesized in a three step sequence starting from the 
corresponding cyclic amides 22, according to Thomsen et al.111 By thionation with 
Lawesson´s reagent the amides 22 were converted into the the thiocarbonyl compounds 23 in 
excellent yields (85−95 %). After methylation with methyl iodide and recrystallizsation from 
acetone S-alkylated iodide salts 24 (75−90 %) were treated with potassium tert.-butoxide to 
furnish the N,S-ketene acetals  25 in moderate overall yields (35−65 %, Scheme 47). 
 
N
S
N
S
N
O
CH3I
N
S
I
n = 1-3
n
25
( )
n
( )
n
( )
Lawesson's Reagent
 Acetone, 
20 min., rt 
KOtBu Et2O, 5 h, ∆
22 23
THF, 1 h, rt n
( )
24
+
 
 
Scheme 47 Three-steps synthesis of ketene N,S-acetals. 
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4.5.3 One-Pot Three-Component CIR-Ketene Acetals-Cycloaddition Synthesis of 
Pyrrolo[2,3-b]pyridines, [1,8]Naphthyridines and Pyrido[2,3-b]azepines 
 
Based upon our experience in diversity oriented heterocycle syntheses in a consecutive 
one-pot fashion and preliminary studies on CIR-cycloaddition sequences,112 the retrosynthetic 
analysis of 5-, 6-, and 7-membered annelated amino pyridines based upon the CI-approach 
(Scheme 48) suggests enimines as key intermediates. Since N,S-ketene acetals are fairly 
electron rich dienophiles for [4+2] cycloadditions with inverse electron demand a facile three-
component CI-cycloaddition-aromatization synthesis of annelated 2-amino pyridines can be 
easily envisioned. 
 
N
R'
RS
Ar1 Hal
Ar2
NTosH
N
R'
NAr2
Ar1
Ar2 = (het)aryl
Ar1 = EWG(het)aryl
+ +
 
Scheme 48 Retrosynthetic concept of a consecutive one-pot three-component annelated 2-
amino pyridine synthesis. 
 
Thus, we submitted p-bromo benzonitrile (1a), 2-bromo pyrimidine (1b), or 2-bromo 
pyridine (1c) and N-[1-aryl-prop-2-ynyl] tosyl amides 18, and after some reaction time cyclic 
N,S-ketene acetals 25 to the reaction conditions of the CIR in boiling mixture of THF and 
triethylamine. After aqueous workup the annelated 2-aminopyridines 27 were obtained in 31-
66 % yield as light yellow crystalline solids (27a-e, 26g-i) or brown oils (27f, 27i) (Scheme 
49, Table 16). 
 
HalAr1
Ar2
NH Ts
Ar2
Ar1
N N
CH3
n
 
N
CH3
n
 
H3CS
+
2% (Ph3P)2PdCl2, 1% CuI
THF, NEt3, 24 h, ∆
1 18 25
then:
27 (31-66 %)
THF,
∆
n = 1, 2, 3
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Scheme 49 One-pot synthesis of annelated 2-amino pyridines 27. 
Table 16 One-pot synthesis of annelated 2-amino pyridines 27. 
Entry Aryl halide 
1 
Propargyl N-tosyl 
amine 18 
N,S-ketene 
acetal 25 
2-Amino pyridines 27 
(Yield) 
1 Ar1 = p-C6H4CN 
(1a) 
Ar2 = p-C6H4OMe 
(19a) N
CH3
H3CS
 
(25a) 
N
MeO
N
CH3
CN
 
27a (64 %)  
 
2 Ar1 = 2-pyrimidyl 
(1b) 
18a 25a 
N
NN
MeO
N
CH3
 
27b (66 %) 
 
3 Ar1 = 2-pyridyl 
(1c) 
18a 25a  
N
N
MeO
N
CH3
 
27c (49 %) 
 
4 1a 18a 
N
CH3
H3CS
  
(25b) 
N N
CH3MeO
CN
 
27d (31 %) 
 
5 1a Ar2 = p-C6H4OPh 
(18b) 
25b 
N
CN
O
N
CH3Ph
 
27e (43 %)  
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Table 16 continued  
 
 
6 1c 18a 25b 
N
N
N
CH3MeO
 
27f (48 %)  
 
7 1a 18a 
N
CH3
H3CS
 
(25c) 
N N
CH3MeO
CN
 
27g (52 %) 
 
8 1a 18b 25c 
N N
CH3
CN
OPh
 
27h (43 %) 
 
9 1b 18a 25c 
N N
CH3
NN
MeO
 
27i (56 %) 
 
10 1c 18a 25c 
N N
CH3
N
MeO
 
27j (52 %)  
 
 
 
The tentative mechanism of this one-pot sequence can be described as follows (Scheme 
50). After the CIR of the electron-deficient (hetero)aryl halide 1 and the propargyl tosyl 
amides 18 furnishing an enimine 19 the added N,S-ketene acetal 25 readily undergoes a [4+2] 
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cycloadditions with inverse electron demand with 19 to give the annelated tetrahydropyridine 
26 as the expected cycloadduct. However, under the reaction conditions the twofold base- 
assisted elimination of tolylsulfinate and methyl mercaptane from 26 furnishes upon 
aromatization the annelated pyridine 27. 
 
HalAr1
Ar2
NH Ts
N
CH3
n
 
H3CS
Ar2
Ar1
N N
CH3
n
 
Ar2
N TsAr1
Ar2
Ar1
N N
CH3
n
 
Ts SMe
H
27
PdCl2(PPh3)2, CuI]
NEt3, THF, ∆
then
Coupling-Isomerization-
Diels-Alder-Aromatization
Sequence
1 18
25
Coupling-
Isomerization
Reaction
[4+2]-Cycloaddition
Aromatization
by
Twofold Elimination
19 26
+
 
 
Scheme 50 Mechanistic rationale of the CIR-Diels-Alder-aromatization sequence. 
 
In conclusion, the mild reaction conditions of the CI sequence of electron poor 
(hetero)aryl halides with 1-aryl propargyl N-tosyl amines giving rise to enimines, can be 
extended to a one-pot three-component synthesis of annelated 2-amino pyridines, such as 
pyrrolo[2,3-b]pyridines, [1,8]naphthyridines, and pyrido[2,3-b]azepines, applying a 
cycloaddition with N,S-ketene acetals and subsequent aromatization. This methodology 
combines modern catalytic cross-coupling processes with pericyclic reactions and, therefore, 
opens new one-pot synthetic strategies as a consequence of mild reaction conditions and 
functional group compatibility.  
Moreover all annelated 2-amino pyridines display pronounced blue or green 
fluorescence (see spectral data) that can be controlled by reversible protonation in weakly 
acidic media for pyrido[2,3-b]azepines. Therefore, the fluorescence dyes, synthesized in a 
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modular diversity oriented fashion are ideal candidates for fluorescence labels for studying 
pH dependent and pH alternating cellular processes. 
 
Spectroscopic data 
 
The structures of the annulation products 27 were unambiguously assigned by 1H, 13C, 
COSY, and NOESY NMR experiments. Most characteristically, in the 1H NMR spectra of 27 
the appearance of the methine singlets at δ 6.87–7.81 can be clearly attributed to the 
formation of pentasubstituted pyridyl core unit. In addition, the signals of N-methyl protons 
are found as singlets at δ 3.02–3.22.  
The mass spectra of all compounds show the molecular peaks. The usual fragmentation 
mode for all pyridine derivatives leads to the loss of methyl fragment.  
Furthermore, the mass spectrometric and IR spectroscopic data are in full agreement 
with structural assignments.  
All annelated 2-amino pyridines 27 absorb in the UV between 338 and 392 nm (Table 
17). As a consequence of steric interactions between the annelated ring and the acceptor 
substituents in the position 4 of the central pyridine ring the latter are twisted out of 
coplanarity with increasing conformational bias of the annulated moiety. Hence, the longest 
wavelength maxima are found for the pyrrolo[2,3-b]pyridines 27a−c. Furthermore, these 
longest wave length pi–pi* transitions, also reflecting the S0–S1 excitation, display dominant 
charge transfer character with a significant mutual HOMO-LUMO overlap in a 
conformationally flexible 4-acceptor pyridyl framework. This is also nicely supported by 
calculations on the DFT level of theory (B3LYP G-31** density functional)113 performed on 
the 2-pyrimidyl substituted pyrrolo[2,3-b]pyrimidine 27b (Fig. 26) and the pyrido[2,3-
b]azepine 27i (Fig. 27). The increase of steric bias upon enlarging the annelated five 
membered to a seven membered ring affects the orbital overlap and correlates with the 
absorption energy. Therefore, in all series the absorption maxima are bathochromically 
shifted upon increasing the acceptor strength of the substituent at position 4 of the pyridine 
moiety from 2-pyridyl over p-cyanophenyl to 2-pyrimidyl. 
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Table 17 Selected UV/Vis and fluorescence properties (recorded in dichloromethane) of 
annelated 2-amino pyridines 27. 
Compound Absorption 
λmax,abs [nm],(ε) 
Emission 
λmax,em [nm] 
Quantum yield 
Φf [%] 
∆ν 
[cm-1]a 
Fluorescence 
color 
27a 372 (3200) 310 
(4400) 258 
(21900) 
469 32 5600 green 
27b 392 (6500) 284 
(12900) 252 
(40700)  
468 
516 sh 
63 4200 green 
27c 360 (15900) 276 
(41700) 248 
(47900) 
466 
512 sh 
53 6300 green 
27d 362 (5900) 306 
(5900) 258 
(31600)  
438 
512 sh 
12 4800 blue 
27e 364 (6600) 312 
(5200) 258 
(38000)  
444 
518 sh 
17 5000 blue 
27f 358 (6200) 256 
(20400)  
445 
513 sh 
25 5500 blue 
27g 338 (3500) 260 
(18200) 
501 24 9600 blue 
27h 340 (6600) 258 
(38900)  
495 34 9200 blue 
27i 348 (5500) 280 
(14800) 254 
(23400) 
511 15 9200 green 
27j 338 478 26 8700 blue 
a∆ ~ν  = 1/λmax, abs – 1/λmax, em [cm-1]. 
4 General Part – Results and Discussion  87 
        
 
Fig. 25 Solid-state fluorescence of single crystals of 27a (left) and 27b (right). 
 
 
 
Fig. 26 LUMO (top) and HOMO (bottom) of the pyrrolo[2,3-b]pyrimidine 27b. 
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Fig. 27 LUMO (top) and HOMO (bottom) of the pyrido[2,3-b]azepine 27i. 
 
Furthermore, all annelated 2-amino pyridines 27 emit blue (27d−h, 27j) or green light 
(27a−c, 27i) upon excitation at the corresponding absorption wavelengths (Table 17). The 
Stokes shifts are rather pronounced and lie between 4200 and 9600 cm-1. For all 
representatives the quantum yields Φf were determined.114 Pyrrolo[2,3-b]pyridines (27a−c) 
fluoresce with significantly higher quantum yields (Φf = 32−63 %) than [1,8]naphthyridines 
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(27d−f,Φf = 12−25 %), and pyrido[2,3-b]azepines (27g−j,Φf = 15−34 %). The longest 
wavelength emission maxima, however, are found in the series of pyrido[2,3-b]azepines. As 
pointed out before for the absorption properties the emission behavior is as well affected by 
steric biases that control the efficiency of the spontaneous emission. Therefore, the charge 
transfer character of the HOMO-LUMO transition responsible for the electronic absorption 
spectra is well reflected in the torsion dependent emission efficiency from the excited S1 
state.115 
The presence of a basic pyridyl nitrogen in the annelated 2-amino pyridines 27 invites to 
scrutinize the pH-dependence of the absorption and emission properties (Table 3). A discrete 
halochromicity can be detected for the 2-pyrimidyl substituted pyrrolo[2,3-b]pyridine 27b and 
the pyrido[2,3-b]azepine 27i, where bathochromic shifts of the longest wave length 
absorption maxima are found by lowering the pH from pH 9 (27b: 384 nm, 27i: 372 nm) to 
pH 1 (27b: 392 nm) or pH 4 (27i: 380 nm). This decrease of the HOMO-LUMO gap upon 
protonation is also reproduced in DFT calculations (B3LYP G-31** density functional)113 on 
27b, 27b-H+, 28i, and 27i-H+. For the couple 27b/27b-H+ the HOMO-LUMO gap reduces 
slightly upon protonation (27b: ∆HOMO-LUMO 3.35 eV; 27b-H+: ∆HOMO-LUMO 3.29 eV) whereas 
the decrease of the HOMO-LUMO gap is larger for the couple 27i/27i-H+ (27i: ∆HOMO-LUMO 
3.50 eV; 27i-H+: ∆HOMO-LUMO 3.38 eV). However, the emission behavior is even more 
affected from protonation than the absorption properties. The emission spectra of the 
2-pyrimidyl substituted pyrrolo[2,3-b]pyridine 27b (Fig. 28) and the pyrido[2,3-b]azepine 27i 
(Fig. 29) display a quite different behavior upon altering the pH. Whereas for the 
pyrrolo[2,3-b]pyridine 27b the emission maximum only shifts slightly upon protonation 
(478 nm at pH 9; 482 nm at pH 1), for the pyrido[2,3-b]azepine 27i a significant 
bathochromic shift from 478 nm at pH 9 to 512 nm at pH 4 is observed. In the latter case 
protonation of the pyridyl nitrogen is obviously occurring at higher pKa as a consequence of 
an increase in basicity. Again, the steric bias causes a twist out of coplanarity of the 2-pyridyl 
substituent (vide supra) and, hence, exerts a diminished electron withdrawing effect. The 
appearance of the fluorescence spectra of 27b and 27i with shoulders at longer wavelengths 
indicates that dual fluorescence of these donor-acceptor substituted pyridines is obviously 
responsible for the variable pH-sensitivity. In the former system the 2-pyrimidyl substituent is 
already coplanar with the pyridine in the ground state and the geometrical changes upon 
protonation are only minimal, whereas in the latter fluorophore the S0–S1 excitation from the 
pyridyl core to the pyrimidine occurs with dominant charge transfer character to an excited 
state that is coplanar and has to relax to a twisted state again. All this makes the 
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pyrido[2,3-b]azepine 27i a pH-sensitive fluorescence sensor that can be operative in neutral 
and weakly acidic media. 
 
Table 18 Selected UV/Vis and fluorescence properties (recorded in 0.1 M acetate buffered 
DMSO solution, T = 298 K) and calculated HOMO and LUMO energies of 
pyrrolo[2,3-b]pyridines 27b and pyrido[2,3-b]azepine 27i. 
Compound Absorption 
λmax,abs [nm] 
(ε) 
Emission 
λmax,em 
[nm] 
∆ν [cm-1]a HOMO 
[eV] 
LUMO 
[eV] 
∆HOMO-LUMO 
[eV] 
4c 384 (2700)b 
250 (8600)  
478b 5100 -4.889 -1.544 3.345 
4c-H+ 392 (10900)c 
280 (15100)  
482c 4800 -8.563 -5.269 3.294 
4j 372 (9500)b 
298 (11800) 
268 (12300)  
478b 6000 -4.911 -1.409 3.502 
4j-H+ 380 (6300)d 
282 (7600) 
512d 6800 -8.605 -5.224 3.381 
a∆ ~ν  = 1/λmax, abs – 1/λmax, em [cm-1]. bAt pH 9. cAt pH 1. dAt pH 4. 
 
 
Fig. 28 Emission maxima λmax,em [nm] (arbitrary units) of 28b at pH 1.00, 2.00, 3.00, 4.00 and 
9.00 (recorded in 0.1 M acetate buffered DMSO solution, T = 298 K, λmax, excitation = 340 nm). 
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Fig. 29 Emission maxima λmax,em [nm] (arbitrary units) of 28i at pH 4.00, 5.00, 6.00, 7.00, 
8.00 and 9.00 (recorded in 0.1 M acetate buffered DMSO solution, T = 298 K, λmax, excitation = 
340 nm). 
 
Finally, the structure of 27 was unambiguously supported by X-ray crystal structure 
analyses of compounds 27a, 27b, 27e, 27h, and 27j (Fig. 30−Fig. 34). Depending on the 
conformational bias of the annelated ring the steric interactions force the acceptor substituted 
(hetero)aryl ring to twist out of coplanarity with the pyridyl core. The interplanar angle of p-
cyano phenyl ring and the central pyridine moiety increases from the pyrrolo[2,3-b]pyridine 
27a (42.4°) over the pyrido[2,3-b]azepine 27h (64.6°) to the [1,8]naphthyridine 27e (88.8°). 
However, 2-pyrimidyl substituents as shown in the crystal structure analysis of 27c (5.5°) 
impose the least steric bias.  
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Fig. 30 ORTEP plot of compound 27a. 
 
 
 
 
 
Fig. 31 ORTEP plot of compound 27b. 
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Fig. 32 ORTEP plot of compound 27e. 
 
 
 
 
 
 
 
Fig. 33 ORTEP plot of compound 27h. 
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Fig. 34 ORTEP plot of compound 27j. 
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4.6 One-Pot Microwave-Assisted Multicomponent Synthesis of 
Cyclohexadienes and Cyclohexenone Derivatives Based upon CIR 
 
In previous chapters it was shown that Sonogashira coupling-ismerizations offer the 
most elegant and atom-economic way of transforming electron poor arylhalides into 
chalcones. Moreover, microwave-assisted CIR, not only reduces reaction times, but also 
inserts electron donating arylhalides as reactive halides in CIR, now completing the generality 
of the CIR. 
The excellent results obtained for the microwave-assisted CIR, encouraged me to 
investigate the microwave effect on the CIR-enamine addition-cyclocondensation 
multicomponent reactions, where conventional procedures furnished only moderate yields. 
 
4.6.1 Synthesis of β-Enaminones  
 
β-Enaminones are interesting building-blocks due to their ability to function as both 
ambident nucleophiles and electrophiles.116 Typical electrophilic positions are C-3 
(alkylamino methylene group) and C-1 (the carbonyl group). Secondly, β-enaminones exhibit 
enamine character towards electrophiles, with a nucleophilic position at C-2 (Fig. 35).  
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Fig. 35 Reactivity of β-enaminones. 
 
The β-enaminones 30 can be easily synthesized by a condensation reaction between 
1,3-dicarbonylic compounds 28 and substituted amines 29, under acidic conditions, in boiling 
benzene, using Dean-Stark trap117 (Scheme 51). 
 
 
4 General Part – Results and Discussion  96 
O NHR2
R1
O O
R1
H2NR
2
30
+
benzene, ∆
 overnight
PTSA
28 29
 
 
Scheme 51 Synthesis of β-enaminones 30. 
 
The condensation reaction can be applied for a large variety of substrates, furnishing 
β-enaminones in excellent yields (70-98 %, Table 19). 
 
Table 19 Synthesis of β-enaminones 30. 
R1 Amine Enamine 30, Yield (%) 
CH3
 N
H
NH2
 
NHO
NH
 
30a (70) 
CH3
 
NH2
 
NHO
 
30b (98) 
CH3
 
O NH2
 
NHO
OMe
 
30c (80) 
NMe2
 
NH2
 
NHO
Me2N
 
30d (92) 
CH3
 
HNEt2
 
NEt2O
 
30e (74) 
CH3
 
NH2
 
NHO
 
30f (98) 
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4.6.2 One-Pot Synthesis of Cyclohexadienes and Cyclohexenones 
 
In previous chapters it has already been shown that β-enaminones, as the source of 
nitrogen in a [3+3] cycloaddition reaction with chalcones, gave rise to the formation of 
dihydropyridines that oxidised to the corresponding pyridines, in moderate overall yields. 
Following the same mechanistic rationale, the N-substituted enaminones, in a 
[3+3] cyclocondensation fashion, would inhibit the subsequent oxidation step and open a new 
entry to the asymmetrical dihydropyridines. But, similarly to literature reports on Hantzsch 
synthesis, where the use of primary amine as a source of nitrogen led to the low yields or no 
reaction,118 all attempts of the conventional thermal cyclocondensations of chalcones with N-
substituted enaminones gave poor yields of a mixture of products: the dihydropyridines and 
the unexpected cyclohexadienes (Scheme 52). 
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Scheme 52 Thermal conditions CIR-enamine addition-cyclocondesation multicomponent 
synthesis. 
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As microwave heating not only reduces the reaction times from hours to minutes, 
facilitating as well, the optimization studies, but also minimizes the side reactions, increases 
yields and improves reproducibility, I decided to apply this procedure on CIR-enamine-
addition-cyclocondensation multicomponent reactions.  
Thus, upon performing MACIR with aryl halides 1 and the propargylic alcohols 2 and 
subsequent addition of enaminones 30, in presence of acetic acid, in one-pot fashion, various 
intramolecular aldol-type products could be isolated, as cyclohexadienes 31 and 
cyclohexenones 32 (Scheme 53, Table 20). The effect of microwave irradiation allowed these 
compounds to be formed within a few minutes, in high yields (45-74%) via a one-pot 
CIR-enamine addition-condensation reaction.  
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O
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O NHR2
R1
Ar1
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O
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NHR2CH3COOH
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O
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O
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1
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     MW
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32, 48 - 70 %
30, 31
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      CuI
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Scheme 53 Microwave assisted CIR-enamine addition-cyclocondensation multicomponent 
synthesis. 
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Table 20 MW-assisted multicomponent synthesis of cyclohexadiene 31. 
Entry Aryl halide 
1 
Propargyl 
alcohol 
2 
Enamine  
30 
Cyclohexadiene 31 (Yield) 
1 Ar1 = 
p-C6H4CN 
(1a) 
Ar2 = -C6H5 
 (2a) 
NHO
NH
 
(30a) NH
O
PhNH
CN
 
 
31a (68 %)  
 
2 Ar1 =  
2-pyrimidyl 
(1b) 
2a 30a 
N
H
O NN
PhNH
 
 
31b (74 %) 
 
3 Ar1 =  
2-pyridyl  
(1c) 
2a 30a 
N
H
O N
PhNH
 
 
31c (70 %) 
 
4 Ar1 =  
p-C6H4CF3 
(1d) 
2a 30a 
N
H
O
CF3
PhNH
 
 
31d (47 %) 
 
5 1a Ar2 =  
2-thienyl 
(2b) 
30a 
N
H
O
NH
CN
S
 
 
31e (54 %) 
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Table 20 continued  
 
 
6 1a Ar2 =  
3-thienyl 
(2c) 
30a 
N
H
O
NH
CN
S
 
 
31f (64 %) 
 
7 1c 2b 30a 
N
H
O N
NH
S
 
 
31g (60 %) 
 
7 1a Ar2 = 
p-C6H4OMe 
(2f) 
30a 
N
H
O
NH
CN
O
 
 
31h (68 %) 
 
8 1a 2a NHO
 
(30b) 
N
H
O
nBu Ph
CN
 
 
31i (54 %) 
 
9 1b 2a 30b 
N
H
O
nBu
NN
Ph
 
 
31j (52) 
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Table 20 continued 
  
 
10 1c 2a 30b 
N
H
O
nBu
N
Ph
 
 
31k (52 %) 
 
11 1a 2a 
NHO
OMe
 
(30c) 
N
H
O
CN
O
O
 
 
31l (30 %) 
 
 
The use of microwaves was successfully extended to the Sonogashira coupling-
isomerization (CIR) and was found to be very effective for the new multicomponent 
syntheses of cyclohexadienes and cyclohexenones.  
The enamine cycloaddition to the chalcone and the subsequent acidic catalysed ring 
opening and intramolecular aldol-condensation reaction take place in one step, in 10-20 
minutes at 150˚ C, under microwave irradiation.  
Acidic conditions are crucial for the ring opening reaction, since no product formation 
was observed in the absence of acid.  
Although, the aldol-condensation reaction is also a base-catalyzed reaction no product 
formation was detected using different base catalysts (KOiPr, KOH, Na2CO3, Table 21).  
The investigation on the process optimization showed that the amount of enamine is also 
important for product formation. The optimal amount was found for an excess of 3:1 
enamine:chalcone  (Table 21). 
 
Table 21 Optimization experiments for the synthesis of cyclohexadiene 31a. 
Enamine 
[eq] 
CH3COOH 
[ml] 
Reaction Time 
[min] 
Yield 
[%] 
1.1 0.5 20 40 
2 0.5 20 52 
2 2 20 40 
2 0 20 0 
3 0.75 20 60 
3 0.75 10 68 
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The nature of N-substituents, R2, on the enamines, plays an important role. The N-alkyl-
substituted enaminones undergo more readily the addition reactions than the corresponding N-
aryl-substituted enaminones. A plausible explanation is the decrease of the enamine reactivity 
towards addition with the loss of nucleophilicity by the conjugation with the aromatic ring. 
Accordingly, using the enamine 30f, (Table 19) no product formation was observed. This 
drawback is avoided by the insertion of a donor substituent on the aromatic substituent of the 
enaminone, as for the enamine 30c, although the yield of the coresponding cyclohexadiene is 
rather poor, 30 %, entry 11 (Table 20). 
The substituent R1 of the enamines influences the stability of the product (7) towards 
hydrolysis, so a higher electronic withdrawing effect of the carbonyl group on the enamine,  
increases the stability of cyclohexadiene (31). Decreasing the electron withdrawal effect of 
the carbonyl group, as in the case of the amide group, the corresponding cyclohexadiene (31) 
is more susceptible towards hydrolysis (Scheme 53).  
Thus, submitting the (hetero)aryl halides 1 and propargylic alcohols 2 to the microwave-
conditions of the Sonogashira coupling-isomerization and subsequent amide-enamine addition 
under acidic conditions, and after aqueous work up, the cyclohexenones 32 were obtained in 
few minutes, 25-35 minutes, in good to excellent yields (Table 22). 
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Table 22 MW-assisted synthesis of cyclohexanones 32. 
Entry Aryl halide 
1 
Propargyl 
alcohol 2 
Enamine  
30 
Cyclohexenones 32 
(Yield) 
1 Ar1 = 
p-C6H4CN (1a) 
Ar2 = -C6H5 
 (2a) NH
N
O
 
(30d) 
 
O
O
Me2N
Ph
CN
 
 
32a (66 %) 
 
2 Ar1 =  
2-pyrimidyl 
(1b) 
2a 30d  
NN
O
O
Me2N
Ph
 
 
32b (68 %) 
 
3 Ar1 =  
2-pyridyl  
(1c) 
2a 30d 
N
O
O
Me2N
Ph
 
 
32c (48 %) 
 
4 Ar1 =  
p-C6H4CF3 (1d) 
2a 30d 
O
O
Me2N
Ph
CF3
 
 
32d (70 %) 
 
5 Ar1 =  
p-C6H4CO2Et 
(1e) 
2a 30d 
O
O
Me2N
Ph
CO2Et
 
 
32e (48 %) 
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Table 22 continued 
  
 
6 1a Ar2 =  
p-C6H4OMe 
 (2f) 
30d 
O
O
Me2N
CN
O
 
 
32f (58 %) 
 
7 1a Ar2 =  
2-thienyl 
(2b) 
30d 
O
O
Me2N
CN
S
 
 
32g (66 %) 
 
8 1a Ar2 =  
3-thienyl 
(2c) 
30d 
O
O
Me2N
CN
S
 
 
32h (62 %) 
 
9 1c 2b 30d 
N
O
O
Me2N
S
 
 
32i (62 %) 
 
 
 
Mechanistically, the formation of the cyclohexadienes 31 and cyclohexanones 32 
presumes the formation of the [4+2] cycloadducts 33 which in acidic conditions open to the 
iminium ions 35 that now readilly undergo an acid catalyzed aldol condensation.  
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Ar1 O
Ar2
O
R1
NHR2
Ar1 O
Ar2
NHR2O
R1
H+
Ar1 O+
Ar2
NHR2O
R1
Ar1 O
Ar2
O
R1
NHR2
H
Ar1
Ar2
NHR2O
R1
Ar1 O
Ar2
O
R1
NHR2
Ar1
NHR2O
R1
OH
Ar1
Ar1
Ar2
OO
R1
H OAc
H+
31
33
4
34 3530
-OAc
+
+
- H3O+
3637
H2O/H+
    when
 R1 = -NMe2
32
 
 
Scheme 54 Mechanistic rationale for CIR-enamine addition-aldol condensation sequence. 
 
 
The cyclohexanones 32 are formed upon an in situ hydrolisys of the enamine moiety 
that is facilitated by the acidic reaction conditions (Scheme 54). 
 
Spectroscopic data 
 
The structures of cyclohexadiene 31 and cyclohexanone 32 were unambiguously 
assigned by 1H, 13C, COSY, HMBC and NOESY NMR experiments. Characteristically, in the 
1H NMR spectra of 31 and 32 is the appearance of the olefinic proton resonances as dublets, 
at δ 6.31–6.89, with coupling constants of 4J = 1.9−2.8 Hz. The long range coupling between 
the 4-H olefinic protons and the 6-H methylenic protons can be unambiguously assigned from 
the cross-peak in the COSY NMR spectra (Fig. 36). Cross-peaks were also detected between 
the olefinic 4-H protons and the ortho-phenyl or heteroaryl (-Ar2) protons by 2D NOESY 
experiments. 
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Fig. 36 The numeration of cyclohexadiene 31 and cyclohexenone 32. 
 
The NH enamine protons for 31a−l were detected as triplets in the range of δ 
11.7−11.85, with coupling constants of 4.8−6.0 Hz and an intensity of one proton. These 
downfieldshifted NH resonances suggest a six-membered intramolecular hydrogen bonding. 
The sufficiently slow proton exchanges in DMSO-D6, at room temperature, allowed the 
detection of the vicinal couplings 3J between CH-NH protons.  
 Broad singlets at low field between δ 8.86 and 10.92, were assigned to the NH protons 
of the indol moiety for 31a−h. 
The 1-H methine protons resonances for 31a−f,g and 31j─l were found in the range of 
δ 4.13-4.32 as doublets, with coupling contants between J 5.25-8.0 Hz. For 31g,i they were 
identified as doublets of doublets with coupling constants of 6.5, 7.75 Hz (axial-axial 
coupling) and 1.25 and 1.75 Hz as a consequence of equatorial-equatorial or axial-equatorial 
coupling.  
The resonances of the methylenic protons 6-H are more complex, due to the additional 
geminal coupling. Thus, for 31i,j one of the methylenic proton signal appears as doublet of 
doublet at δ 2.98 ( 2J = 16.8 Hz, 3J = 2.0 Hz) and δ 3.51 ( 2J = 16.8, 3J = 1.8 Hz) respectively, 
and the other one as doblet of doublets of doublets at  δ 3.17 (J = 16.8 Hz, J = 7.8 Hz, 
J = 2.5 Hz) and at δ 3.02 (J = 16.8 Hz, J = 7.6, J = 2.9 Hz) respectively. For the 
cyclohexadiene 31a−h and 31j−l the resonances of the 6-methylenic protons are detected as a 
set of doublets of doublets of doublets in the range of δ 2.52−3.14. The n-butyl protons for the 
cyclohexadienes 31i−k were identified as sets of signals, triplets at δ 0.90−0.91 with a 
coupling constant between J 7.25−7.3 Hz, and three multiplets in the range of  δ 1.31−1.52, 
1.52−1.69 and 3.31−3.58. 
Characteristically for the cyclohexenones 32a−i are the protons of the two N-methyl 
groups that resonate in the 1H NMR in the range of δ 2.66−2.75 and δ 2.81−3.14 as singlets.  
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Additionally, the mass spectrometric, IR spectroscopic, and combustion analytical data 
are in full agreement with the suggested molecular structure of the cyclohexadienes 31 and 
cyclohexenones 32. The mass spectra of all obtained compounds show the molecular peaks. 
The usual fragmentation mode for the cyclohexadiene 31 leads to the loss of acetyl groups 
and for the cyclohexenones 32 to the loss of N,N-dimethyl amido fragments (Table 23). 
  
 Table 23 Fragmentation of selected cyclohexadienes 31 and cyclohexenones 32. 
Com-
pound Fragment 
m/z 
(%) Fragment 
m/z 
(%) Fragment 
m/z 
(%) 
31a 
N
H
PhNH
CN
+
 
414 
(12) HN
+
 
130 
(100) O
+
 
43 
(18) 
31c 
N
H
N
PhNH
+
 
390 
(70) HN
+
 
130 
(20) O
+
 
43 
(19) 
31g 
N
H
N
NH
S
+
 
396 
(65) HN
+
 
130 
(100) O
+
 
43 
(25) 
31j 
N
H
nBu
NN
Ph
+
 
304 
(100) O
+
 
43 
(26)   
32a 
O Ph
CN
O+
 
300 
(7) 
O Ph
CN
+
 
272 
(100) O
+Me2N
 
72 
(23) 
 
Furthermore, the structure of 31 and 32 are corroborated by an X-ray crystal structure 
analysis of compound 31a,g and 32b,d,g (Fig. 37−Fig. 41). 
 
4 General Part – Results and Discussion  108 
 
 
Fig. 37 ORTEP plot of compound 31a. 
 
 
 
Fig. 38 ORTEP plot of compound 31g. 
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Fig. 39 ORTEP plot of compound 32b. 
 
 
 
Fig. 40 ORTEP plot of compound 32d. 
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Fig. 41 ORTEP plot of compound 32g. 
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4.7 One-Pot Microwave–Assisted Quinoline Synthesis Based upon MACIR  
 
4.7.1 Quinolines – Literature review 
 
 
Quinoline derivatives represent a major class of heterocycles, and a number of 
preparations have been known since the late 1800s. The quinoline ring system occurs in 
various natural products, especially in alkaloids. The quinoline skeleton is often used for the 
design of many synthetic compounds with diverse pharmacological properties. In 1820, 
quinine (Fig. 42) was isolated as the active ingredient from the bark of Cinchona trees and 
successively replaced the crude bark for the treatment of malaria. Despite its relatively low 
efficacy and tolerability, quinine still plays an important role in the treatment of multiresistant 
malaria.119 Malaria is one of the most devastating infectious diseases in the world, afflicting 
200-500 milion people and killing 1-2 milion annually.120 The worldwide increase in drug-
resistance to many of the affordable chemotherapies, such as chloroquine, has created a 
demand for the development of new malaria treatments, among them, mefloquine, quinacrine 
and other quinoline compounds.121 
 
N
MeO
NOH
N N nPr N C5H11
N
N
R
chimanine B alkaloid with in vitro activity 
   against HIV-1 replication
         (IC50 = 7.9 µΜ) 
quinine
alkaloid with in vitro activity 
   against HIV-1 replication
         (IC50 = 2.9 µΜ) 
2-phenylquinoline R=H, 2-n-propylquinoline
R=OMe, chimanine A
 
 
Fig. 42 Naturally occuring quinolines. 
 
Chimanine alkaloids, simple quinolines, isolated from the bark of galipea longiflora 
trees of the rutaceae family,122 are effective against the parasitic diseases such as 
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leishmaniasis and trypanosomiasis. The leishmaniases123 constitute a diverse group of 
diseases that varies from simple cutaneous leishmaniasis to visceral leishmaniasis (VL), a 
very fatal disease if left untreated. VL, also known as “kala-azar” is a severe disease and 
epidepimcs are generally devastating. More recently, VL has also gained attention as an 
opportunistic infection in AIDS. Owing to the fact that overlapping geographical distribution 
of leishmaniasis and HIV/AIDS is increasing, Leishmania-HIV co-infection has been 
regarded as an emerging infectious disease.  
Figadere et al.124 synthesized a serie of 2-substituted quinolines similar with chimanine 
alkaloids that present in vitro activity against the causal agents of cutaneous leishmaniasis, 
visceral leishmaniasis, African trypanosomiasis and Caga’s disease. Furthermore, several 
quinolines also demonstrated in vitro activity against HIV-1 replication (Fig. 42). 
Thus, substituted quinolines have found attractive applications as pharmaceuticals 
(antimalarials, antibacterials, protein kinase inhibitors) NADH models, and agrochemicals, in 
coordination chemistry as ligands125 as well as being general synthetic blocks.126  
Although numerous elegant syntheses have been developed for quinolines, because of 
their great importance, it is still challenging to explore new and efficient synthetic routes for 
this class of compounds, particularly those with wide general applicability. 
Among the various routes available for the synthesis of quinoline derivatives, 
particularly interesting seems the approach employing aromatic primary amines as the 
nucleophilic nitrogen donating component as C-C-N unit and electrophilic three-carbon unit, 
usually carbonyl compounds, referring to Skraup, Doebner-von Miller, Combes and Conrad-
Limpach syntheses 127 (Scheme 55). 
The classical Skraup and Doebner von Miller synthesis are very similar, the former 
involves heating anilines with acrolein, generated in situ from glycerol and strong acid, 
whereas the latter method is based on generating a substituted acrolein, both methods also 
requiring an oxidant. The Combes method involves heating anilines with acetylacetone 
(Scheme 55). 
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Scheme 55 Approaches involving aromatic primary amine as C-C-N unit. 
 
In spite of their generality, versatility and simplicity, these syntheses have considerable 
drawbacks, such as harsh reaction conditions and highly acidic medium, which makes them 
tedious to isolate the product from the crude mixture. Moreover, reactions of meta- or 3,4-
disubstituted anilines normally give a mixture of regioisomers, which are also difficult to 
separate. In case of Combes synthesis, the use of unsymmetrical 1,3-diketones complicates 
separation process.  
Another way of preparing quinoline derivatives uses ortho-substituted anilines (C-C-C-
N unit) and two carbon unit, usually carbonyl compounds containing a reactive α- methylene 
group. Aniline derivatives substituted at the 2-position and o-substituted nitrobenzenes are 
frequently employed as starting materials. The Friedländer synthesis of quinolines from 
o-aminobenzaldehydes is a staple reaction of organic synthesis. Although it does not require a 
catalyst, the Friedländer synthesis can be acid- or base-catalyzed. The uncatalyzed Friedländer 
synthesis requires more drastic reaction conditions, with temperatures in the range 
150-220 °C. Hydrochloric acid, sulfuric acid, p-toluenesulfonic acid, and polyphosphoric acid 
were widely employed as catalysts. A complicating factor in this reaction is the relative 
instability of the ortho-amino aldehyde, which can readily undergo self-condensation 
reactions. The Pfitzinger reaction, the Niemantowski reaction and the Borsche synthesis128 are 
helpful in reducing problems due to o-aminobenzaldehyde instability.  
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Due to these synthetic problems, there is still a need for developing mild, regioselective 
and practical syntheses for these heterocycles.  
Therefore, new metal-catalyzed coupling cyclizations or acid catalyzed cycloadditions 
of appropriate precursors come to compete with classical syntheses in efficacy and rapidity of 
the quinoline construction. The formation of quinoline skeletons has been attempted by 
remarkable catalytic action of transition metal catalysts such as palladium, rhodium, 
ruthenium, cobalt and iron complexes.129 It was suggested that metal-catalyzed 
heteroannulation proceeds via amine exchange reaction between anilines and alkylamines, 
allyl alcohols or 1,3-diols. For instance, anilines react with 3-amino-1-propanol in dioxane at 
180 °C in the presence of catalytic amounts of RuCl3 in H2O/PPh3 and SnCl2⋅2H2O together 
with hydrogen acceptor (acetone, nitrobenzene or hex-1-ene) to afford the corresponding 
quinolines in moderate yields (29-46%).130 The use of triallylamine and ruthenium (III) 
chloride and bis(diphenylphosphino) methane allowed to obtain the 
3-ethyl-3-methylquinoline derivatives in high yields131 (Scheme 56). The quinoline yield was 
not decisively affected by the electronic nature and the position of the substituent on aniline. 
 
NH2
R1
R2
R3
R4
R1
R2
R3
R4
N
R1
R2
R3
R4
N
OH NH2
RuCl3*nH2O/
3PPh3/ dioxane
180°C
RuCl3*nH2O/ dppm
SnCl4*H2O/ dioxane
180°C
N(CH2-CH=CH2)3
29 - 46 % 65 - 76 %
 
 
Scheme 56 Ruthenium-catalyzed quinoline synthesis. 
 
 
Akiyama and co-workers132 described a novel quinoline synthesis that proceeds via 
catalytically tungsten vinylidene complexes - W(CO)5(THF). Alkynyl imines underwent 
[4+2] electrocyclization in the presence of 20 mol % catalyst to give 2-arylquinolines  in good 
yields (Scheme 57).  
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Scheme 57 Tungsten-catalyzed quinoline synthesis 
 
The elevated temperature for the ruthenium-catalyzed quinoline synthesis and the 
starting material that are not readily available, in case of the cobalt-133 and tungsten-catalyzed 
reactions, 134 do not make these methods versatile and attracting procedures. 
An interesting access to 2-substituted quinolines, recently reported by Shim et al.,135 
makes use of a base-mediated consecutive isomerization and cyclization sequence of 3-(2-
aminophenyl)-1-arylprop-2-yn-1-ols that are easily available by  Sonogashira coupling of 
iodoaniline with propargyl alcohols (Scheme 58). 
 
I
NH2
R
OH
NH2
R
OH
NH2
R
OH
N R
+
[Pd], CuI, NEt3
60 °C
KOH
toluene, 80 °C
      7-20 h
62-89 %
 
 
Scheme 58 Quinoline synthesis by isomerization-cyclocondensation of 3-(2-aminophenyl)-1-
arylprop-2-yn-1-ols. 
 
Remarkable for this approach is that the electron rich coupling compounds do not 
undergo isomerization to the corresponding enones even after prolonged reaction time or 
elevated temperature (180 °C). Stronger anorganic bases, such as KOH, were required that the 
isomerization took place by refluxing in ethanol for several hours (7-20 h). 
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4.7.2 Quinoline Synthesis Based upon MACIR   
 
Microwave irradiation facilites the electron rich aryl halides to undergo successfully 
coupling-isomerization reactions. Para- and meta- donating groups, as methoxy as well as 
amino groups substituents at the aromatic ring are well tolerated in the MACIR conditions. 
Aryl halides with an amino group in ortho position would be even more nucleophilic. 
Generally, ortho positions are not favored due to the steric hindrance, but in this case, the CIR 
product would be an unsaturated 1-amino 5-carbonyl compound that under base conditions of 
the MACIR could easily undergo an intramolecular condensation reaction with the formation 
of a new 6-membered ring. Indeed, subjecting o-amino (hetero)aryl halides 1 and propargyl 
alcohols 2 to the MACIR conditions, after 30 minutes reaction time, I was able to isolate the 
corresponding quinoline derivatives 41 in good to excellent yields (57-92 %, Scheme 59, 
Table 24). 
 
 
NH2
Hal OH
Ar2
N Ar2
R
R
NH2
Ar2
OR
OH
Ar2
NH2
R
O
Ar2
NH2
R
 
+
-H2O
1 2 38
41
2 % mol Pd(PPh3)2Cl2, 
      1 % mol CuI
  2eq. of DBU, THF
120-150 °C, 30 min,
       Microwave
39
40 - 92 %
40
 
Scheme 59 Quinoline Synthesis Based upon MACIR.  
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Furthermore starting with the disubstituted 1,5-diamino 2,4-diiodobenzene 1r, the 
twofold coupling-isomerization reaction followed by intramolecular condensation furnished 
the expected pyrido-quinoline derivative 41i (Scheme 60). 
 
NH2NH2
II
N N
OH 4 % mol PdCl2(PPh3)2, 
      2 % mol CuI
+
1r 2 41i, 64 %
 3eq. of DBU, THF
100-120 °C, 30 min,
            MW
 
 
Scheme 60 Synthesis of pyrido-quinoline derivative 41i via twofold MACIR 
 
The coupling-isomerization reaction and the intramolecular condensation take place in 
one step, without the isolation of the intermediates 38 and 39. Performing the reaction at 
lower temperature, 120 °C the alkyne 38 could be isolated as the main product, entry 6 (Table 
24). 
Mechanistically, the formation of the quinoline core presumes a (Z)-(E) isomerization 
that might readily occur under the MACIR conditions, followed by an intramolecular 
condensation. The isomerization may be favorized by the intramolecular hydrogen bond 
formation. 
 
In conclusion, a new efficient one-pot quinoline and related heterocycles synthesis was 
developed as a direct application of the MACIR of the o-amino (hetero)aryl halides with 
propargyl aclcohols. Moreover, this new method allowed the synthesis of the naturally 
occurring quinolines, as 2-phenylquinoline, 41a, and chimanine B, 41f, within 30 minutes, in 
good to excellent yields (40-81 %). (Table 24) These quinolines have already been tested as 
antileishmanial agents, presenting good in vitro activity (IC50 = 12-100 µM). Further 
investigations for the new 2-quinolines as potential antileishmanial agents are in progress. 
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Table 24 MACIR of o-amino (hetero)aryl halides 1 with propargyl alcohols 2. 
Entry Aryl halide 
1 
Propargyl alcohol 2 Product 38 or 41 
(Yield) 
1[a] 
NH2
I
 
(1m) 
Ar2 = -C6H5 
 (2a) 
 
N
 
 
41a (81 %) 
 
2[a] 1m Ar2 = 2-thienyl 
 (2b) 
 
N
S
 
 
41b (80 %) 
 
3[a] 
NH2
INC
 
(1n) 
2a  
N
NC
 
 
41c (70 %) 
 
4[a] 1n Ar2 = -C6H4OMe 
 (2f) 
 
N
O
NC
 
 
41d (57 %) 
 
5[a] 
NH2
IF3C
 
(1o) 
2a  
N
F3C
 
 
41e (92 %) 
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Table 24 continued 
 
 
6[a] 1m 2g  
NH2
OH
 
 
38a (44 %) 
 
7[b] 1m 2g  
N
 
 
41f (40 %) 
 
8[b] 
N NH2
I
 
(1p) 
2a  
N N
 
 
41g (79 %) 
 
9[b] N
NH2
I
 
(1q) 
2a  
N
N
 
 
41h (78 %) 
 
10[a] 
NH2
II
NH2
 
(1r) 
2a  
NN
 
 
41i (64 %) 
 
[a]Reaction temperature 120 °C.[b]Reaction temperature 150 °C. 
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Spectroscopic data 
 
The structure of the quinoline derivatives 41a−f,i and naphthyridines 41g,h is 
unambiguously supported by the expected appearance of the characteristic proton and carbon 
resonances and multiplicities. In particular, in the 1H NMR spectra of 41 the doublets for the 
3-, 4- methine signals, appear between δ 7.89 and 8.27, with coupling constants 
J = 8.0−8.3 Hz. Additionally, the assignments of 3-positioned methine protons are supported 
by 2D NOESY spectra that indicate clear cross-peaks as a consequence of spatial proximity 
with ortho-phenyl, phenylene, or 3-thienyl protons (-Ar2, Fig. 43). 
 
X
X N Ar2
R
1
2
3
5
6
7
8
4
X = CH, N
 
 
Fig. 43 The numeration of the quinolines and naphthyridines 41. 
 
The thienyl protons for 41b are identified as a triplet at δ 7.16 with a coupling constant 
of J = 4.0 Hz, a doublet at  δ 7.61 with a coupling constant of J = 5.0 Hz, and a multiplet at 
7.69, each of them with an intensity of one proton. The signals of the methyl protons for 41d 
and 41g are detected as singlets at δ 3.89 and 2.54 respectively, with an intensity of three 
protons. The resonances of the methyl protons for 38 and 41f appear as a doublet at δ 1.69 
with a coupling constant of J = 6.3 Hz, and at δ 2.1 with a coupling constant of J = 6.9 Hz 
respectively. The broad singlets in 1H NMR spectrum of compound 38, appear at δ 2.64 and 
4.06 respectively. They clearly support the non-cyclic structure of the alkyn-ol derivative. The 
characteristic α-cleavage detected in the mass spectrum of 38 also confirms the alcohol 
structure. The most downshifted signal in 1H NMR spectrum of compound 41f, was assigned 
to the proton positioned ortho with respect of the pyridine cores that resonate at δ 8.77 as 
singlet with an intensity of one proton.  
The mass spectra of all obtained compounds show the molecular peaks. The usual 
fragmentation mode for the 2-substituted quinoline and naphthyridine derivatives leads to the 
loss of phenyl and thienyl fragments. For 41d,g the loss of methyl group was detected. For 
41c, the cyanohydric acid was identified as a fragment in the mass spectrum. 
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The nitrile vibration was detected in the IR spectrum of compound 41c at 
2224−2227 cm-1.  
Furthermore, the structure of quinolines was corroborated by X-ray crystal structure 
analysis of compound 41c. 
 
 
Fig. 44 ORTEP plot of compound 41c. 
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5 Conclusions and Outlook 
 
It was shown that the major goals in methodological studies on coupling–isomerization 
reaction, as the reduction of reaction times of the rate limiting isomerization step and 
reduction of the amount of base could be achieved by the use of the microwave assisted CIR 
(MACIR). Furthermore, the microwave-assisted coupling–isomerization reaction was 
successfully extended to electron rich aryl halides that commonly do not undergo CIR under 
conventional conditions. As a direct application of MACIR of electron rich aryl halides, a 
novel one-pot synthesis of quinoline derivatives was developed via MACIR of o-amino aryl 
halides with propargyl alcohols. Based upon this methodology, chimanine alkaloids were 
synthesized in 30 minutes, 40-81%. New rapid and efficient syntheses of the pyrido-quinoline 
derivatives as multidentate ligands can be envisioned by use of this methodology. 
Also the microwave effects on multicomponent synthesis were investigated. Thus, while 
conventional heated muticomponent processes furnished pyridines or dihydropyridines as 
main reaction products by a CIR-enamine addition cyclocondensation sequence, in 48-72 h, 
the same reaction components under microwave irradiation underwent a CIR-enamine 
addition-intra-aldol condensation sequence, with the formation of the cyclohexadienes or 
cyclohexanones as main reaction products, within 25-35 minutes.  
The potential of MACIR-enamine addition-intra-aldol condensation sequence is not 
limited to the reactions described in this thesis. The microwave assisted three component 
syntheses might be further developed to new four-component processes. For example, the 
cyclohexadienes can be subjected to subsequent Lewis acid catalyzed Diels-Alder or Pictet-
Spengler reactions in one-pot fashion.  Similarly, the keto-cyclohexadiene can be used in 
1,3-cycloaddition reactions for the synthesis of new annelated heterocycles. 
The mechanism of enamine addition to the chalcones under conventional heating 
conditions was elucidated by the isolation of the Diels-Alder cycloadduct 6. This result was 
also confirmed by the molecular modeling investigations. 
It was discovered that the enimines, as products of CIR of aryl halides with propargyl 
amines, could be used as electron poor heterodienes in a Diels-Alder reaction with inverse 
electron demand, furnishing pyridine derivatives, among them, interesting fluorescent 
2-amino annelated pyridines with high florescence quantum yields of 12–63 %. 
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6 Experimental Part 
 
6.1 General Considerations 
 
 All reactions involving palladium-copper catalysis were performed in degassed oxygen 
free solvents under a nitrogen atmosphere using Schlenk and syringe techniques. Halogen 
compounds 1, (Ph3P)2PdCl2, and CuI were purchased reagent grade from ACROS, Aldrich, 
Fluka or Merck and used without further purification. Triethylamine and THF were dried and 
distilled according to standard procedures.103 All reactions involving microwave irradiation 
were conducted under nitrogen in heavy-walled glass Smith process vials sealed with 
aluminum crimp caps fitted with a silicon septum. The inner diameter of the vial filled to the 
height of 2 cm was 1.3 cm. The microwave heating was performed in a Smith Synthesizer 
single-mode microwave cavity producing continuous irradiation at 2450 MHz (Personal 
Chemistry AB, Uppsala, Sweden). Reaction mixtures were stirred with a magnetic stir bar 
during the irradiation. The temperature, pressure and irradiation power were monitored during 
the course of the reaction. The average pressure during the reaction was 3-4 bar. After 
completed irradiation, the reaction tube was cooled with highpressure air until the temperature 
had fallen below 39 °C (ca. 2 min). – Column chromatography: silica gel 60 (Merck, 
Darmstadt), mesh 70–230. TLC: silica gel plates (60 F254 Merck, Darmstadt). Melting points 
(uncorrected values): Büchi Melting Point B-540. – 1H and 13C NMR spectra: Bruker ARX 
300, Varian VXR 400S CDCl3, C2D6O and [D6]DMSO. The assignments of quaternary C CH, 
CH2 and CH3 have been made by using DEPT spectra. – IR: Perkin Elmer Lambda 3. – 
UV/vis: Perkin Elmer Models Lambda 16. – Fluorescence: Perkin Elmer LS-55. – MS: 
Finnigan MAT 90 and MAT 95 Q. – Elemental analysis were carried out in the 
Microanalytical Laboratories of the Organisch-Chemisches Institut, Ruprecht-Karls-
Universität Heidelberg. 
 
6.2 General Procedure for the Coupling Reactions/Coupling-Isomerization 
Reactions of Aryl halides 1 with Propargylyl Alcohols 2 
 
A magnetically stirred solution of 1.00 mmol of halogen compound 1, 1.05 mmols of 
propargyl alcohol 2, 20 mg (0.02 mmols) of (PPh3)2PdCl2, and 2 mg (0.01 mmols) of CuI in 
2-5 eq. of degassed base and 1.5 mL of THF under nitrogen was stirred under nitrogen in a 
heavy-walled SmithCreator process vial at the microwave generated temperature and for the 
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time indicated, (for experimental details see Table 25) in the microwave cavity. After cooling 
to room temp. the reaction mixture was poured to 40 mL of ethyl acetate and 40 mL of water 
were added and stirring was continued for 5 to 10 min. The aqueous layer was extracted with 
ethyl acetate (4 × 15 mL) and the combined organic phases were dried over magnesium 
sulfate. After filtration the solvents were removed in vacuo and the residue was 
chromatographed on silica gel (hexane/ethyl acetate 4:1 or 1:1) and crystallized from ethanol 
or pentane/chloroform (1:1) to give the analytically pure alkyne 3 and chalcone 4, 
respectively. 
 
Table 25 Experimental details of the coupling/coupling-Isomerization reactions 
Entry Aryl halide 1 
Propargyl 
alcohol 2 
Base 
Tempe- 
rature  
[°C] 
t 
[min] 
Product 
(Yield, %) 
1 
182 mg (1.00 
mmol) of 1a 
139 mg (1.05 
mmols) of 2a 
505 mg (5.0 
mmols) of NEt3 
120 8 
79 mg (34 
%) of 3a 
2 
225 mg (1.00 
mmol) of 1d 
139 mg (1.05 
mmols) of 2a 
505 mg (5.0 
mmols) of NEt3 
120 10 
80 mg (29 
%) of 3d 
3 
229 mg (1.00 
mmol) of 1e 
139 mg (1.05 
mmols) of 2a 
505 mg (5.0 
mmols) of NEt3 
120 10 
69 mg (25 
%) of 3e 
4 
182 mg (1.00 
mmol) of 1a 
74 mg (1.05 
mmols) of 2e 
608 mg (4.0 
mmols) of DBU 
120 10 
157 mg (92 
%) of 3k 
5 
204 mg (1.00 
mmol) of 1i 
139 mg (1.05 
mmols) of 2a 
153 mg (1.05 
mmols) of DBU 
100 60 
145 mg (70 
%) of 3l 
6 
234 mg (1.00 
mmol) of 1k 
139 mg (1.05 
mmols) of 2a 
304 mg (2.0 
mmols) of DBU 
100 30 
109 mg (46 
%) of 3n 
7 
182 mg (1.00 
mmol) of 1a 
139 mg (1.05 
mmols) of 2a 
505 mg (5.0 
mmols) of NEt3 
150 15 
224 mg (96 
%) of 4a 
8 
159 mg (1.00 
mmol) of 1b 
139 mg (1.05 
mmols) of 2a 
505 mg (5.0 
mmols) of NEt3 
120 15 
176 mg (84 
%) of 4b 
9 
158 mg (1.00 
mmol) of 1c 
139 mg (1.05 
mmols) of 2a 
505 mg (5.0 
mmols) of NEt3 
150 15 
163 mg (78 
%) of 4c 
10 
225 mg (1.00 
mmol) of 1d 
139 mg (1.05 
mmols) of 2a 
505 mg (5.0 
mmols) of NEt3 
170 15 
180 mg (65 
%) of 4d 
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Table 25 continued      
11 
229 mg (1.00 
mmol) of 1e 
139 mg (1.05 
mmols) of 2a 
505 mg (5.0 
mmols) of NEt3 
150 30 
173 mg (62 
%) of 4e 
12 
202 mg (1.00 
mmol) of 1a 
139 mg (1.05 
mmols) of 2a 
505 mg (5.0 
mmols) of NEt3 
150 15 
160 mg (63 
%) of 4f 
13 
236 mg (1.00 
mmol) of 1g 
139 mg (1.05 
mmols) of 2a 
505 mg (5.0 
mmols) of NEt3 
150 15 
178 mg (62 
%) of 4g 
14 
182 mg (1.00 
mmol) of 1a 
145 mg (1.05 
mmols) of 2b 
505 mg (5.0 
mmols) of NEt3 
175 10 
208 mg (87 
%) of 4h 
15 
182 mg (1.00 
mmol) of 1a 
145 mg (1.05 
mmols) of 2c 
505 mg (5.0 
mmols) of NEt3 
175 10 
224 mg (96 
%) of 4i 
16 
182 mg (1.00 
mmol) of 1a 
103 mg (1.05 
mmols) of 2d 
153 mg (1.05 
mmols) of DBU 
200 10 
123 mg (62 
%) of 4j 
17 
204 mg (1.00 
mmol) of 1i 
139 mg (1.05 
mmols) of 2a 
304 mg (2.0 
mmols) of DBU 
100 30 
191 mg (92 
%) of 4l 
18 
218 mg (1.00 
mmol) of 1j 
139 mg (1.05 
mmols) of 2a 
304 mg (2.0 
mmols) of DBU 120 30 
204 mg (92 
%) of 4m 
19 
234 mg (1.00 
mmol) of 1k 
139 mg (1.05 
mmols) of 2a 
304 mg (2.0 
mmols) of DBU 
120 30 
202 mg (85 
%) of 4n 
20 
219 mg (1.00 
mmol) of 1l 
139 mg (1.05 
mmols) of 2a 
304 mg (2.0 
mmols) of DBU 
120 30 
162 mg (73 
%) of 4o 
 
 4-(3-Hydroxy-3-phenyl-prop-1-ynyl)-benzonitrile (3a)136 
 
OH
NC
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 79 mg (34 
%) of 3a were isolated as a red-brown oil. 1H NMR (CDCl3, 300 MHz): δ 2.67 (d, J = 5.8, 1 
H), 5.70 (d, J = 5.5 Hz, 1 H), 7.30−7.46 (m, 3 H), 7.41−7.59 (m, 6 H). 13C NMR (CDCl3, 75 
MHz): δ 64.9 (CH), 84.7 (Cquat.), 93.2 (Cquat.), 111.9 (Cquat.), 118.3 (Cquat.), 126.6 (CH), 127.3 
(Cquat.), 128.6 (CH), 128.8 (CH), 132.0 (CH), 132.2 (CH), 140.0 (CH). EI MS (70 eV), m/z 
(%): 233 (M+, 71), 232 (M+- H, 100), 204 (48), 156 (M+- C6H5, 4), 77 (C6H5+, 57). IR (KBr): 
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ν~  3431, 3061, 3032, 2226, 2203, 1639, 1602, 1499, 1453, 1387, 1287, 1176, 1012, 959, 835, 
765, 699 cm-1. UV/Vis (CH2Cl2): λmax (ε) 250 nm (14700), 262 (25300), 274 (25300). 
 
1-Phenyl-3-(4-trifluormethyl-phenyl)-prop-2-yn-1-ol (3d) 
 
OH
F3C
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 80 mg (29 
%) of 3e were isolated as a brown oil.  1H NMR (CDCl3, 300 MHz): δ 2.00−2.23 (m, 1 H), 
5.70 (s, 1 H), 7.36−7.44 (m, 3 H), 7.57−7.62 (m, 6 H). 13C NMR (CDCl3, 75 MHz): δ 65.0 
(CH), 91.1 (Cquat.), 125.2 (Cquat.), 126.7 (CH), 128.6 (CH), 128.8 (CH), 132.0 (CH), 140.2 
(Cquat.). EI MS (70 eV), m/z (%): 276 (M+, 100), 259 (M+- OH, 26), 207 (M+- CF3, 43), 170 
105 (C7H5O+, 16), 77 (C6H5+, 47). IR (film): ν~  1615, 1405, 1324, 1168, 1126, 1106, 1068, 
1018, 1002, 964, 843, 762, 749, 717, 698, 598 cm-1. UV/Vis (CH2Cl2): λmax (ε) 210 nm 
(17500), 248 (21400), 258 (18600). 
 
Ethyl 4-(3-hydroxy-3-phenylprop-1-ynyl)benzoate (3e) 
 
OH
EtO2C
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 69 mg (25 
%) of 3e were isolated as a yellow oil. 1H NMR (CDCl3, 300 MHz): δ 1.38 (t, J = 7.1 Hz, 3 
H), 3.63 (s 1 H), 4.37 (q, J = 7.1 Hz, 2 H), 5.70 (s, 1 H), 7.35−7.44 (m, 3 H), 7.50−7.52 (d, J = 
8.4 Hz, 2 H), 7.59−7.71 (m, 2 H), 7.97−8.00 (d, J = 8.4 Hz, 2 H). 13C NMR (CDCl3, 75 
MHz): δ 14.3 (CH3), 61.2 (CH2), 65.1 (CH), 85.8 (Cquat.), 91.6 (Cquat.), 126.7 (CH), 127.0 
(Cquat.), 127.9 (CH), 128.4 (CH), 128.6 (CH), 128.7 (CH), 129.4 (CH), 131.4 (CH), 140.3 
(Cquat.), 166.0 (Cquat.). EI MS (70 eV), m/z (%): 280 (M+, 100), 251 (M+- C2H5, 25), 207 (M+- 
CO2C2H5, 54), 105 (C7H5O+, 11), 77 (C6H5+, 8). IR (film): ν~  3428, 3065, 2931, 1713, 1602, 
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1275, 1107, 770, 725, 696, 596, 565, 542, cm-1. UV/Vis (CH2Cl2): λmax (ε) 254 nm (9700), 
266 (10500), 376 (9300). 
 
4-(3-hydroxybut-1-ynyl)benzonitrile (3k) 
 
OH
NC
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 158 mg 
(92 %) of 3k were isolated as a light brown oil.  1H NMR (CDCl3, 300 MHz): δ 1.48 (d, J = 
4.75 Hz, 3 H), 2.5 (s, 3 H), 4.67 (q, J = 5.5 Hz, 1 H), 7.39 (d, J = 7.0 Hz, 2 H), 7.49 (d, J = 7.0 
Hz, 2 H). 13C NMR (CDCl3, 75 MHz): δ 24.0 (CH3), 58.6 (CH), 82.2 (Cquat.), 95.5 (Cquat.), 
111.5 (Cquat.), 118.3 (Cquat.), 128.4 (Cquat.), 131.9 (CH), 132.1 (CH). EI MS (70 eV), m/z (%): 
171.07 (M+, 20), 156 (M+- CH3, 100), 128 (M+- CH3, - CO, 25). HRMS calcd. for C11H9NO: 
171.0684; found 171.0672. 
 
1, 3-Diphenylprop-2-yn-1-ol (3l)137 
 
OH
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 145 mg 
(70 %) of 3l were isolated as a yellow oil. 1H NMR (C3D6O, 300 MHz), δ  5.18 (d, J = 5 Hz, 
1 H), 5.71 (d, J = 5 Hz, 1 H), 7.29–7.47 (m, 8 H), 7.62 (d, J = 6.3 Hz, 1 H). 13C NMR 
(C3D6O, 100 MHz), δ 63.9 (CH), 84.8 (Cquat.), 90.5 (Cquat.), 122.9 (CH), 126.6 (CH), 127.7 
(CH), 128.0 (CH), 128.3 (CH), 128.5 (CH), 131.4 (CH
.
), 142.1 (Cquat.). (70 eV, EI): m/z (%): 
208.0 (M+, 100), 191 (M+ - OH, 25), 77 (C6H5+, 35). 
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3-(4-Methoxyphenyl)-1-phenylprop-2-yn-1-ol (3n)138 
 
OH
O
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 110 mg 
(46 %) of 3n were isolated as a yellow oil. 1H NMR (CDCl3, 300 MHz), δ  2.62 (s, 1 H), 3.68 
(s, 3 H), 5.56 (s, 1 H), 6.71 (d, J = 8.5 Hz, 2 H), 7.14–7.31 (m, 5 H), 7.49 (d, J = 6.8 Hz, 2 H). 
13C NMR (C3D6O, 100 MHz), δ  55.2 (CH3), 65.0 (CH), 86.4 (Cquat.), 87.4 (Cquat.), 113.9 
(CH), 114.5 (Cquat.), 126.7 (CH), 128.4 (CH), 128.7 (CH), 132.1 (CH), 140.8 (Cquat.), 159.7 
(Cquat.). (70 eV, EI): m/z (%): 238.0 (M+, 100), 221 (M+ - OH, 30), (C6H5+, 40). 
 
(E)-3-(4-Cyanophenyl)-1-phenylprop-2-en-1-one (4a)139 
 
NC
O
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate 4:1) and 
recrystallization from ethanol 224 mg (96 %) of 4a were isolated as light yellow crystals. 
M.p.159−160 °C (lit. 156−157 °C).139 1H NMR (CDCl3, 300 MHz): δ = 7.46−7.53 (m, 2 H), 
7.56−7.64 (m, 1 H), 7.59 (d, J = 15.8 Hz, 1 H), 7.67−7.73 (m, 4 H), 7.76 (d, J = 15.8 Hz, 1 
H), 8.00-8.04 (m, 2 H). 13C NMR (CDCl3, 75 MHz): δ 113.5 (Cquat.), 118.3 (Cquat.), 125.1 
(CH), 128.5 (CH), 128.6 (CH), 128.7 (CH), 132.6 (CH), 133.2 (CH), 137.6 (Cquat.), 139.2 
(Cquat.), 142.0 (CH), 189.7 (Cquat.). EI MS (70 eV), m/z (%): 233 (M+, 100), 232 (M+- H, 86), 
205 (13), 204 (37), 190 (12), 156 (M+- C6H5, 33), 128 (M+- C6H5 - CO, 20), 105 (C7H5O+, 
38), 77 (C6H5+, 29). IR (KBr): ν~   2222, 1664, 1605, 1578, 1412, 1336, 1311, 1223, 1017, 
988, 833, 779, 727, 697, 689, 650, 549 cm-1. UV/Vis (CH2Cl2): λmax (ε) 302 nm (27249). 
Anal. calcd. for C16H11N0 (233.3): C 82.38, H 4.75, N 6.00; found: C 82.40, H 4.85, N 5.84. 
(E)/(Z)-configurated chalcones were obtained in different ratios from 4:1 up to pure 
(E)-chalcone. Characteristic for (Z)-chalcone: 1H NMR (CDCl3, 300 MHz): δ  7.01 (d, J = 
12.8 Hz, 1 H), 6.82 (d, J = 12.8 Hz, 1 H). Characteristic for (E)-chalcone: 1H NMR (CDCl3, 
300 MHz): δ  7.59 (d, J = 15.8 Hz, 1 H), 7.76 (d, J = 15.8 Hz, 1 H). 
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 (E)-1-Phenyl-3-pyrimidinprop-2-en-1-one (4b) 
 
N
N
O
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate 3:1) 176 mg 
(84 %) of 4b were isolated as a light-brown solid. 1H NMR (CDCl3, 300 MHz): δ  7.22 (d, J = 
2.94 Hz, 1 H), 7.23−7.59 (m, 3 H), 7.72 (d, J = 9.3 Hz, 1 H), 8.05−8.047 (m, 2 H), 8.25 (d, 
J = 9.27 Hz, 1 H),  8.77 (d, J = 2.91 Hz, 2 H). 13C NMR (CDCl3, 75 MHz): δ 120.2 (CH), 
128.7 (CH), 128.8 (CH), 130.5 (CH), 133.3 (CH), 137.4 (Cquat.), 142.2 (CH), 157.3 (CH), 
163.3 (Cquat.), 190.4 (Cquat.). EI MS (70 eV), m/z (%): 210 (M+, 50), 181 (100), 133 (M+- C6H5, 
15), 105 (M+- C7H5O+, 43), 77 (C6H5+, 56). IR (KBr): ν~  1680, 1620, 1596, 1564, 1443, 1422, 
1371, 1328, 1297, 1223, 1183, 1011, 809, 757, 727, 695, 635, 607, 523 cm-1. UV/Vis 
(CH2Cl2): λmax (ε) 254 nm (13667), 278 (13000). Anal. calcd. for C13H10N2O (210.2): 
C 74.27, H 4.79, N 13.32; found: C 74.01, H 4.82, N 12.98. 
 
(E)-1-Phenyl-3-pyridinprop-2-en-1-one (4c) 
 
N
O
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate 3:1) 163 mg (78 
%) of 4c were isolated as a brown oil. 1H NMR (CDCl3, 300 MHz): δ  7.06−7.10 (m, 1 H), 
7.27−7.42 (m, 5 H), 7.51 (dd, J = 1.8 Hz, J = 7.7 Hz, 1 H), 7.58 (d, J = 15.8 Hz, 1 H), 
7.88−7.91 (m, 2 H), 7.92 (d, J = 15.8 Hz, 1 H). 13C NMR (CDCl3, 75 MHz):  δ 124.3 (CH), 
125.2 (CH), 125.4 (CH), 128.4 (CH), 128.5 (CH), 128.6 (CH), 133.0 (CH), 136.8 (CH), 137.7 
(Cquat.), 142.7 (CH), 150.0 (CH), 153.1 (Cquat.), 190.3 (Cquat.). EI MS (70 eV), m/z (%): 209 
(M+, 100), 180 (M+- H - CO, 12), 149, 132 (M+- C6H5, 42), 105 (C7H5O+, 8), 104 (M+- C6H5 
- O, 22), 77 (C6H5+, 12). IR (KBr): ν~  3056, 2927, 1722, 1665, 1613, 1594, 1578, 1563, 1446, 
1430, 1329, 1317, 1299, 1289, 1216, 1150, 1014, 991, 972, 759, 691, 593 cm-1. UV/Vis 
(CH2Cl2): λmax (ε) 276 nm (11800), 304 (16100). 
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(E)-3-(4-Trifluormethylphenyl)-1-phenylprop-2-en-1-one (4d)140 
 
F3C
O
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate 5:1) and 
recrystalization from ethanol, 180 mg (65 %) of 4d were isolated as light-yellow crystals. 
M.p.128−29 °C (lit. 116−118 °C).140 1H NMR (CDCl3, 300 MHz): δ 7.49−7.65 (m, 4 H), 
7.66−7.77 (m, 4 H), 7.82 (d, J = 18.9 Hz, 1 H), 8.02−8.05 (m, 2 H). 13C NMR (CDCl3, 75 
MHz):  δ 123.8 (q, J = 272.3 Hz, Cquat.), 124.3 (CH), 125.9 (q, J = 3.8 Hz, CH), 128.5 (CH), 
128.6 (CH), 128.7 (CH), 131.9 (q, J = 32.6 Hz, Cquat.), 133.1 (CH), 137.8 (Cquat.), 138.3 (q, J = 
1.4 Hz, Cquat.), 142.7 (q, J = 0.6 Hz, CH), 190.0 (Cquat.). EI MS (70 eV), m/z (%): 276 (M+), 
257, 207, 199 (M+- C6H5), 179, 171 (M+- C6H5 - CO), 151, 105 (C7H5O+), 77 (C6H5+). IR 
(film): ν~  3063, 2928, 1664, 1637, 1611, 1578, 1448, 1416, 1319, 1170, 1113, 1018, 984, 838, 
779, 738, 697 cm-1. UV/Vis (CH2Cl2): λmax (ε) 294 nm (16522). Anal. calcd. for C16H11F30 
(276.3): C 69.56, H 4.01; found: C 69.43, H 4.10. 
 
(E)-Ethyl 4-(3-oxo-3-phenylprop-1-enyl)benzoate (4e)141 
 
O
EtO2C
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate 5:1) 173 mg (62 
%) of 4e were isolated as brown powder. M.p. 82 °C (lit. 83−84 °C).141 1H NMR (CDCl3, 300 
MHz): δ 1.41 (t, J = 6.9 Hz, 3 H), 4.39 (q, J = 6.9 Hz, 2 H), 7.49-7.62 (m, 4 H), 7.68-7.71 (m, 
2 H), 7.81 (d, J = 15.5 Hz, 1 H), 8.01-8.09 (m, 4 H). 13C NMR (CDCl3, 75 MHz): δ 14.1 
(CH3), 61.0 (CH2), 123.9 (CH), 128.0 (CH), 128.4 (CH), 128.5 (CH), 129.9 (CH), 131.7 
(Cquat.), 132.8 (CH), 137.7 (Cquat.), 138.8 (Cquat.), 143.1 (CH), 165.7 (Cquat.), 190.0 (Cquat.). EI 
MS (70 eV), m/z (%): 280 (M+), 279 (M+- H), 251 (M+- C2H5, 14), 207 (M+- C2H5CO2, 11), 
105 (C7H5O+), 77 (C6H5+). IR (film): ν~  1713, 1684, 1669, 1639, 1608, 1447, 1367, 1319, 
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1280, 1219, 1180, 1124, 1105, 1018, 849, 756, 692, 681, 618 cm-1. UV/Vis (CH2Cl2): λmax (ε) 
248 nm (14400), 310 (14600). 
(E)/(Z)-configurated chalcones were obtained in different ratios from 5:1 up to pure (E)-
chalcone. Characteristic signals for (Z)-chalcone: 1H NMR (CDCl3, 300 MHz): δ 7.05 (d, J = 
12.5 Hz, 1 H). Characteristic signals for (E)-chalcone: 1H NMR (CDCl3, 300 MHz): δ 7.50 (d, 
J = 15.5 Hz, 1 H), 7.81 (d, J = 15.5 Hz, 1 H). 
 
(E)-3-(4-Nitrophenyl)-1-phenylprop-2-en-1-one (4f)142 
 
O
O2N
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate 3:1) 160 mg (63 
%) of 4f were isolated as a yellow solid. M.p. 163−164 °C (lit. 164 °C).142 1H NMR (CDCl3, 
300 MHz): δ 7.49−7.55 (m, 2 H), 7.59−7.64 (m, 1 H), 7.64 (d, J = 15.7 Hz, 1 H), 7.78 (d, J = 
8.7 Hz, 2 H), 7.81 (d, J = 15.6 Hz, 1 H), 8.01−8.04 (m, 2 H), 8.26 (d, J = 8.8 Hz, 2 H). 
13C NMR (CDCl3, 75 MHz): δ 124.2 (CH), 125.7 (CH), 128.6 (CH), 128.8 (CH), 128.9 (CH), 
133.3 (CH), 137.5 (Cquat.), 141.0 (Cquat.), 141.5 (CH), 148.6 (Cquat.), 189.6 (Cquat.). EI MS (70 
eV), m/z (%): 253 (M+, 67), 252 (M+- H, 15), 176 (M+- C6H5, 18), 105 (C7H5O+, 61), 77 
(C6H5+, 100). IR (KBr): ν~  1659, 1609, 1598, 1517, 1340, 1320, 1220, 1016, 983, 845, 784, 
746, 705, 687, 658, 622, 539 cm-1. UV/Vis (CH2Cl2): λmax (ε) 316 nm (25600).  
 
(E)-4-(3-Oxo-3-phenyl-propenyl)-benzolsulfonamide (4g) 
 
O
H2NO2S
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate 1:1) and 
recrystallization from ethanol, 178 mg (62 %) of 4g were isolated as a yellow solid. 
M.p. 182 °C. 1H NMR (CDCl3, 300 MHz): δ 6.68 (s, 2 H), 7.54−7.66 (m, 5 H), 7.81 (d, J = 
15.7 Hz, 1 H), 7.94−8.04 (m, 4 H), 8.17 (d, J = 15.7 Hz, 1 H). 13C NMR (CDCl3, 75 MHz): 
δ 125.3 (CH), 127.4 (CH), 128.7 (CH), 129.2 (CH), 129.4 (CH), 129.5 (CH), 129.6 (CH), 
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129.8 (CH), 132.7 (Cquat.), 133.9 (CH), 138.8 (Cquat.), 139.4 (Cquat.), 142.8 (CH), 146.2 (Cquat.), 
189.8 (Cquat.). EI MS (70 eV), m/z (%): 287 (M+), 286 (M+- H), 271, 210 (M+ - C6H5+), 105 
(C7H5O+), 77 (C6H5+). IR (KBr): ν~  1657, 1605, 1569, 1407, 1337, 1287, 1221, 1182, 1165, 
1096, 1017, 979, 827, 778, 724, 698, 646, 576, 544 cm-1. UV/Vis (CH2Cl2): λmax (ε) 272 nm 
(11000), 300 (18900). Anal. calcd. for C15H13NO3S  (287.3): C 62.70, H 4.56, N 4.87, 
S 11.16; found: C 62.39, H 4.62, N 4.86, S 11.03. 
 
(E)-4-(3-Oxo-3-(thiophen-2-yl)prop-1-enyl)benzonitrile (4h)143 
 
O
NC
S
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate 1:1) 208 mg (87 
%) of 4h were isolated as a light brown powder. M.p. 187 °C. 1H NMR (CDCl3, 300 MHz): 
δ 7.19 (dd, J = 3.6 Hz, J = 4.8 Hz, 1 H), 7.45 (d, J = 15.6 Hz, 1 H), 7.71−7.73 (m, 5 H), 7.78 
(d, J = 15.3 Hz, 1 H), 7.87 (dd, J = 0.9 Hz, J = 3.9 Hz, 1 H). 13C NMR (CDCl3, 75 MHz): 
δ 113.5 (Cquat.), 118.3 (Cquat.), 124.7 (CH), 128.4 (CH), 128.7 (CH), 132.3 (CH), 132.7 (CH), 
134.6 (CH), 139.0 (Cquat.), 141.4 (Cquat.), 145.0 (CH), 181.3 (Cquat.). EI MS (70 eV), m/z (%): 
239 (M+, 85), 156 (M+ - C4H3S, 40), 111 (C5H3OS+, 100). IR (KBr): ν~  3436 cm-1, 2226, 
1651, 1597, 1559, 1513, 1413, 1355, 1331, 1302, 1241, 1227, 1179, 1087, 1065, 975, 862, 
827, 740, 549. UV/Vis (CH2Cl2): λmax (ε) 300 nm (25400), 318 (32900).  
 
 (E)-4-(3-Oxo-3-(thiophen-3-yl)prop-1-enyl)benzonitrile (4i) 
 
O
NC
S
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate 1:1) 167 mg 
(70 %) of 4i were isolated as a brown oil. 1H NMR (CDCl3, 300 MHz): δ 7.38 (dd, J = 3.0 
Hz, J = 6.0 Hz, 1 H), 7.45 (d, J = 15.6 Hz, 1 H), 7.66 (dd, J = 1.5 Hz, J = 5.1 Hz, 1 H), 
7.70−7.72 (m, 4 H), 7.74 (d, J = 15.9 Hz, 1 H). 13C NMR (CDCl3, 75 MHz): δ 113.4 (Cquat.), 
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118.3 (Cquat.), 125.7 (CH), 126.8 (CH), 127.3 (CH), 128.5 (CH), 128.6 (CH), 132.6 (CH), 
132.7 (CH), 139.1 (Cquat.), 141.4 (Cquat.), 141.3 (CH), 142.6 (Cquat.), 183.0 (Cquat.). EI MS (70 
eV), m/z (%): 239 (M+, 85), 111 (C5H3OS+, 100). HRMS calcd. for C14H9NOS: 239.0405; 
found 239.0415. 
 
 (E)-4-(3-oxohex-1-enyl)benzonitrile (4j) 
 
O
NC
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate 1:1) and 
recrystallization from ethanol, 123 mg ( 62 %) of 4j were isolated as a brown oil. 1H NMR 
(CDCl3, 300 MHz): δ 0.94 (t, J = 7.2 Hz, 3 H), 1.61−1.76 (m, 2 H), 2.62 (t, J = 7.5 Hz, 2 H), 
6.74 (d, J = 16.2 Hz, 1 H), 7.45 (d, J = 16.2 Hz, 1 H), 7.57−7.65 (m, 4 H). 13C NMR (CDCl3, 
75 MHz): δ 13.7 (CH3), 17.5 (CH2), 43.2 (CH2), 113.3 (Cquat.), 118.3 (Cquat.), 128.4 (CH), 
128.5 (CH), 131.9 (CH), 132.5 (CH), 138.9 (Cquat.), 139.5 (CH), 199.7 (Cquat.). EI MS (70 eV), 
m/z (%): 199 (M+, 20), 156 (M+ - C3H7, 100), 128 (M+ - C3H7CO, 60), 71 (C3H7CO, 11). 
HRMS calcd. for C13H13NO: 199.0997; found 199.1000. 
 
(E)-Chalcone (4l)144 
 
O
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 191 mg 
(92 %) of 4m were isolated as light yellow crystals. M.p. 58 °C (lit. 57−59 °C).145 1H NMR 
(C3D6O, 300 MHz), δ  7.44–7.46 (m, 3 H), 7.53–7.58 (m, 2 H), 7.62–7.66 (m, 2 H), 7.77–7.90 
(m, 4 H), 8.14–8.17 (m, 2 H). 13C NMR (C3D6O, 100 MHz), δ 122.0 (CH), 128.4 (CH), 128.6 
(CH), 128.64 (CH), 128.8 (CH), 128.9 (CH), 132.8 (CH), 135.1 (Cquat.), 138.2 (Cquat.), 144.0 
(CH), 189.1 (Cquat.). (70 eV, EI): m/z (%): 208.0 (M+, 70), 131 (M+ - C6H5, 45), 105 (M+ - 
C9H7O, 28), 77 (C6H5+, 100). 
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(E)-1-Phenyl-3-p-tolylprop-2-en-1-one (4m)146 
 
O
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 204 mg 
(92 %) of 4m were isolated as yellow crystals. M.p. 75 °C (lit. 73−75°C).147 1H NMR (CDCl3, 
300 MHz), δ  2.4 (s, 3 H), 7.22 (d, J = 8.1 Hz, 2 H), 7.47–7.59 (m, 6 H), 7.78 (d, J = 15.3 Hz, 
1 H), 8.00−8.03 (m, 2 H). 13C NMR (C3D6O, 100 MHz), δ  21.5 (CH3), 121.2 (CH), 128.5 
(CH), 128.6 (CH), 129.0 (CH), 129.7 (CH), 132.2 (Cquat.), 132.7 (CH), 138.4 (Cquat.), 141.1 
(Cquat.), 145.0 (CH), 190.7 (Cquat.). (70 eV, EI): m/z (%): 222.1 (M+, 80), 207.05 (M+ - CH3, 
100), 179.06 (M+ - CH3CO, 20), 77 (C6H5+, 25). IR (KBr), ~ν  3442 cm-1, 3347, 1659, 1626, 
1598, 1582, 1494, 1448, 1342, 1311, 1284, 1216, 1179, 1033, 1019, 983, 772, 708, 689, 584. 
UV/vis (CH2Cl2), λmax (ε) 264 nm (7000), 320 (20500). 
 
 (E)-3-(4-Methoxyphenyl)-1-phenylprop-2-en-1-one (4n)148 
 
O
O
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 202 mg 
(85 %) of 4n were isolated as yellow crystals. M.p. 75 °C (lit. 76-77 °C).149 1H NMR (CDCl3, 
300 MHz), δ  3.62 (s, 3 H), 6.70 (d, J = 8.0 Hz, 2 H), 7.05–7.40 (m, 6 H), 7.55 (d, J = 15.5 
Hz, 1 H), 7.78 (d, J = 9.0 Hz, 2 H). 13C NMR (C3D6O, 100 MHz), δ 55.4 (CH3), 114.5 (CH), 
119.8 (CH), 127.6 (Cquat.), 128.4 (CH), 128.6 (CH), 130.3 (CH), 132.6 (CH),   138.5 (Cquat.), 
144.7 (CH), 161.7 (Cquat.), 190.5 (Cquat.). (70 eV, EI): m/z (%): 238.1 (M+, 100), 223 (M+ - 
CH3, 18), 207 (M+ - CH3O, 15), 77 (C6H5+, 19). HRMS calcd. for C16H14O2: 238.0993; found 
238.0981. 
 
 
 
 
6 Experimental Part  135 
  
 (E)-3-(3-Aminophenyl)-1-phenylprop-2-en-1-one (4o)150 
 
ONH2
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 1:1), 162 mg 
(73 %) of 4o were isolated as yellow crystals. M.p. 163 °C. 1H NMR (CDCl3, 300 MHz), 
δ 3.8 (s, 2 H), 6.75 (dd, J = 8.0 Hz, J = 2.0 Hz, 1 H), 6.97 (s, 1 H), 7.06 (d, J = 8.3 Hz, 1 H), 
7.20–7.29 (m, 1 H), 7.47–7.64 (m, 4 H), 7.72 (d, J = 15.8 Hz, 1 H), 8.03 (d, J = 7.0 Hz, 2 H). 
13C NMR (C3D6O, 100 MHz), δ 114.5 (CH), 117.4 (CH), 119.0 (CH), 122.0 (CH), 128.5 
(CH), 128.6 (CH),   1129.9 (CH), 132.7 (CH), 135.9 (Cquat.), 138.3 (Cquat.), 145.2 (CH), 146.9 
(Cquat.), 190.7 (Cquat.). (70 eV, EI): m/z (%): 223.08 (M+, 100), 207.06 (M+ - NH2, 35), 146.04 
(M+ - C6H5, 18), 77 (C6H5+, 18). IR (KBr), ~ν  3442, 3347, 1659, 1626, 1598, 1582, 1494, 
1448, 1342, 1311, 1284, 1216, 1179, 1033, 1019, 983, 772, 708, 689, 584 cm-1. UV/vis 
(CH2Cl2), λmax (ε) 266 nm (16300), 308 (18800). 
 
6.3 General Procedure for the Coupling-Isomerization-Enamine-Addition-
Amino-Cyclocondensation Sequence to Pyridines 10 
 
A magnetically stirred solution of 1.0-2.0 mmols of 1, 1.05-2.8 mmols of propargyl 
alcohol 2, 28 mg (0.04 mmols) of Pd(PPh3)2Cl2, and 4 mg (0.02 mmols) of CuI in 4 mL of a 
degassed mixture of triethylamine and THF (3 : 1) or in 4 mL of triethylamine or 
diethylamine under nitrogen was heated to reflux temperature for 12-16 h. After cooling to 
room temperature 2.5−7 mmols of enamine 5 in 1 mL of triethylamine were added and the 
reaction mixture was heated to reflux temperature for 16 h. After cooling to room temperature 
(4-8 mmols) of ammonium chloride (9) and 5 mL of acetic acid were added and the mixture 
was heated to reflux temperature for the time indicated. After cooling to room temperature, 
40 mL of an aqueous solution of K2CO3 and 40 mL of ethylacetate were added. The aqueous 
layer was extracted several times with ethylacetate (4 x 20 mL). The combined organic phases 
were dried with magnesium sulfate and the solvents were removed in vacuo and the residue 
was chromatographed on silica gel (hexane/ethylacetate or n-heptane/ethylacetate 2:1) and/or 
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recrystallized from ethanol to give the analytically pure tetrahydronaphthyridines, 
dihydropyrindines and tetrahydroquinolines 10.  
 
Table 26 Experimental details for one-pot synthesis of pyridine derivatives 10 
Entry Aryl halide 1 Propargyl 
alcohol 2 
Enamine 5 Amine 9 t 
(h) 
Pyridines 10  
(Yield, %) 
1[a,b] 182 mg 
(1.00 mmol) 
of 1a 
139 mg (1.05 
mmols) of 2a 
300 mg (1.25 
mmols) of 5a 
214 mg (4.00 
mmols) of 9 
24 234 mg (61 %) 
of 10a 
2[a,b] 160 mg 
(1.00 mmol) 
of 1b 
139 mg (1.05 
mmols) of 2a 
300 mg (1.25 
mmols) of 5a 
214 mg (4.00 
mmols) of 9 
24 206 mg (57 %) 
of 10b 
3[a,b] 159 mg 
(1.00 mmol) 
of 1c 
139 mg (1.05 
mmols) of 2a 
300 mg (1.25 
mmols) of 5a 
214 mg (4.00 
mmols) of 9 
24 148 mg (41 %) 
of 10c 
4[a,b] 225 mg 
(1.00 mmol) 
of 1d 
139 mg (1.05 
mmols) of 2a 
300 mg (1.25 
mmols) of 5a 
214 mg (4.00 
mmols) of 9 
24 248 mg (58 %) 
of 10d 
5[b,c] 322 mg 
(2.03 
mmols) of 
1b 
278 mg (2.10 
mmols) of 2a 
404 mg (2.64 
mmols) of 5b 
428 mg (8.00 
mmols) of 9 
48 330 mg (59 %) 
of 10e 
6[b,c] 320 mg 
(2.03 
mmols) of 
1c 
278 mg (2.10 
mmols) of 2a 
404 mg (2.64 
mmols) of 5b 
428 mg (8.00 
mmols) of 9 
36 344 mg (62 %) 
of 10f 
7[c,d] 455 mg 
(2.02 
mmols) of 
1d 
278 mg (2.10 
mmols) of 2a 
404 mg (2.64 
mmols) of 5b 
428 mg (8.00 
mmols) of 9 
48 368 mg (54 %) 
of 10g 
8[b,c] 465 mg 
(2.03 
mmols) of 
1e 
278 mg (2.10 
mmols) of 2a 
404 mg (2.64 
mmols) of 5b 
428 mg (8.00 
mmols) of 9 
36 296 mg (42 %) 
of 10h 
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Table 26 continued      
9[a] 364 mg 
(2.00 
mmols) of 
1a 
280 mg (2.10 
mmols) of 2a 
460 mg (2.84 
mmols) of 5c 
428 mg (8.00 
mmols) of 9 
14 432 mg (70 %) 
of 10i 
10[b,c] 322 mg 
(2.03 
mmols) of 
1b 
 
278 mg (2.10 
mmols) of 2a 
427 mg (2.55 
mmols) of 5c 
428 mg (8.00 
mmols) of 9 
48 290 mg (50 %) 
of 10j 
11[c,d] 320 mg 
(2.03 
mmols) of 
1c 
278 mg (2.10 
mmols) of 2a 
427 mg (2.55 
mmols) of 5c 
428 mg (8.00 
mmols) of 9 
48 372 mg (64 %) 
of 10k 
12[a,b] 182 mg 
(1.00 mmol) 
of 1a 
139 mg (1.05 
mmols) of 2a 
275 mg (1.25 
mmols) of 5d 
214 mg (4.00 
mmols) of 9 
24 177 mg (54 %) 
of 10l 
13[a,b] 159 mg 
(0.87 
mmols) of 
1a 
139 mg (1.05 
mmols) of 2a 
245 mg (1.25 
mmols) of 5e 
214 mg (4.00 
mmols) of 9 
24 136 mg (46 %) 
of 10m 
14[b,c] 161 mg 
(1.01 
mmols) of 
1b 
139 mg (1.05 
mmols) of 2a 
427 mg (2.26 
mmols) of 5f 
214 mg (4.00 
mmols) of 9 
48 211 mg (68 %) 
of 10n 
15[a,b] 160 mg 
(1.00 mmol) 
of 1b 
139 mg (1.05 
mmols) of 2a 
275 mg (1.25 
mmols) of 5d 
214 mg (4.00 
mmols) of 
10a 
24 132 mg (39 %) 
of 10o 
[a]Reaction time of the CIR 16 h. [b]In NEt3. [c]Reaction time of the CIR 12 h. [d]In HNEt2. 
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4-(4-Cyano-phenyl)-2-phenyl-7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid ethyl 
ester (10a) 
 
N
CN
NEtO2C
 
 
According to the GP after work up, chromatography on silica gel (hexane/ethyl acetate, 4:1) 
and recrystallization from ethanol, 234 mg (61 %) of 10a were isolated as light yellow 
crystals. M.p. 189 ºC. 1H NMR (CDCl3, 300 MHz), δ 1.20−1.31 (m, 3 H), 3.19 (t,  J = 6.0 Hz, 
2 H), 3.83 (t, J = 6.1 Hz, 2 H), 4.10 (q, J = 7.1 Hz, 2 H),  4.48 (s, 2 H),  7.38−7.49 (m, 6 H), 
7.77 (d, J = 8.2 Hz, 2 H), 7.96 (dd, J = 1.5, 8.2 Hz, 2 H). 13C NMR (CDCl3, 75 MHz), δ 14.7 
(CH3), 32.6 (CH2), 41.4 (CH2), 43.6 (CH2), 61.7 (CH2), 112.5 (Cquat.), 118.3 (Cquat.), 119.0 
(CH), 126.9 (CH), 128.8 (CH), 129.2 (CH), 129.2 (CH), 132.6 (CH), 138.6 (Cquat.), 142.8 
(Cquat.), 155.5 (Cquat.), 155.7 (Cquat.). MS (70 eV, EI): m/z (%): 383 (M+, 18), 354 (M+ 
- CH2CH3, 100), 310 (M+ - CO2CH2CH3, 55). IR (KBr), ~ν  2984 cm-1, 2225, 1698, 1591, 
1545, 1482, 1468, 1418, 1386, 1329, 1270, 1240, 1190, 1135, 1103, 1024, 846, 781, 697. 
UV/vis (CH2Cl2), λmax (ε) 254 nm (47900), 300 (12900). Anal. calcd. for C22H14N2S (383.4): 
C 75.18, H 5.52, N 10.96; found C 74.91, H 5.53, N 10.83. 
 
2-Phenyl-4-pyrimidin-2-yl-7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid ethyl 
ester (10b) 
 
NN
N
NEtO2C
 
 
According to the GP after work up, chromatography on silica gel (hexane/ethyl acetate, 4:1) 
and recrystallization from ethanol, 206 mg (57 %) of 10b were isolated as yellow crystals. 
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M.p. 163 ºC. 1H NMR (CDCl3, 300 MHz), δ 1.18−1.23 (m, 3 H), 3.13 (t,  J = 6.0 Hz, 2 H), 
3.78 (t, J = 6.1 Hz, 2 H), 4.05 (q, J = 7.1 Hz, 2 H), 5.00 (s, 2 H), 7.23 (t, J = 4.9 Hz, 1 H), 
7.29−7.41 (m, 3 H), 7.73 (d, J = 8.1 Hz, 2 H), 7.96 (dt, J = 1.5, 6.9 Hz, 2 H), 8.16 (s, 1 H), 
8.80 (d, J = 4.9 Hz, 2 H). 13C NMR (CDCl3, 75 MHz), δ 14.7 (CH3), 33.0 (CH2), 41.1 (CH2), 
44.6 (CH2), 61.4 (CH2), 119.4 (CH.), 119.8 (CH), 125.7 (CH), 126.9 (CH), 128.6 (CH), 128.8 
(CH), 138.9 (Cquat.), 155.5 (Cquat.), 155.5 (Cquat.), 157.1 (CH), 164.7 (Cquat.). MS (70 eV, EI): 
m/z (%): 360 (M+, 92), 287 (M+ - CO2CH2CH3, 100), 260 (M+, 58). IR (KBr), ~ν  2984 cm-1, 
2939, 1685, 1589, 1542, 1468, 1437, 1415, 1385, 1306, 1287, 1274, 1169, 1105, 818, 782, 
739, 704. UV/vis (CH2Cl2), λmax (ε) 250 nm (30900), 288 (6000), 312 (8100). Anal. calcd. for 
C21H20N4O2 (360.4): C 69.98, H 5.59, N 15.55; found C 69.52, H 5.56, N 15.22. 
 
2-Phenyl-4-pyridin-2-yl-7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid ethyl ester 
(10c) 
 
N
N
NEtO2C
 
 
According to the GP after work up, chromatography on silica gel (hexane/ethyl acetate, 4:1), 
148 mg (41 %) of 10c were isolated as a yellow oil. 1H NMR (CDCl3, 300 MHz), δ 1.20−1.26 
(m, 3 H), 3.13 (t,  J = 6.0 Hz, 2 H), 3.85 (t, J = 6.1 Hz, 2 H), 4.12 (q, J = 7.0 Hz, 2 H),  4.82 
(s, 2 H),  7.42−7.51 (m, 4 H), 7.76 (dd, J = 1.0, 8.0 Hz, 1 H), 7.85 (s, 1 H), 7.97 (dt, J = 1.8, 
8.0 Hz, 1 H),  8.16−8.20 (m, 2 H), 8.74−8.76 (m, 1 H). 13C NMR (CDCl3, 75 MHz), δ 14.9 
(CH3), 33.4 (CH2), 42.0 (CH2), 44.7 (CH2), 61.7 (CH2), 119.2 (CH.), 124.1 (CH), 124.9 (CH), 
127.5 (CH), 129.4 (CH), 129.7 (CH), 138.0 (CH), 139.8 (Cquat.), 147.5 (Cquat.), 151.4 (CH), 
156.3 (Cquat.), 157.8 (Cquat.). IR (KBr), ~ν  2980 cm-1, 1696, 1583, 1547, 1430, 1384, 1332, 
1271, 1239, 1203, 1172, 1144, 1107, 1048, 1024, 794, 774, 748, 696. UV/vis (CH2Cl2), λmax 
(ε) 254 nm (19100), 300 (9100), 366 (900). HRMS calcd. for C22H21N3O2: 359.1634; found 
359.1645.   
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2-Phenyl-4-(4-trifluoromethyl-phenyl)-7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic 
acid ethyl ester (10d) 
 
N
CF3
NEtO2C
 
 
According to the GP after work up, chromatography on silica gel (hexane/ethyl acetate, 4:1) 
and recrystallization from ethanol, 248 mg (58 %) of 10d were isolated as yellow crystals. 
M.p. 126 ºC. 1H NMR (CDCl3, 300 MHz), δ 1.22−1.25 (m, 3 H), 3.19 (t,  J = 6.1 Hz, 2 H), 
3.84 (t, J = 6.1 Hz, 2 H), 4.11 (q, J = 7.1 Hz, 2 H), 4.51 (s, 2 H), 7.38−7.49 (m, 6 H), 7.73 (d, 
J = 8.1 Hz, 2 H), 7.96−7.99 (m, 2 H). 13C NMR (CDCl3, 75 MHz), δ 14.7 (CH3), 32.6 (CH2), 
41.4 (CH2), 43.6 (CH2), 61.6 (CH2), 119.3 (CH.), 119.0 (CH), 125.7 (CH), 125.8 (CH), 125.8 
(CH), 126.9 (CH), 128.7 (CH), 130.4 (CH), 130.9 (CH), 138.8 (Cquat.), 141.7 (Cquat.), 155.5 
(Cquat.), 155.5 (Cquat.), 155.7 (Cquat.). MS (70 eV, EI): m/z (%): 426 (M+, 10), 397 (M+ 
- CH2CH3, 100), 353 (M+ - CO2CH2CH3, 30). IR (KBr), ~ν  2984 cm-1, 1698, 1592, 1548, 
1469, 1431, 1387, 1326, 1284, 1270, 1243, 1198, 1169, 1129, 1108, 1065, 1019, 847, 778, 
696. UV/vis (CH2Cl2), λmax (ε) 250 nm (22400), 288 (10000), 298 (9500). Anal. calcd. for 
C24H21N2O2 (426.4): C 67.60, H 4.96, N 6.57; found C 67.30, H 5.19, N 6.81. 
 
2-Phenyl-4-pyrimidin-2-yl-6,7-dihydro-5H-[1]pyrindine (10e) 
 
N
NN
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 4:1) and 
recrystallization from ethanol 330 mg (59 %) of 10e were isolated as light brown crystals. 
M.p. 120 °C.  1H NMR (CDCl3, 300 MHz), δ 2.09-2.20 (m, 2 H), 3.11 (t, J = 7.8 Hz, 2 H), 
6 Experimental Part  141 
  
3.38 (t, J = 7.5 Hz, 2 H), 7.16 (t, J = 4.8 Hz, 1 H), 7.25−7.47 (m, 3 H), 8.02−8.06 (m, 2 H), 
8.37 (s, 1 H), 8.79 (d, J = 4.8 Hz, 2 H). 13C NMR (CDCl3, 75 MHz), δ 22.9 (CH2), 32.0 
(CH2), 34.1 (CH2), 117.6 (CH), 119.3 (CH), 126.9 (CH), 127.1 (CH), 128.3 (CH), 128.4 
(CH), 128.5 (CH), 133.9 (Cquat.), 139.5 (Cquat.), 141.5 (Cquat.), 156.1 (Cquat.), 156.7 (CH), 156.8 
(CH), 164.4 (Cquat.), 167.6 (Cquat.). MS (70 eV, EI): m/z (%): 273 (M+, 100), 245 (M+ - C2H4, 
5), 194 (M+ - C5H5N 8). IR (KBr), ~ν  = 3063 cm-1, 3040, 2961, 1592, 1569, 1548, 1457, 1424, 
1375, 1261, 1232, 1186, 1176, 1075, 818, 773, 696, 628. UV/vis (CH2Cl2), λmax (ε) 250 nm 
(30900), 290 (5100), 342 (6600). Anal. calcd. for C18H15N3 (273.3): C 79.10, H 5.53, N 15.37; 
found C 78.66, H 5.53, N 14.55. 
 
2-Phenyl-4-pyridin-2-yl-6,7-dihydro-5H-[1]pyrindine (10f) 
 
N
N
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 4:1) and 
recrystallization from ethanol 344 mg (62 %) of 10f were isolated as light brown crystals. 
M.p. 93 °C.  1H NMR (CDCl3, 300 MHz), δ 2.06−2.17 (m, 2 H), 3.10−3.17 (m, 4 H), 
7.22−7.44 (m, 4 H), 7.45−7.69 (m, 1 H), 7.70 (dt, J = 1.8, 7.7 Hz, 1 H), 7.87 (s, 1 H), 
8.00−8.03 (m, 2 H), 8.70−8.72 (m, 1 H). 13C NMR (CDCl3, 75 MHz), δ 23.2 (CH2), 30.9 
(CH2), 34.3 (CH2), 117.3(CH), 122.7 (CH), 122.8 (CH), 126.8 (CH), 128.3 (CH), 128.4 (CH), 
133.2 (Cquat), 136.3 (CH), 139.6 (Cquat), 143.8 (Cquat), 149.5 (CH), 156.24 (Cquat), 156.28 
(Cquat), 167.0 (Cquat.). MS (70 eV, EI): m/z (%): 272.1 (M+, 100), 217.1 (M+ - C3H6N 10), 
167.1 (M+ - C5H6N 12). IR (KBr), ~ν  3060 cm-1, 2957, 2927, 1587, 1577, 1556, 1476, 1458, 
1434, 1423, 1376, 1231, 992, 879, 793, 778, 748, 733, 696. UV/vis (CH2Cl2), λmax (ε) 248 nm 
(24000), 266 (21900), 310 (8300). Anal. calcd. for C19H16N2 (272.4): C 83.79, H 5.90, 
N 10.29; found C 83.31, H 6.10, N 10.06. 
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2-Phenyl-4-(4-trifluoromethyl-phenyl)-6,7-dihydro-5H-[1]pyrindine (10g) 
 
N
CF3
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 4:1) and 
recrystallization from ethanol, 368 mg (54 %) of 10g were isolated as light-brown crystals. 
M.p. 115−118 °C. 1H NMR (CDCl3, 300 MHz), δ 2.12−2.22 (m, 2 H), 3.01 (t, J = 7.3 Hz, 2 
H), 3.17 (t, J = 7.6 Hz, 2 H), 7.37−7.5 (m, 3 H), 7.50 (s, 1 H), 7.62−7.76 (m, 4 H), 7.97−7.99 
(m, 2 H). 13C NMR (CDCl3, 75 MHz), δ 23.5 (CH2), 30.4 (CH2), 34.6 (CH2), 118.0 (CH), 
122.2 (CH), 125.6 (CH), 125.5 (CH), 125.6 (CH), 125.8 (Cquat.), 133.2 (Cquat.), 139.3 (Cquat.), 
142.5 (Cquat.), 144.7 (Cquat.), 156.6 (Cquat.), 166.9 (Cquat.). MS (70eV, EI): m/z (%): 339 (M+, 
65), 338 (M+ - H, 100), 320 (M+ - F, 7), 270 (M+, - F, - HF, 7). IR (KBr), ~ν  = 3058 cm-1, 
2993,2974, 2954, 2885, 2836, 1619, 1592, 1576, 1560, 1438, 1425, 1412, 1373, 1324, 1160, 
1134, 1126, 1109, 1065, 1016, 846, 776, 695. UV/vis (CH2Cl2), λmax (ε) 254 nm (30900), 306 
(8700). Anal. calcd. for C21H16F3N (339.4): C 74.33, H 4.75, N 4.13; found C 74.08, H 4.45, 
N 4.25. 
 
4-(2-Phenyl-6,7-dihydro-5H-[1]pyrindin-4-yl)-benzoic acid ethyl ester (10h) 
 
N
CO2Et
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 4:1) and 
recrystallization from ethanol 296 mg (42 %) of 10h were isolated as light yellow crystals. 
M.p. 95−96 °C.  1H NMR (CDCl3, 300 MHz), δ 1.42 (t, J = 7.1 Hz, 3 H), 2.15 (m, 2 H), 3.03 
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(t, J = 7.3 Hz, 2 H), 3.16 (t, J = 7.6 Hz, 2 H) 4.4 (q, J = 7.1 Hz, 2 H), 7.32−7.48 (m, 3 H), 7.51 
(s, 1 H), 7.56 (dt, J = 1.8, 8.6 Hz, 2 H), 7.96−7.98 (m, 2 H), 8.13 (d, J = 8.3 Hz, 2 H). 
13C NMR (CDCl3, 75 MHz), δ 14.3 (CH3), 23.5 (CH2), 30.5 (CH2), 34.7 (CH2), 61.1 (CH2), 
117.9 (CH), 127.0 (CH), 128.1 (CH), 128.6 (CH), 128.7 (CH), 129.8 (CH), 130.2 (Cquat.), 
133.1 (Cquat.), 139.5 (Cquat.), 143.3 (Cquat.), 144.9 (Cquat.), 156.5 (Cquat.), 166.2 (Cquat.), 166.8 
(Cquat.). MS (70 eV, EI): m/z (%): 343 (M+, 100), 342 (M+ - H, 70), 314 (M+ - C2H5, 38). IR 
(KBr), ~ν  2975 cm-1, 1715, 1610, 1591, 1577, 1554, 1458, 1440, 1424, 1367, 1311, 1274, 
1182, 1106, 1021, 859, 776, 708, 698. UV/vis (CH2Cl2), λmax (ε) 262 nm (34700), 308 (7800). 
Anal. calcd. for C23H21NO2 (343.4): C 80.44, H 6.16, N 4.08; found C 80.11, H 6.19, N 4.08. 
 
4-(2-Phenyl-5,6,7,8-tetrahydroquinolin-4-yl)-benzonitrile (10i) 
 
N
CN
 
 
According to the GP after chromatography on silica gel (cyclohexane/ethylacetate 1:1) and 
recrystallization from ethanol 432 mg (70 %) of analytically pure 10i were isolated as 
colorless crystals. M.p. 194−195 °C. 1H NMR (CDCl3, 400 MHz), δ 1.77 (m, J = 7.0 Hz, 2 
H), 1.95 (m, J = 6.0 Hz, 2 H), 2.59 (t, J = 6.4 Hz, 2 H), 3.10 (t, J = 6.6 Hz, 2 H), 7.26 (s, 1 H), 
7.34−7.50 (m, 5 H), 7.75 (dd, J = 8.6 Hz, J = 2.0 Hz, 2 H), 7.96 (dd, J = 8.0 Hz, J = 1.8 Hz, 2 
H). 13C NMR (CDCl3, 100 MHz), δ 22.8 (CH2), 22.9 (CH2), 27.1 (CH2), 33.2 (CH2), 111.7 
(Cquat.), 118.3 (CH.), 118.5 (Cquat.), 126.8 (CH.), 127.8 (Cquat.), 128.7 (CH), 128.7 (CH), 129.4 
(CH), 132.2 (CH
.
), 139.2 (Cquat.), 144.5 (Cquat.), 148.2 (Cquat.), 154.6 (Cquat.), 158.1 (Cquat.). MS 
(70 eV, EI): m/z (%): 310 (M+, 92), 309 (M+ - H, 100). IR (KBr), ~ν  2934 cm-1, 2224 (C≡N), 
1590, 1537, 1442, 1433, 1381, 901, 843, 774, 691, 590. Anal. calcd. for C22H18N2 (310.4): C 
85.13, H 5.85, N 9.02; found C 84.80, H 5.87, N 8.94. 
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2-Phenyl-4-pyrimidin-2-yl-5,6,7,8-tetrahydro-quinoline (10j) 
 
N
NN
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 4:1) and 
recrystallization from ethanol 290 mg (50 %) of 10j were isolated as light brown crystals. 
M.p. 120 °C. 1H NMR (CDCl3, 300 MHz), δ 1.33−1.82 (m, 2 H), 1.90−2.16 (m, 2 H), 2.94 (t, 
J = 6.4 Hz, 2 H), 3.11 (t, J =6.4 Hz, 2 H), 7.26 (t, J = 4.8 Hz, 1 H), 7.32-7.46 (m, 3 H), 7.84 
(s, 1 H), 7.98−8.02 (m, 2 H), 8.85 (d, J 4.8 Hz, 2 H). 13C NMR (CDCl3, 75 MHz), δ 22.6 
(CH2), 22.7 (CH2), 26.7 (CH2), 33.3 (CH2), 118.8 (CH), 119.3 (CH), 126.7 (CH), 128.3 (CH), 
128.9 (CH), 129.1 (Cquat.), 139.3 (Cquat.), 145.8 (Cquat.), 154.3 (Cquat.), 156.8 (CH), 158.2 
(Cquat.), 166.1 (Cquat.). MS (70 eV, EI): m/z (%): 287 (M+, 100), 272 (M+ - CH3, 32), 259 (M+ 
- C2H4, 12). IR (KBr), ~ν  3050 cm-1, 2939, 2915, 2878, 2857, 1592, 1564, 1543, 1456, 1440, 
1419, 1378, 1228, 845, 831, 771, 736, 694, 633. UV/vis (CH2Cl2), λmax (ε) 250 nm (26300), 
286 (7100), 308 (7600). Anal. calcd. for C19H17N3 (287.4): C 79.41, H 5.96, N 14.62; found C 
79.15, H 5.93, N 14.49. 
 
2-Phenyl-4-pyridin-2-yl-5,6,7,8-tetrahydro-quinoline (10k) 
 
N
N
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 4:1) and 
recrystallization from ethanol 372 mg (64 %) of 10k were isolated as red-brown crystals. M.p. 
95−96 °C.  1H NMR (CDCl3, 300 MHz), δ 1.73−1.81 (m, 2 H), 1.90−2.03 (m, 2 H), 2.74 (t, J 
= 6.36 Hz, 2 H), 3.07 (t,  J = 6.45 Hz, 2 H), 7.29−7.46 (m, 5 H), 7.52 (s, 1 H), 7.76 (dt, J = 
6 Experimental Part  145 
  
1.8, 7.7 Hz, 1 H), 7.95−7.99 (m, 2 H), 8.71−8.73 (m, 1 H). 13C NMR (CDCl3, 75 MHz), 
δ 22.7 (CH2), 22.8 (CH2), 22.6 (CH2), 33.2 (CH2), 118.5 (CH), 122.4 (CH), 123.6 (CH), 126.7 
(CH), 128.3 (CH), 128.4 (CH), 136.6 (CH), 139.4 (Cquat.), 148.2 (Cquat.), 149.2 (CH), 154.3 
(Cquat.), 157.9 (Cquat.). MS (70 eV, EI): m/z (%): 287 (M+ + 1, 28), 286 (M+ - C2H4, 68), 77 
(C6H5+, 100). IR (KBr), ~ν  2936 cm-1, 2858, 1630, 1583, 1567, 1544, 1473, 1455, 1444, 1429, 
1383, 793, 776, 753, 695, 657, 602, 584, 549. UV/vis (CH2Cl2), λmax (ε) 240 nm (19500), 258 
(21400), 300 (9300). Anal. calcd. for C20H18N2 (286.4): C 83.88, H 6.34, N 9.78; found 
C 83.76, H 6.30, N 9.80. 
 
4-[2-(4-Methoxy-phenyl)-6-phenyl-pyridin-4-yl]-benzonitrile (10l) 
 
N
CN
MeO
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate, 4:1) and 
recrystallization from ethanol 177 mg (54 %) of 10l were isolated as colorless crystals. M.p. 
134−135 ºC. 1H NMR (CDCl3, 300 MHz), δ 3.88 (s, 3 H), 7.02 (d, J = 8.9 Hz, 2 H), 
7.45−7.54 (m, 3 H), 7.75−7.79 (m, 6 H), 8.13−8.19 (m, 4 H). 13C NMR (CDCl3, 75 MHz), 
δ 55.4 (OCH3), 112.5 (Cquat.), 114.1 (CH), 116.0 (CH), 116.1 (CH), 118.5 (Cquat.), 127.0 (CH), 
127.9 (CH), 128.4 (CH), 128.7 (CH), 129.3 (CH), 131.6 (Cquat.), 132.8 (CH), 139.1 (Cquat.), 
143.6 (Cquat.), 148.0 (Cquat.), 157.4 (Cquat.), 157.7 (Cquat.), 160.8 (Cquat.). MS (70 eV, EI): m/z 
(%): 362 (M+, 100), 347 (M+ - CH3, 20). IR (KBr), ~ν  2922 cm-1, 2227, 1599, 1580, 1566, 
1542, 1513, 1432, 1417, 1391, 1249, 1178, 1209, 831, 776, 694, 586, 547, 516. UV/vis 
(CH2Cl2), λmax (ε) 250 nm (36300), 282 (28200), 332 (5900). Anal. calcd. for C25H18N2O 
(326.4): C 82.85, H 5.01, N 7.73; found C 82.61, H 5.01, N 7.71. 
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4-(2-Phenyl-6-thiophen-2-yl-pyridin-4-yl)-benzonitrile (10m) 
 
N
CN
S
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate, 4:1) and 
recrystallization from ethanol 136 mg (46 %) of 10m were isolated as yellow crystals. M.p. 
192 ºC. 1H NMR (CDCl3, 300 MHz), δ 7.14−7.16 (m, 1 H), 7.33−7.54 (m, 4 H), 7.71−7.74 
(m, 3 H), 7.80−7.81 (m, 4 H), 8.14−8.17 (m, 2H). 13C NMR (CDCl3, 75 MHz), δ 112.6 
(Cquat.), 114.8 (CH), 116.3 (CH), 118.2 (Cquat.), 126.8 (CH), 127.7 (CH), 127.9 (CH), 127.9 
(CH), 128.6 (CH), 129.3 (CH), 132.7 (CH), 138.3 (Cquat.), 143.1 (Cquat.), 144.7 (Cquat.), 148.0 
(Cquat.), 152.9 (Cquat.), 157.5 (Cquat.). MS (70eV, EI): m/z (%): 338 (M+, 100), 305 (M+ - HS, 
8). IR (KBr), ~ν  2227 cm-1, 1597, 1581, 1569, 1544, 1508, 1497, 1437, 1419, 1389, 1236, 
832, 775, 732, 695, 634. UV/vis (CH2Cl2), λmax (ε) 268 nm (55000), 290 (31600), 336 
(11000). Anal. calcd. for C22H14N2S (338.4): C 78.08, H 4.17, N 8.28; found C 77.66, H 4.23, 
N 8.28. 
 
2-(2,6-Diphenyl-pyridin-4-yl)-pyrimidine (10n) 
 
NN
N
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 1:1) and 
recrystallization from ethanol, 211 mg (68 %) of 10n were isolated as light-brown crystals. 
M.p. 224 °C. 1H NMR (CDCl3, 300 MHz), δ 7.32 (t, J = 4.8 Hz, 1 H), 7.42−7.56 (m, 6 H), 
8.29−8.32 (m, 4 H), 8.75 (s, 2H), 8.90 (d, J = 4.89, 2H). 13C NMR (CDCl3, 75 MHz), δ 116.9 
(CH), 120.3 (CH), 127.0 (CH), 128.5 (CH), 128.9 (CH), 129.1 (CH), 139.2 (Cquat.), 146.2 
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(Cquat.), 157.2 (CH), 157.5 (Cquat.), 163.0 (Cquat.). MS (70eV, EI): m/z (%): 309 (M+, 68), 77 
(C6H5+, 100). IR (KBr), ~ν  3038 cm-1, 1602, 1580, 1565, 1549, 1462, 1449, 1424, 1399, 1233, 
896, 811, 772, 732, 691, 669, 640, 629, 618. UV/vis (CH2Cl2), λmax (ε) 248 nm (79400), 270 
(38000), 332 (11200). Anal. calcd. for C21H15N3 (309.4): C 81.53, H 4.89, N 13.58; found C 
81.30, H 4.84, N 13.23. 
 
2-[2-(4-Methoxy-phenyl)-6-phenyl-pyridin-4-yl]-pyrimidine (10o) 
 
NN
N
MeO
 
 
According to the GP after work up, chromatography on silica gel (hexane/ethyl acetate, 1:1) 
and recrystallization from ethanol, 132 mg (39 %) of 10o were isolated as yellow crystals. 
M.p. 144 ˚C. 1H NMR (CDCl3, 300 MHz), δ 3.87 (s, 3 H), 7.02 (dt, J = 1.5, 5.3 Hz, 2H), 7.29 
(t, J = 2.9 Hz, 1 H), 7.43−7.52 (m, 3 H), 8.24−8.28 (m, 4 H), 8.52 (s, 1 H), 8.53 (s, 1 H), 8.87 
(d, J = 2.9 Hz, 2 H). 13C NMR (CDCl3, 75 MHz), δ 55.3 (OCH3), 114.0 (CH), 116.3 (CH), 
116.3 (CH), 120.5 (CH), 127.1 (CH), 128.4 (CH), 128.6 (CH), 129.0 (CH), 132.0 (Cquat.), 
139.5 (Cquat.), 146.3 (Cquat.), 157.3 (Cquat.), 157.4 (Cquat.), 157.4 (Cquat.), 160.6 (Cquat.), 163.2 
(Cquat.). MS (70 eV, EI): m/z (%): 339 (M+, 100), 324 (M+ - CH3, 20), 296 (M+, 18). IR (KBr), 
~ν
 3043 cm-1, 2831, 1606, 1580, 1566, 1547, 1515, 1457, 1434, 1419, 1400, 1305, 1251, 
1232, 1176, 1031, 835, 807, 773, 696, 640. UV/vis (CH2Cl2), λmax (ε) 282 (20900), 344 
(8300). Anal. calcd. for C20H17N3O (339.4): C 77.88, H 5.01, N 12.39; found C 77.66, H 5.08, 
N 12.27.  
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6.4 General Procedure for the One-Pot Coupling-Isomerization-Enamino 
Ester-Cyclocondensation Synthesis of Dihydropyrines 12 and 
Pyridines 13  
 
A magnetically stirred solution of 1.0 mmol of halogen compound 1, 1.05 mmols of propargyl 
alcohol 2a, 0.02 mmols of Pd(PPh3)Cl2, and 0.01 mmols of CuI in 4 mL of degassed 
triethylamine or diethylamine under nitrogen was heated to reflux temperature for 12 h (for 
experimental details see Table 7). After cooling at room temperature solution of 2.0 mmols of 
ethyl 3-amino crotonate (11) in 1 mL of triethylamine or diethylamine and 2 mL of acetic acid 
were added and the reaction mixture was heated to reflux temperature for 24 h. After cooling 
to room temperature 40 mL of ethyl acetate and 40 mL of water were added and stirring was 
continued for 5 to 10 min. The aqueous layer was extracted with ethyl acetate (4 × 15 mL) 
and the combined organic phase was dried with magnesium sulfate. After filtration the 
solvents were removed in vacuo and the residue was chromatographed on silica gel 
(hexane/ethyl acetate 4:1 or 1:1) and recrystallized from ethanol or pentane/chloroform (1:1) 
to give the analytically pure dihydropyridine (12) and pyridine derivatives (13).  
 
Table 27 Experimental Details for the One-Pot Three-Component Synthesis of 
Dihydropyridines 12 and Pyridines 13. 
Entry Aryl halide 1 1-Phenyl propargyl 
alcohol (2a) 
Ethyl 3-
aminocrotonate (11) 
Dihydropyridine 12 / 
Pyridines 13 (Yield) 
1[a] 182 mg (1.00 
mmol) of 1a 
139 mg (1.05 
mmols) 
263 mg (2.00 
mmols) 
155 mg (45 %) of 12a 
2[b] 561 mg (2.00 
mmols) of 1f 
278 mg (2.10 
mmols) 
526 mg (4.00 
mmols) 
268 mg (37 %) of 12b 
3[a] 182 mg (1.00 
mmol) of 1a 
139 mg (1.05 
mmols) 
263 mg (2.00 
mmols) 
137 mg (40 %) of 13a 
4[a] 161 mg (1.00 
mmol) of 1e 
139 mg (1.05 
mmols) 
263 mg (2.00 
mmols) 
154 mg (50 %) of 13b 
5[c] 140 mg (1.00 
mmol) of 1b 
139 mg (1.05 
mmols) 
263 mg (2.00 
mmols) 
85 mg (26 %) of 13c 
6[b] 320 mg (2.00 
mmol) of 1d 
139 mg (1.05 
mmols) 
263 mg (2.00 
mmols) 
83 mg (26 %) of 13d 
[a]In NEt3. [b]In HNEt2. [c]In NEt3/THF (1:1). 
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Ethyl 4-(4-cyanophenyl)-2-methyl-6-phenyl-1,4-dihydropyridine-3-carboxylate (12a) 
 
N
CN
EtO2C
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 4:1) 155 mg 
(45 %) of 12a were isolated as yellow crystals. 1H NMR (CDCl3, 200 MHz), δ 1.01 (t, J = 
7 Hz, 3 H), 2.34 (s, 3 H), 3.89−3.98 (m, 2 H), 4.66 (d, J = 5.5 Hz, 1 H), 5.00 (dd, J = 2, 5.3 
Hz, 1 H), 5.78 (s, 1 H), 7.18−7.35 (m, 7 H), 7.45−7.48 (m, 2 H). 13C NMR (CDCl3, 75 MHz), 
δ 14.5 (CH3), 19.7 (CH3), 41.6 (CH), 59.5 (CH2), 97.5 (Cquat.), 103.9 (CH), 110.1 (Cquat.), 
119.7 (Cquat.), 126.3 (CH), 127.1 (CH), 129.2 (CH), 132.9 (CH), 133.2 (CH), 136.2 (Cquat.), 
136.6 (Cquat.), 150.2 (Cquat.), 151.3 (Cquat.), 155.5 (Cquat.), 168.3 (Cquat.). MS (70eV, EI): m/z 
(%): 344.2 (M+, 15), 315.1 (M+ - C2H5, 36), 271.2 (M+ - CO2C2H5, 20), 242.2 (M+ - C7H4N, 
100). 
 
Ethyl 2-methyl-6-phenyl-4-(4-(trifluoromethyl)phenyl)-1,4-dihydropyridine-3-
carboxylate (12b) 
 
N
CF3
EtO2C
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 5:1) 268 mg 
(37 %) of 12b were isolated as yellow crystals. 1H NMR (CDCl3, 200 MHz), δ 1.01 (t, J = 7 
Hz, 3 H), 2.30 (s, 3 H), 3.86−3.94 (m, 2 H), 4.64 (d, J = 5.25 Hz, 1 H), 5.00 (dd, J = 1.75, 
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5.25 Hz, 1 H), 5.65 (s, 1 H), 7.20−7.33 (m, 7 H), 7.40 (d, J = 8 Hz, 2 H). 13C NMR (CDCl3, 
75 MHz), δ 14.1 (CH3), 20.6 (CH3), 41.0 (CH), 59.3 (CH2), 98.4 (Cquat.), 104.1 (CH), 125.1 
(CH), 128.3 (CH), 128.7 (CH), 134.9 (Cquat.), 147.4 (Cquat.), 152.7 (Cquat.), 168.0 (Cquat.). MS 
(70eV, EI): m/z (%): 387.1 (M+, 15), 358.1 (M+ - C2H5, 18), 314.1 (M+ - CO2C2H5, 25), 242.1 
(M+ - C7H4F3, 100). HRMS calcd. for (C22H20F3NO2): 387.1446; found 387.1453.   
 
4-(4-Cyano-phenyl)-2-methyl-6-phenyl-nicotinic acid ethyl ester (13a) 
 
N
CN
EtO2C
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 4:1) and 
recrystallization from ethanol, 137 mg (40 %) of 13a were isolated as light-brown crystals. 
M.p. 131 ºC. 1H NMR (CDCl3, 300 MHz), δ 1.01 (t, J = 7.1 Hz, 3 H), 2.73 (s, 1 H), 4.09 (q, J 
= 7.2 Hz, 2 H), 7.43−7.53 (m, 6 H), 7.72−7.75 (m, 2 H), 8.00−8.03 (m, 2 H). 13C NMR 
(CDCl3, 75 MHz), δ 13.7 (CH3), 23.2 (CH3), 61.5 (CH2), 112.4 (Cquat.), 117.9 (CH), 118.3 
(Cquat.), 126.1 (Cquat.), 127.1 (CH), 128.7 (CH), 128.8 (CH), 129.6 (CH), 132.1 (CH), 132.2 
(CH), 138.2 (Cquat.), 143.6 (Cquat.), 147.1 (Cquat.), 156.3 (Cquat.), 157.7 (Cquat.), 168.1 (Cquat.). 
MS (70eV, EI): m/z (%): 342 (M+, 100), 313 (M+ - C2H5, 60), 297 (M+ - C2H5O, 76). IR 
(KBr), ~ν  3060 cm-1, 2993, 2229, 1722, 1588, 1567, 1540, 1500, 1380, 1361, 1280, 1265, 
1243, 1184, 1148, 1097, 1078, 850, 772, 695, 587. UV/vis (CH2Cl2), λmax (ε) 256 (35500), 
298 (12000). Anal. calcd. for C22H18N2O2 (342.4): C 77.17, H 5.30, N 8.18; found C 76.84, H 
5.33, N 8.12. 
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2-Methyl-6-phenyl-4-pyrimidin-2-yl-nicotinic acid ethyl ester (13b) 
 
NN
N
EtO2C
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 1:1) and 
recrystallization from ethanol, 154 mg (50 %) of 13b were isolated as light-brown crystals. 
M.p. 115−118 °C. 1H NMR (CDCl3, 300 MHz), δ 1.27−1.35 (m, 3 H), 2.77 (s, 3 H), 4.36 (q, J 
= 7.2 Hz, 2 H), 7.28 (t, J = 4.9 Hz, 1 H), 7.44−7.53 (m, 3 H), 8.13−8.15 (m, 2 H), 8.49 (s, 1 
H), 8.83 (d, J = 4.9 Hz, 2 H). 13C NMR (CDCl3, 75 MHz), δ 13.9 (CH3), 22.8 (CH3), 61.2 
(CH2), 117.3 (CH), 120.2 (CH), 126.5 (Cquat.), 127.0 (CH), 127.1 (CH), 128.6 (CH), 129.3 
(CH), 138.5 (Cquat.), 143.8 (Cquat.), 156.1 (Cquat.), 156.9 (CH), 157.6 (Cquat.), 162.9(Cquat.), 
169.3 (Cquat.). MS (70eV, EI): m/z (%): 319 (M+, 93), 274 (M+ - C2H5O, 100), 246 (M+ - 
C3H5O2, 36). IR (KBr), ~ν  2975 cm-1, 1715, 1585, 1565, 1550, 1457, 1424, 1386, 1369, 1274, 
1175, 1158, 1110, 1075, 1010, 837, 813, 760, 696. UV/vis (CH2Cl2), λmax (ε) 250 nm 
(28200), 314 (10200). Anal. calcd. for C19H17N3O2 (319.4): C 71.46, H 5.37, N 13.16; found 
C 71.28, H 5.35, N 13.08. 
 
Etyl 2-methyl-6-phenyl-4-(thiazol-2-yl)nicotinate (13c) 
 
N
EtO2C
S
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 5:1) 85 mg 
(26 %) of 14c were isolated as yellow crystals. 1H NMR (CDCl3, 200 MHz), δ 1.30 (t, J = 7 
Hz, 3 H), 2.90 (s, 3 H), 4.36 (q, J = 7 Hz 2 H), 7.4 (d, J = 3.25 Hz, 1 H), 7.47−7.51 (m, 3 H), 
7.88 (s, 1 H), 7.94 (d, J = 3.25 Hz, 1 H), 8.03−8.06 (m, 2 H). 13C NMR (CDCl3, 75 MHz), 
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δ 14.1 (CH3), 22.9 (CH3), 62.1 (CH2), 117.2 (CH), 122.6 (CH), 123.1 (CH), 126.1 (Cquat.), 
127.9 (CH), 129.6 (CH), 130.5 (CH), 138.8 (Cquat.), 139.9 (Cquat.), 144.9 (CH), 156.8 (Cquat.), 
158.2 (Cquat.), 164.4 (Cquat.), 168.7 (Cquat.). MS (70eV, EI): m/z (%) = 324.0 (M+, 38), 295.0 
(M+ - C2H5, 10), 279.1 (M+ - C2H5O, 36).387.1446.  
 
2’-Methyl-6’-phenyl-1’-4’-dihydro-[2,4’]bipyridinyl-3’-carboxilyc acid ethyl ester (13d) 
 
N
N
EtO2C
 
 
According to the GP after chromatography on silica gel (hexane/ethylacetate, 1:1) and 
recrystallization from ethanol, 83 mg (26 %) of 13d were isolated as a brown oil. 1H NMR 
(CDCl3, 3000 MHz), δ 1.03 (t, J = 7 Hz, 3 H), 2.68 (s, 3 H), 4.12 (q, J = 7 Hz, 2 H), 
7.23−7.28 (m, 1 H), 7.35−7.45 (m, 3 H), 7.57 (d, J = 8 Hz, 1 H), 7.70−7.77 (m, 2 H), 7.96-
8.00 (m, 2 H), 8.59-8.61 (m, 1 H). 13C NMR (CDCl3, 75 MHz), δ 13.7 (CH3), 23.1 (CH3), 
61.2 (CH2), 117.3 (CH), 122.3 (CH), 122.3 (CH), 123.3 (CH), 127.4 (Cquat), 128.7 (CH), 
136.8 (CH), 138.7 (Cquat), 147.0 (Cquat), 149.3 (CH), 156.0 (Cquat), 156.5 (Cquat), 157.6 (Cquat), 
169.0 (Cquat). IR (KBr), ~ν  3060 cm-1, 2980, 2930, 2902, 2860, 1952, 1728, 1585, 1549, 1474, 
1434, 1383, 1364, 1344, 1269, 1183, 1153, 1106, 1028, 994, 859, 797, 768, 695. UV/vis 
(CH2Cl2), λmax (ε): 252 nm (19500), 304 (9300). HRMS calcd. for C20H18N2O2: 318.1368; 
found 318.1367. 
 
6.5 General Procedure for N-[1-(Hetero)aryl-prop-2-ynyl] tosyl Amides 18  
 
To 1.3 equiv. of a 0.5 M solution of ethynyl magnesium bromide in THF at 0 °C (ice-
water) 1.0 eq. of a solution of the corresponding azomethine 16 in THF (1.25 mmols/mL) was 
added dropwise within 15 min. After stirring of the suspension for 15 min at 0 °C the reaction 
mixture was stirred for 1 h at room temperature. After the reaction was complete according to 
TLC monitoring 120 mL of a saturated aqueous solution of NH4Cl was added to the reaction 
mixture and the aqueous phase was extracted three times with diethylether (3×100 mL). The 
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combined organic layers were dried with anhydrous magnesium sulfate and after evaporation 
sufficiently pure (according to 1H NMR spectra) N-[1-(hetero)aryl-prop-2-ynyl] tosyl amide 
18 was isolated such that it could be recrystallized from ethanol in case of impurities. 
 
N-[1-(4-Methoxyphenyl)-prop-2-ynyl]-4-methyl-benzenesulfonamide (18a) 
 
NH
S OO
O
 
 
According to the GP from the reaction of 10.1 g (34.5 mmols) of N-(4-methoxybenzylidene)-
4-methyl-benzenesulfonamide (16a) and 102 ml (52 mmols) of a 0.5 M solution of ethynyl 
magnesium bromide in 45 ml of THF, 7.3 g (89 %) of 18a were obtained as colorless crystals. 
M.p. 124.5−125.5 °C.  1H NMR (300 MHz, CDCl3): δ 2.29 (d, J = 2.3 Hz, 1 H), 2.41 (s, 3 H), 
3.76 (s, 3 H), 5.17 (d, J = 8.6 Hz, 1 H), 5.23 (dd, J = 2.2, 8.6 Hz, 1 H), 6.79 (d, J = 8.7 Hz, 2 
H), 7.25 (d, J = 8.0 Hz, 2 H), 7.33 (d, J = 8.7 Hz, 2 H), 7.73 (d, J = 8.3 Hz, 2 H). 13C NMR 
(75 MHz, CDCl3): δ 21.5 (CH3), 48.4 (CH), 55.2 (CH3), 74.5 (CH), 80.6 (Cquat.), 113.9 (CH), 
127.4 (CH), 128.4 (CH), 129.1 (Cquat.), 129.4 (CH), 137.3 (Cquat.), 143.4 (Cquat.), 159.6 (Cquat.). 
MS (70 eV, EI): m/z (%): 315 (M+, 2), 159 (M+ - C7H7SO2 - H, 100), 145 (M+ - C7H7SO2 
- NH, 45), 91 (C7H7, 13).  
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4-Methyl-N-(1-(4-phenoxyphenyl)prop-2-ynyl)benzenesulfonamide (18b) 
 
NH
S OO
O
 
 
According to the GP from the reaction of 12.1 g (34.5 mmols) of N-(4-phenoxybenzylidene)-
4-methylbenzenesulfonamide (16b) and 102 ml (52 mmols) of a 0.5 M solution of ethynyl 
magnesium bromide in 45 ml of THF, 10.7 g (82 %) of 18b were obtained as colorless 
crystals. M.p. 96−97 °C. 1H NMR (CDCl3, 300 MHz): δ 2.31 (d, J = 0.7 Hz, 1 H), 2.41 (s, 
3H, CH3), 5.27 (s, 2 H, NH, CH), 6.90 (d, J = 8.7 Hz, 2 H), 6.97(dd, J = 8.7 Hz, J = 0.8 Hz, 2 
H), 7.11 (t, J = 7.4 Hz, 1 H), 7.26 (d, J = 8.1 Hz, 2 H), 7.31 (dd, J = 8.0, J = 0.8 Hz, 2 H), 
7.35−7.40 (m, 2 H), 7.75 (d, J = 8.3 Hz, 2 H). 13C NMR (CDCl3, 75 MHz): δ 21.49 (CH3), 
48.38 (CH), 74.68 (CH), 80.41 (Cquat.), 118.57 (CH), 119.06 (CH), 123.57 (CH), 127.38 (CH), 
128.69 (CH), 129.43 (CH), 129.76 (CH), 131.61 (Cquat.), 137.23 (Cquat.), 143.52 (Cquat.), 
156,63 (Cquat.), 157.48 (Cquat.). MS (70 eV, EI): m/z (%): 377 (M+, 2), 222 (M+ - C7H7SO2, 
80), 207 (M+ - C7H7SO2 -NH, 28), 155 (C7H7SO2, 7), 91 (C7H7, 44).  
 
6.6 General Procedure for the Enimine 19 Synthesis  
 
A magnetically stirred solution of 1.0 mmol of (het)arylhalide 1, 1.05 mmols of 
propargyl N-tosyl amine 18, 14 mg (0.02 mmols) of Pd(PPh3)Cl2, and 2 mg (0.01 mmols) of 
CuI in 4 mL of degassed triethylamine and 5 mL of THF under nitrogen was heated to reflux 
temperature for 24 – 48 h. After cooling to room temperature 30 mL of diethyl ether was 
added to the reaction mixture. After filtration the solvents were removed in vacuo and the 
residue was washed with ethanol to give the enimines 19. Further purification could be 
achieved by recrystallization from ethanol or trituration with ethanol. 
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N-[3-(4-Cyanophenyl)-1-(4-methoxyphenyl)-allylidene]-4-methyl-benzenesulfonamide 
(19a) 
NC
N
O
SO O
 
 
According to the GP the reaction of 182 mg (1.00 mmol) of 4-bromobenzonitrile (1a) and 331 
mg (1.05 mmols) of 18a furnished, after recrystallization from ethanol, 375 mg (90 %) of 19a 
as light yellow crystals. M.p. 129–132 °C. 1H NMR (300 MHz, CDCl3): δ 2.42 (s, 3 H), 3.87 
(s, 3 H), 6.94 (d, J = 8.8 Hz, 2 H), 7.04 (d, J = 16.3 Hz, 1 H), 7.32 (d, J = 8.2 Hz, 2 H), 7.71 
(d, J = 8.6 Hz, 2 H), 7.72 (d, J = 8.7 Hz, 2 H), 7.90 (d, J = 8.3 Hz, 2 H), 8.03 (d, J = 16.1 Hz, 
1 H), 8.24 (d, J = 8.7 Hz, 2 H). 13C NMR (75 MHz, CDCl3): δ 21.5 (CH3), 55.5 (CH3), 114.0 
(CH), 124.1 (CH), 127.1 (CH), 128.8 (CH), 129.4 (CH), 130.9 (Cquat.), 132.5 (CH), 138.5 
(Cquat.), 140.8 (Cquat.), 142.4 (CH), 143.6 (Cquat.), 148.5 (Cquat.), 163.7 (Cquat.), 175.2 (Cquat.). 
MS (70 eV, EI): m/z (%): 416 (M+ +2H, 2), 261 (M+ - C7H7SO2, 100), 247 (M+ - C7H7SO2 - 
NH, 12), 155 (C7H7SO2, 6), 91 (C7H7, 20).  
 
N-[1-(4-Methoxy-phenyl)-3-pyrimidin-2-yl-allylidene]-4-methyl-benzenesulfonamide 
(19b) 
 
N
N
N
O
SO O
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1H NMR (250 MHz, CDCl3), mixture of two isomers (trans/cis = 1:1): δ 2.21 (s, 3 H, TolMe), 
3.71 (s, 3 H, OMe), 6.78–6.88 (m, 3 H), 7.01–7.23 (m, 4 H), 7.57–7.69 (m, 2 H), 7.78 (d, J = 
6.0 Hz, 1 H), 7.73 (dt, J = 2.0, 7.0 Hz, J = 2 Hz, 1 H), 8.64–8.67 (m, 2 H). 
 
N-[1-(4-Methoxyphenyl)-3-(pyridin-2-yl)-allylidene]-4-methyl-benzenesulfonamide (19c)  
 
N
N
O
SO O
 
 
1H NMR (250 MHz, CDCl3), mixture of two isomers (trans/cis = 7:1): δ 2.29 (s, 3 H, TolMe), 
3.73 (s, 3 H, OMe), 6.80–6.88 (m, 2 H), 6.87 (d, J =16.0 Hz, 1 H), 7.07 – 7.20 (m, 4 H), 7.40 
(d, J =7.6 Hz, 1 H), 7.58–7.68 (m, 6 H), 7.76–7.79 (m, 3 H), 7.80 (dt, J = 1.7, 8.4 Hz, 1 H), 
7.98–8.19 (m, 1H), 8.55 (d, J = 4.8 Hz, 1 H). HRMS calcd. for C22H20N2O3S: 392.1195; 
found: 392.1206. 
 
N-[1-(4-Methoxyphenyl)-3-(4-trifluoromethylphenyl)-allylidene]-4-methyl 
benzenesulfonamide (19d) 
 
F3C
N
O
SO O
 
 
1H NMR (250 MHz, CDCl3), mixture of two isomers (trans/cis = 4 : 1): δ 2.24 (s, 3 H), 3.69 
(s, 3 H), 6.76–6.84 (m, 1 H), 6.87 (d, J = 16.2 Hz, 1 H), 7.03–7.22 (m, 2 H), 7.47–7.67 (m, 
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6 H), 7.76–7.79 (m, 2 H), 7.87–7.93 (m, 2 H). HRMS calcd. for C24H20F3N2O3S: 459.1116; 
found: 459.1128. 
 
N-[3-(4-Cyanophenyl)-1-(4-phenoxyphenyl)-allylidene]-4-methyl-benzenesulfonamide 
(19e) 
NC
N
O
SO O
 
 
According to the GP the reaction of 182 mg (1.00 mmol) of 4-bromobenzonitrile (1a) and 396 
mg (1.05 mmols) of 18b furnished, after recrystallization from ethanol, 450 mg (94 %) of 19e 
as light yellow crystals. M. p. 137.5–138.5 °C. 1H NMR (300 MHz, CDCl3): δ 2.42 (s, 3 H), 
6.99 (d, J = 8.6 Hz, 2 H), 7.03 (d, J = 16.2 Hz, 1 H), 7.07 (d, J = 8.0 Hz, 2 H), 7.18–7.25 (m, 
1 H), 7.32 (d, J = 8.2 Hz, 2 H), 7.37–7.42 (m, 2 H), 7.64–7.71 (m, 6 H), 7.91 (d, J = 8.2 Hz, 
2 H), 8.02 (d, J = 9.0 Hz, 1 H). 13C NMR (75 MHz, CDCl3): δ 21.5 (CH3), 117.3 (CH), 118.3 
(Cquat.), 120.2 (CH), 124.8 (CH), 126.2 (Cquat.), 127.1 (CH), 128.7 (CH), 129.5 (CH), 130.1 
(CH), 130.1 (Cquat.), 132.4 (CH), 132.6 (CH), 138.4 (Cquat.), 138.8 (Cquat.), 143.6 (CH), 155.2 
(Cquat.), 162.1 (Cquat.), 175.2 (Cquat.). MS (70 eV, EI); m/z (%): 478 (M+, 1), 323 (M+ 
- C7H7SO2, 100), 231 (C7H8+, 25), 155 (C7H7SO2, 3), 91 (C7H7, 8).  
 
6.7 General Procedure for the One-Pot Synthesis of 2-Ethoxy-6-p-
anisylpyridines 21 
 
A magnetically stirred solution of 1.00 mmol of (het)arylhalide 1, 1.05 mmols of 
propargyl N-tosyl amine 18, 14 mg (0.02 mmols) of Pd(PPh3)Cl2, and 2 mg (0.01 mmols) of 
CuI in 4 mL of degassed triethylamine and 5 mL of THF or toluene under nitrogen was heated 
to reflux temperature for 24–48 h. After cooling to room temperature a solution of 4 mmols of 
diethyl ketene acetal in 5 mL of THF or acetonitrile were added and the reaction mixture was 
heated to reflux temperature for 24–48 h. After cooling to room temperature 40 mL of ethyl 
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acetate and 40 mL of water were added and stirring was continued for 5 to 10 min. The 
aqueous layer was extracted with ethyl acetate (4×15 mL) and the combined organic phases 
were dried with magnesium sulfate. After evaporation of the solvents in vacuo the residue was 
chromatographed on silica gel (hexane/ethyl acetate 4:1 or 1:1) and recrystallized from 
ethanol or pentane/chloroform (1:1) to give the analytically pure pyridine derivatives 21. 
 
4-[2-Ethoxy-6-(4-methoxyphenyl)-pyridin-4-yl]-benzonitrile (21a) 
 
N
OMe
OEt
NC
 
 
According to the GP the reaction of 182 mg (1.00 mmol) of 4-bromobenzonitrile (1a), 331 mg 
(1.05 mmols) of 18a, and 470 mg (4.00 mmols) of diethyl ketene acetal in acetonitrile 
furnished, after chromatography on silica gel (hexane/ethyl acetate, 4:1) and recrystallization 
from ethanol, 188 mg (57 %) of 21a as yellow crystals. M.p. 97–98 °C. 1H NMR (CDCl3, 300 
MHz): δ 1.46 (t, J = 7.3 Hz, 3 H), 3.86 (s, 3 H), 4.53 (q, J = 7.1 Hz, 2 H), 6.77 (d, J = 1.1 Hz, 
1 H), 6.98 (d, J = 8.9 Hz, 2 H), 7.41 (d, J = 1.1 Hz, 1 H), 7.70–7.76 (m, 4 H), 8.02 (d, J = 8.8 
Hz, 2 H). 13C NMR (CDCl3, 75 MHz): δ 14.7 (CH3), 55.4 (CH3, OMe), 61.9 (CH2, 
OCH2CH3), 106.5 (CH), 110.4 (CH), 112.5 (Cquat.), 114.1 (CH), 118.6 (Cquat.), 127.8 (CH), 
128.1 (CH), 131.4 (Cquat.), 132.7 (CH), 143.5 (Cquat.), 149.9 (Cquat.), 155.5 (Cquat.), 160.7 
(Cquat.), 164.2 (Cquat.). MS (70 eV, EI): m/z (%): 330.1 (M+, 43), 315 (M+ - CH3, 100), 302 (M+ 
- C2H4, 30). IR (KBr): ~ν  3065, 2973, 2227 (C≡N), 1602, 1545, 1515, 1425, 1380, 1342, 
1296, 1260, 1260, 1176, 1037, 830, 586, 516 cm−1. Anal. calcd. for C21H18N2O2 (330.4): C 
76.34, H 5.49, N 8.48; found C 76.25, H 5.47, N 8.39. 
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2-[2-Ethoxy-6-(4-methoxyphenyl)-pyridin-4-yl]-pyrimidine (21b) 
 
N
OMe
OEt
N
N
 
 
According to the GP the reaction of 160 mg (1.00 mmol) of 2-bromopyrimidine (1b), 331 mg 
(1.05 mmols) of 18a, and 470 mg (4.00 mmols) of diethyl ketene acetal in toluene furnished, 
after chromatography on silica gel (hexane/ethyl acetate, 1:1) and recrystallization from 
ethanol, 141 mg (46 %) of 21b as colorless crystals. M.p. 120.9 °C. 1H NMR (CDCl3, 300 
MHz): δ 1.27−1.35 (m, 3 H, CH3), 3.77 (s, 3 H), 4.36 (q, J = 7.2 Hz, 2 H), 7.28 (t, J = 4.9 Hz, 
1 H), 7.44–7.53 (m, 3 H), 8.13–8.15 (m, 2 H), 8.49 (s, 1 H), 8.83 (d, J = 4.9 Hz, 2 H). 13C 
NMR (CDCl3, 75 MHz): δ 14.8 (CH3), 55.4 (CH3, OMe), 61.9 (CH2, OCH2CH3), 107.2 (CH), 
110.6 (CH), 113.9 (CH), 128.2 (CH), 131.8 (Cquat.), 155.2 (Cquat.), 157.3 (Cquat.), 160.4 (Cquat.), 
164.5 (Cquat.). MS (70 eV, EI): m/z (%): 307 (M+, 57), 291 (M+ - CH3, 100), 279 (M+ - C2H4, 
34). UV/vis (CH2Cl2): λmax (ε) 272 nm (4.62), 322 (4.00). IR (KBr): ~ν  2979, 1715, 1605, 
1549, 1516, 1427, 1342, 1278, 1253, 1241, 1208, 1183, 1105, 834, 774 cm−1. Anal. calcd. for 
C18H17N3O2 (307.4): C 70.34, H 5.58, N 13.67; found C 70.12, H 5.50, N 13.66. 
 
2’-Ethoxy-6’-(4-methoxyphenyl)-[2,4’]bipyridinyl (21c) 
 
N
OMe
OEt
N
 
 
According to the GP the reaction of 158 mg (1.00 mmol) of 2-bromo pyridine (1c), 331 mg 
(1.05 mmols) of 18a, and 470 mg (4.00 mmols) of diethyl ketene acetal in toluene furnished, 
after chromatography on silica gel (hexane/ethyl acetate, 1:1) and recrystallization from 
ethanol, 199 mg (65 %) of 21c as yellow crystals. M.p. 98.5 °C. 1H NMR (CDCl3, 300 MHz): 
δ 1.38 (t, J = 7.3, 3 H, CH3), 3.73 (s, 3 H, OMe), 4.39 (q, J = 7.0 Hz, 2 H), 6.85–6.91 (m, 
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2 H), 7.05 (d, J = 1.3 Hz, 1 H), 7.15–7.23 (m, 1 H), 7.64–7.67 (m, 2 H), 7.83 (d, J = 1.3 Hz, 1 
H), 7.96–8.02 (m, 2 H), 8.6 (dt, J = 1.3, 4.5 Hz, 1 H). 13CNMR (CDCl3, 75 MHz): δ 14.8 
(CH3), 55.3 (CH3, OMe), 61.7 (CH2, OCH2CH3), 106.0 (CH), 110.1 (CH), 113.9 (CH), 121.1 
(CH), 123.6 (CH), 128.2 (CH), 131.1 (Cquat.), 137.1 (CH), 149.8 (CH), 155.2 (Cquat.), 155.3 
(Cquat.), 160.4 (Cquat.), 164.3 (Cquat.). MS (70 eV, EI): m/z (%): 306.2 (M+, 90), 291 (M+ - CH3, 
100), 278 (M+ - C2H4, 30), 247 (M+ - CH3, - C2H5O, 12). UV/vis (CH2Cl2): λmax (ε) 254 nm 
(4.25), 264 (4.39), 290 (4.12), 328 (4.03). IR (KBr): ~ν  2970, 2935, 2895, 1611, 1588, 1577, 
1555, 1516, 1473, 1432, 1416, 1383, 1343, 1297, 1255, 1215, 1205, 1178, 1040, 833, 785 
cm−1. Anal. calcd. for  C19H18N2O2 (306.4): C 74.49, H 5.92, N 9.14; found C 73.96, H 5.91, 
N 8.93. 
 
2-Ethoxy-6-(4-methoxyphenyl)-4-(4-trifluoromethylphenyl)-pyridine (21d) 
 
N
OMe
OEt
F3C
 
 
According to the GP the reaction of 272 mg (1.00 mmol) of 4-iodobenzotrifluoride (1d), 331 
mg (1.05 mmols) of 18a, and 470 mg (4.00 mmols) of diethyl ketene acetal in toluene 
furnished, after chromatography on silica gel (hexane/ethyl acetate, 1:1) and recrystallization 
from ethanol, 111 mg (30 %) of 21d as a light yellow oil. 1H NMR (CDCl3, 300 MHz): δ 1.37 
(t, J = 7.0 Hz, 3 H, CH3), 3.8 (s, 3 H, OMe), 4.43 (q, J = 7.0 Hz, 2 H), 6.74 (d, J = 1.3 Hz, 1 
H), 6.91–6.96 (m, 2 H), 7.40 (d, J = 1.3 Hz, 1 H) 7.63–7.71 (m, 4 H), 7.94–8.00 (m, 2 H). 
13CNMR (CDCl3, 75 MHz): δ 14.72 (CH3), 55.36 (CH3, OMe), 61.78 (CH2, OCH2CH3), 
106.6 (CH), 110.6 (CH), 114.0 (CH), 125.86 (CH), 125.91 (CH), 127.4 (CH), 128.1 (CH), 
131.6 (CH), 150.4 (Cquat.), 155.3 (Cquat.), 160.5 (Cquat.), 164.2 (Cquat.). UV/vis (CH2Cl2): λmax (ε) 
260 nm (4.40), 290 (4.00), 296 (3.98), 322 (4.05), 348 (3.36). IR (KBr): ~ν  2981, 2932, 1607, 
1551, 1515, 1428, 1381, 1342, 1326, 1252, 1207, 1177, 1127, 1068, 1036, 1017, 830 cm−1. 
HRMS calcd. for  C21H18F3NO2: 373.1281; found 373.1303. 
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4-[2-Ethoxy-6-(4-methoxyphenyl)-pyridin-4-yl]-benzoic acid ethyl ester (21e) 
 
N
OMe
OEt
EtO2C
 
 
According to the GP the reaction of 229 mg (1.00 mmols) of ethyl 4-bromobenzoate (1e), 331 
mg (1.05 mmols) of 18a, and 470 mg (4.00 mmols) of diethyl ketene acetal in toluene 
furnished, after chromatography on silica gel (hexane/ethyl acetate, 5:1) and recrystallization 
from ethanol, 94 mg (25 %) of 21e as colorless crystals. M.p. 96 °C. 1H NMR (CDCl3, 300 
MHz): δ 1.30 (t, J = 7 Hz, 3 H, CH3), 1.34 (t, J = 7 Hz, 3 H, CH3), 3.76 (s, 3 H, OMe), 4.27 
(q, J = 7 Hz, 2 H), 4.40 (q, J = 7 Hz, 2 H), 6.73 (d, J = 1.25 Hz, 1 H), 6.87–6.93 (m, 2 H), 
7.37 (d, J = 1.0 Hz, 1 H), 7.59–7.62 (m, 2 H), 7.91–7.97 (m, 2 H), 8.01–8.07 (m, 2 H).  
13C NMR (CDCl3, 75 MHz): δ 14.3 (CH3), 14.7 (CH3), 55.3 (CH3, OMe), 61.07 (CH2, 
OCH2CH3), 61.67 (CH2, OCH2CH3), 106.5 (CH), 110.5 (CH), 114.0 (CH), 125.9 (CH), 128.0 
(CH), 130.1 (CH), 130.6 (Cquat.), 131.6 (Cquat.), 143.2 (Cquat.), 150.7 (Cquat.), 155.1 (Cquat.), 
160.5 (Cquat.), 164.1 (Cquat.), 166.2 (Cquat.).  MS (70 eV, EI): m/z (%): 377 (M+, 72), 362 (M+ - 
CH3, 100), 348.9 (M+ - C2H4, 42). UV/vis (CH2Cl2): λmax (ε) 272 (4.62), 322 (4.00).  IR (KBr): 
~ν  2979, 1715, 1605, 1549, 1516, 1427, 1342, 1278, 1253, 1241, 1208, 1183, 1105, 834, 774, 
587 cm−1. Anal. calcd. for C23H23NO4 (377.4): C 73.19, H 6.14, N 3.71; found C 73.18, H 
6.09, N 3.82. 
 
6.8 General Procedure for the Coupling-Isomerization-Cycloaddition 
Sequence to Annelated 2-Amino Pyridines 27 
 
A  magnetically stirred solution of 1.00 mmol of halogen compound 1, 1.05 mmols of 
propargyl tosyl amide 18, 20 mg (0.02 mmols) of (PPh3)2PdCl2, and 2 mg (0.01 mmols) of 
CuI in 3.5 mL of degassed triethylamine and 5 mL THF under nitrogen was heated to reflux 
temperature for 24 h (for experimental details, see Table 28). After cooling to room 
temperature a solution of 5 mmols of N,S-ketene acetals 25 in 1 mL of THF were added and 
the reaction mixture was heated to reflux temperature for 12 h. After cooling to room 
temperature 40 mL of ethyl acetate and 40 mL of water were added and stirring was 
6 Experimental Part  162 
  
continued for 5 to 10 min. The aqueous layer was extracted with ethyl acetate (4 × 15 mL) 
and the combined organic phases were dried with magnesium sulfate. After filtration the 
solvents were removed in vacuo and the residue was chromatographed on silica gel 
(hexane/ethyl acetate 4:1 or 1:1) and recrystallized from ethanol or pentane/chloroform (1:1) 
to give the analytically pure annelated 2-amino pyridine derivatives 27. 
 
 Table 28 Experimental details for the synthesis of annelated 2-amino pyridines 27. 
Aryl halide 1 Propargyl N-tosyl 
amine 18 
N,S-ketene acetal 25 Annelated 2-amino 
pyridines 27 (yield) 
182 mg (1.00 mmol) 
of 1a 
331 mg (1.05 mmols) 
of 18a 
650 mg (5.00 mmols) 
of 25a 
219 mg (64 %) of 
27a 
159 mg (1.00 mmol) 
of 1b 
331 mg (1.05 mmols) 
of 18a 
650 mg (5.00 mmols) 
of 25a 
210 mg (66 %) of 
27b 
158 mg (1.00 mmol) 
of 1c 
331 mg (1.05 mmols) 
of 18a 
650 mg (5.00 mmols) 
of 25a 
156 mg (49 %) of 
27c 
182 mg (1.00 mmol) 
of 1a 
331 mg (1.05 mmols) 
of 18a 
720 mg (5.00 mmols) 
of 25 (2 h) 
111 mg (31 %) of 
27d 
182 mg (1.00 mmol) 
of 1a 
400 mg (1.05 mmols) 
of 18b 
720 mg (5.00 mmols) 
of 25b 
180 mg (43 %) of 
27e 
158 mg (1.00 mmol) 
of 1c 
331 mg (1.05 mmols) 
of 18a 
720 mg (5.00 mmols) 
of 25b 
160 mg (48 %) of 
27f 
182 mg (1.00 mmol) 
of 1a 
331 mg (1.05 mmols) 
of 18a 
790 mg (5.00 mmols) 
of 25c 
192 mg (52 %) of 
27g 
182 mg (1.00 mmol) 
of 1a 
400 mg (1.05 mmols) 
of 18b 
790 mg (5.00 mmols) 
of 25c 
186 mg (43 %) of 
27h 
159 mg (1.00 mmol) 
of 1b 
331 mg (1.05 mmols) 
of 18a 
790 mg (5.00 mmols) 
of 25c 
194 mg (56 %) of 
27i 
158 mg (1.00 mmol) 
of 1c 
331 mg (1.05 mmols) 
of 18a 
790 mg (5.00 mmols) 
of 25c 
180 mg (52 %) of 
27j 
 
 
6 Experimental Part  163 
  
4-[6-(4-Methoxy-phenyl)-1-methyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-4-yl]-
benzonitrile (27a) 
 
N
MeO
N
CH3
CN
 
 
According to the GP after chromatography on silica gel (hexane/acetone, 5:1) and 
recrystallization from diethylether 219 mg (64 %) of 27a were isolated as yellow crystals. 
M.p. 162 °C. 1H NMR (CDCl3, 300 MHz): δ  3.03 (t, J = 8.1 Hz, 2 H), 3.05 (s, 3 H), 3.5 (t, J 
= 8.1 Hz, 2 H), 3.84 (s, 3 H), 6.87 (s, 1 H), 6.94 (d, J = 8.9 Hz, 2 H), 7.57 (d, J = 8.5 Hz, 2 H), 
7.71 (d, J = 8.5 Hz, 2H), 7.95 (d, J = 8.9 Hz, 2 H). 13C NMR (CDCl3, 75 MHz): δ  25.7 (CH2), 
32.8 (CH3), 52.2 (CH2), 55.3 (CH3), 107.6 (CH), 111.5 (Cquat.), 118.2 (Cquat.), 118.6 (Cquat.),  
127.8 (CH), 128.5 (CH), 132.3 (CH
.
), 132.4 (CH), 142.2 (Cquat.), 142.8 (Cquat.), 154.9 (Cquat.), 
160.0 (Cquat.), 164.3 (Cquat.). EI MS (70 eV): m/z (%): 341.1 (M+, 100), 313.1 (M+ - CH3, 8), 
250.2 (M+ - CO, - OH, 15). IR (KBr): ~ν  2228 cm–1 (C≡N), 1606, 1583, 1553, 1510, 1465, 
1438, 1405, 1366, 1332, 1299, 1242, 1182, 1032, 853, 824, 576, 548, 513. UV/vis (CH2Cl2): 
λmax (ε) 258 nm (21900), 310 (4400), 372 (3200). Anal. calcd. for C22H19N3O (341.4): 
C 77.40, H 5.61, N 12.31; found C 76.43, H 5.63, N 12.32. 
 
6-(4-Methoxy-phenyl)-1-methyl-4-pyrimidin-2-yl-2,3-1H-pyrrolo[2,3-b]pyrimidine (27b) 
 
N
NN
MeO
N
CH3
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According to the GP after chromatography on silica gel (hexane/acetone, 2.5:1) and 
recrystallization from diethylether 210 mg (66 %) of 27b were isolated as yellow crystals. 
M.p. 190 °C.  1H NMR (CDCl3, 300 MHz): δ  3.02 (s, 3 H), 3.44–3.57 (m, 4 H), 3.85 (s, 3 H), 
6.99 (d, J = 9.0 Hz, 2 H), 7.20 (t, 1 H), 7.43 (t, J = 4.8 Hz, 1 H),  7.91 (s, 1 H), 8.07 (d, J = 8.9 
Hz, 2 H),  8.93 (d, J = 5.0 Hz, 1 H). 13C NMR (CDCl3, 75 MHz): δ  28.7 (CH2), 32.9 (CH3), 
53.8 (CH2), 55.6 (CH3), 107.1 (CH), 114.6 (CH), 120.8 (CH), 122.7 (Cquat.), 128.4 (CH), 
141.0 (Cquat.), 154.7 (Cquat.), 158.1 (CH), 160.9 (Cquat.), 161.0 (Cquat.), 165.8 (Cquat.). EI MS (70 
eV): m/z (%) = 318.2 (M+, 100), 303.2 (M+ - CH3, 7). IR (KBr): ~ν  3003 cm–1, 2929, 2874, 
2836, 1610, 1601, 1584, 1570, 1554, 1512, 1477, 1441, 1417, 1370, 1335, 1299, 1282, 1260, 
1240, 1170, 1036, 807, 568. UV/vis (CH2Cl2): λmax (ε) 252 (40700), 284 (12900), 392 (6500). 
Anal. calcd. for C19H18N4O (318.4): C 71.68, H 5.70, N 17.60; found: C 71.58, H 5.70, N 
17.86. 
 
6-(4-Methoxy-phenyl)-1-methyl-4-pyridin-2-yl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine 
(27c) 
N
N
MeO
N
CH3
 
 
According to the GP after chromatography on silica gel (hexane/acetone, 4:1) and 
recrystallization from diethylether 156 mg (49 %) of 27c were isolated as light yellow 
crystals. M.p. 191 °C. 1H NMR (CDCl3, 300 MHz): δ  3.01 (s, 3 H), 3.02–3.32 (m, 2 H), 
3.49–3.55 (m, 2 H), 3.85 (s, 3 H), 6.98 (d, J = 8.9 Hz, 2 H), 7.36–7.41 (m, 1 H), 7.47 (s, 1 H), 
7.90–7.92 (m, 2 H), 8.09 (d, J = 8.9 Hz, 2 H), 8.72–8.74 (m, 1 H). 13C NMR (CDCl3, 75 
MHz): δ 27.7 (CH2), 33.0 (CH3), 53.0 (CH2), 55.9 (CH3), 107.3 (CH), 114.5 (CH), 120.3 
(Cquat.), 123.2 (CH), 123.7 (CH), 128.5 (CH), 133.7 (Cquat.), 137.5 (CH), 143.0 (Cquat.), 150.4 
(CH), 157.5 (Cquat.), 161.0 (Cquat.), 165.8 (Cquat.). EI MS (70 eV), m/z (%): 317.1 (M+, 92), 
316.1 (M+, - H, 100), 302.1 (M+ - CH3, 8), 287.1 (M+ - CH3, - CH3, 5). IR (KBr): ~ν  2901 
cm-1, 1609, 1585, 1571, 1555, 1514, 1444, 1430, 1417, 1403, 1368, 1334, 1276, 1260, 1247, 
1182, 1172, 811, 568. UV/vis (CH2Cl2): λmax (ε) 248 (47900), 276 (41700), 360 (15900). 
C20H19N3O (317.4): calcd. C 75.69, H 6.03, N 13.24; found C 75.36, H 6.03, N 12.91. 
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4-[2-(4-Methoxy-phenyl)-8-methyl-5,6,7,8-tetrahydro-[1,8]naphthyridin-4-yl]-
benzonitrile (27d) 
 
N N
CH3MeO
CN
 
 
According to the GP after chromatography on silica gel (hexane/acetone, 4:1) and 
recrystallization from diethylether 111 mg (31 %) of 27d were isolated as light yellow 
crystals. M.p. 202 °C.  1H NMR (CDCl3, 300 MHz): δ 1.88 (tt, J = 6.2 Hz, 2 H), 2.63 (t, J = 
6.3 Hz, 2 H), 3.25 (s, 3 H), 3.45 (t, J = 5.7 Hz, 2 H), 3.83 (s, 3 H), 6.89 (s, 1 H), 6.96 (d, J = 
8.9 Hz, 2 H), 7.60 (d, J = 8.2 Hz, 2 H), 7.86 (d, J = 8.2 Hz, 2 H), 8.04 (d, J = 8.9 Hz, 2 H). 13C 
NMR (CDCl3, 75 MHz): δ 22.1 (CH2), 26.0 (CH2), 36.9 (CH3), 50.4 (CH2), 55.5 (CH3), 108.4 
(CH), 112.0 (Cquat.), 113.0 (Cquat.), 114.3 (CH), 114.4 (CH), 128.3 (CH), 130.5 (CH), 132.5 
(CH), 133.2 (Cquat.), 146.1 (Cquat.), 147.7 (Cquat.), 152.9 (Cquat.), 156.8 (Cquat.), 161.0 (Cquat.). EI 
MS (70 eV): m/z (%): 355.1 (M+, 100), 340.1 (M+ - CH3, 18), 326.0 (M+ - HCN, 54). IR 
(KBr): ~ν  2934 cm–1, 2841, 2224, 1609, 1589, 1545, 1514, 1461, 1443, 1410, 1371, 1356, 
1328, 1253, 1201, 1177, 1033, 1003, 828, 578. UV/vis (CH2Cl2): λmax (ε) 258 (31600), 306 
(5900), 362 (5900). Anal. calcd. for C23H21N3O (355.4): C 77.72, H 5.96, N 11.82; found C 
77.42, H 5.93, N 11.72. 
 
4-[2-(4-Phenoxy-phenyl)-8-methyl-5,6,7,8-tetrahydro-[1,8]naphthyridin-4-yl]-
benzonitrile (27e) 
N
CN
O
N
CH3
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According to the GP after chromatography on silica gel (hexane/acetone, 4:1) and 
recrystallization from diethylether 180 mg (43 %) of 27e were isolated as light yellow 
crystals. M.p. 219 °C.  1H NMR (CDCl3, 300 MHz): δ  1.87 (m, 2 H), 2.63 (t, J = 6.3 Hz, 2 
H), 3.25 (s, 3 H), 3.45 (t, J = 5.8 Hz, 2 H), 6.95 (s, 1 H), 7.03–7.07 (m, 4 H), 7.18 (t, J = 7.5 
Hz, 1 H), 7.41 (t, J = 7.7 Hz, 2 H), 7.62 (d, J = 8.5 Hz, 2 H), 7.87 (d, J = 8.5 Hz, 2 H), 8.12–
8.15 (m, 2 H). 13C NMR (CDCl3, 75 MHz): δ  22.0 (CH2), 26.0 (CH2), 36.9 (CH3), 50.3 
(CH2), 108.8 (CH), 112.1 (Cquat.), 113.6 (Cquat.), 119.1 (CH), 119.7 (CH), 124.2 (CH), 128.7 
(CH), 130.5 (CH), 130.7 (CH), 132.9 (CH), 135.9 (Cquat.), 146.0 (Cquat.), 147.7 (Cquat.), 152.4 
(Cquat.), 156.9 (Cquat.), 157.9 (Cquat.), 158.5 (Cquat.). EI MS (70 eV): m/z (%): 416.9 (M+, 100), 
388 (M+ – HCN, 20), 77.1 (C6H5+, 8). IR (KBr): ~ν  3052 cm–1, 2924, 2841, 2229, 1591, 1562, 
1547, 1507, 1489, 1459, 1407, 1371, 1357, 1329, 1202, 1164, 873, 845, 829, 754, 692. 
UV/vis (CH2Cl2): λmax (ε) 258 (38000), 312 (5200), 364 (6600). Anal. calcd. for C28H23N3O 
(417.5): C 80.55, H 5.55, N 10.06; found C 80.39, H 5.89, N 9.83. 
 
4-[2-(4-Methoxy-phenyl)-8-methyl-5,6,7,8-tetrahydro-[1,8]naphthyridin-4-yl]pyridine 
(27f) 
N
N
N
CH3MeO
 
 
According to the GP after chromatography on silica gel (hexane/acetone, 3:1) 160 mg (48 %) 
of 27f were isolated as a brown oil.  1H NMR (CDCl3, 300 MHz): δ 1.88  (m, 2 H), 2.74 (t, J = 
6.3 Hz, 2 H), 3.24 (s, 3 H), 3.45 (t, J = 5.7 Hz, 2 H), 3.82 (s, 3 H), 6.95 (d, J = 8.9 Hz, 2 H), 
7.05 (s, 1 H), 7.35–7.37 (m, 1H), 7.51 (d, J = 7.8 Hz, 1 H), 7.84 (t, J = 7.9 Hz, 1 H), 8.05 (d, J 
= 8.9 Hz, 2 H), 8.66–8.68 (m, 1 H). 13C NMR (CDCl3, 75 MHz): δ 22.3 (CH2), 26.2 (CH2), 
37.1 (CH3), 50.5 (CH2), 55.5 (CH3), 108.8 (CH), 113.9 (Cquat.), 113.0 (Cquat.), 114.5 (CH), 
123.2 (CH), 124.7 (CH), 128.0 (CH), 128.3 (CH), 133.5 (Cquat.), 137.2 (CH), 148.0 (Cquat.), 
150.0 (CH), 157.1 (Cquat.), 159.5 (Cquat.), 160.9 (Cquat.). IR (KBr): ~ν  2834 cm–1, 1665, 1609, 
1585, 1572, 1555, 1513, 1471, 1428, 1410, 1399, 1369, 1356, 1327, 1246, 1202, 1179, 1170, 
1032, 831, 792. UV/vis (CH2Cl2): λmax (ε) 256 (20400), 358 (6200). HRMS calcd. for 
C21H21N3O: 331.1685; found 331.1679. 
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4-[2-(4-Methoxy-phenyl)-9-methyl-6,7,8,9-tetrahydro-5H-pyrido[2,3-b]azepin-4-yl]-
benzonitrile (27g) 
 
N N
CH3MeO
CN
 
 
According to the GP after chromatography on silica gel (hexane/acetone, 4:1) and 
recrystallization from diethylether 192 mg (52 %) of 27g were isolated as light yellow 
crystals. M.p. 142 °C.  1H NMR (CDCl3, 300 MHz): δ 1.66–1.73 (m, 2 H), 1.83–1.89 (m, 2 
H), 2.16–2.57 (m, 2 H), 3.16 (s, 3 H), 3.26–3.30 (m, 2 H), 3.84 (s, 3 H), 6.93–6.96 (m, 1 H), 
6.97 (d, J = 6.5 Hz, 2 H), 7.44 (d,  J = 8.4 Hz, 2 H), 7.71 (d, J = 8.37 Hz, 2 H), 7.97 (d, J = 
8.88 Hz, 2 H). 13C NMR (CDCl3, 75 MHz): δ  25.1 (CH2), 27.8 (CH2), 28.5 (CH2), 40.8 
(CH3), 54.0 (CH2), 55.31 (CH3), 111.2 (CH), 111.4 (Cquat.), 113.9 (CH), 118.7 (Cquat.), 120.7 
(Cquat.), 127.7 (CH), 129.7 (CH), 132.1 (CH), 146.0 (Cquat.), 149.0 (Cquat.), 151.6 (Cquat.), 160.1 
(Cquat.), 162.2 (Cquat.). IR (KBr): ~ν  2932 cm–1, 2228 (C≡N), 1636, 1608, 1586, 1573, 1561, 
1541, 1514, 1439,1369, 1353, 1253, 1236, 1182, 1181, 831, 584, 562, 551. UV/vis (CH2Cl2): 
λmax (ε) 260 (18200), 338 (3500). EI MS (70 eV): m/z (%): 369.2 (M+, 100), 340.2 (M+ – 
HCN, 41), 325.2 (M+ - HCN - CH3, 16). Anal. calcd. for C24H23N3O (369.5): C 78.02, H 6.27, 
N 11.37; found C 77.68, H 6.64, N 11.26. 
 
4-[9-Methyl-2-(4-phenoxy-phenyl)-6,7,8,9-tetrahydro-5H-pyrido[2,3-b]azepin-4-yl]-
benzonitrile (27h) 
 
N N
CH3
CN
O
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According to the GP after chromatography on silica gel (hexane/acetone, 4:1) and 
recrystallization from diethylether 186 mg (43 %) of 27h were isolated as light yellow 
crystals. M.p. 187 °C. 1H NMR (CDCl3, 300 MHz): δ  1.70–1.76 (m, 2 H), 1.83–1.88 (m, 2 
H), 2.56–2.60 (m, 2 H), 3.13 (s, 3 H), 3.29–3.33 (m, 2 H), 7.03–7.07 (m, 4 H), 7.15 (t, J = 7.4 
Hz, 1 H), 7.20 (s, 1 H), 7.37–7.40 (m, 2 H), 7.62 (d, J = 8.3 Hz, 2 H), 7.87 (d, J = 8.4 Hz, 2 
H), 8.15 (d, J = 8.9 Hz, 2 H). 13C NMR (CDCl3, 75 MHz): δ 25.7 (CH2), 28.6 (CH2), 29.4 
(CH2), 41.0 (CH3), 54.6 (CH2), 112.2 (CH), 112.3 (CH), 119.2 (CH), 119.3 (CH), 120.0 (CH), 
121.9 (Cquat.), 124.4 (CH), 128.9 (CH), 130.8 (CH), 133.0 (CH), 135.5 (Cquat.), 146.5 (Cquat.), 
150.3 (Cquat.), 151.7 (Cquat.), 158.0 (Cquat.), 158.7 (Cquat.), 163.1 (Cquat.). EI MS (70 eV): m/z 
(%): 431.3 (M+, 83), 416 (M+ – CH3, 17), 402.2 (M+ - C2H5, 34), 77.1 (C6H5+). IR (KBr): ~ν  
3051 cm–1, 2933, 2858, 2228, 1588, 1573, 1542, 1504, 1489, 1440, 1408, 1369, 1353, 1334, 
1234, 1164, 970, 873, 836, 754, 692. UV/vis (CH2Cl2): λmax (ε) 258 (38900), 340 (6600). 
Anal. calcd. for C29H25N3O (431.5): C 80.72, H 5.84, N 9.74; found C 80.39, H 5.89, N 9.83. 
 
2-(4-Methoxy-phenyl)-9-methyl-4-pyrimidin-2-yl-6,7,8,9-tetrahydro-5H-pyrido[2,3-
b]azepine (27i) 
 
N N
CH3
NN
MeO
 
 
According to the GP after chromatography on silica gel (hexane/acetone, 4:1) and 
recrystallization from diethylether 194 mg (56 %) of 27i were isolated as a brown oil. 1H 
NMR (CDCl3, 300 MHz): δ 1.83–1.89 (m, 4 H), 2.73–2.77 (m, 2 H), 3.15 (s, 3 H), 3.27–3.30 
(m, 2 H), 3.79 (s, 3 H), 6.92 (d, J = 8.9 Hz, 2 H), 7.17 (t, J = 4.9 Hz, 1 H), 7.47 (s, 1 H), 8.04 
(d, J = 8.9 Hz, 2 H), 8.78 (d, J = 4.9 Hz, 2 H). 13C NMR (CDCl3, 75 MHz): δ 24.3 (CH2), 27.3 
(CH2), 28.3 (CH2), 40.4 (CH3), 53.7 (CH2), 55.1 (CH3), 111.1 (CH), 113.6 (CH), 119.1 (CH), 
121.9 (Cquat.), 127.6 (CH), 132.3 (Cquat.), 147.1 (Cquat.), 151.3 (Cquat.), 156.8 (CH), 159.7 
(Cquat.), 162.0 (Cquat.), 167.1 (Cquat.). IR (KBr): ~ν  2932 cm–1, 1608, 1589, 1566, 1547, 1513, 
1492, 1443, 1418, 1368, 1350, 1333, 1296, 1247, 1191, 1179, 1032, 838, 813. UV/vis 
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(CH2Cl2): λmax (ε) 254 (23400), 280 (14800), 348 (5500). HRMS calcd. for C21H22N4O: 
346.1794; found 346.1797. 
 
2-(4-Methoxy-phenyl)-9-methyl-4-pyridin-2-yl-6,7,8,9-tetrahydro-5H-pyrido[2,3-
b]azepine (27j) 
 
N N
CH3
N
MeO
 
 
According to the GP after chromatography on silica gel (hexane/acetone, 4:1) and 
recrystallization from diethylether 180 mg (52 %) of 27j were isolated as yellow crystals. 
M.p. 121 °C.  1H NMR (CDCl3, 300 MHz): δ 1.75–1.90 (m, 4 H), 2.63–2.85 (m, 2 H), 3.12 (s, 
3 H), 3.27–3.30 (m, 2 H), 3.84 (s, 3 H), 6.98 (d, J = 9.0 Hz, 2 H), 7.31 (s, 1 H), 7.38–7.42 (m, 
1 H), 7.55 (dt , J = 1.0 Hz, J = 6.8 Hz, 1 H), 7.87 (td, J = 7.5 Hz,  J = 1.75 Hz, 2 H), 8.09 (d, J 
= 9.0 Hz, 2 H).  13C NMR (CDCl3, 75 MHz): δ 25.6 (CH2), 28.7 (CH2), 29.3 (CH2), 30.1 
(CH2), 41.1 (CH3), 54.9 (CH2), 55.6 (CH3), 112.0 (CH), 114.5 (CH), 122.1 (Cquat.), 123.2 
(CH), 124.8 (CH), 128.3 (CH), 133.1 (Cquat.), 137.1 (CH), 150.1 (CH), 150.6 (Cquat.), 151.8 
(Cquat.), 159.8 (Cquat.), 161.0 (Cquat.), 163.0 (Cquat.). EI MS (70 eV): m/z (%): 345.2 (M+, 100), 
330.1 (M+ – CH3, 20), 316.2 (M+ – C2H5, 48), 302.2 (M+ – C3H7, 22), 288.2 (M+ - C4H9, 18).  
Anal. calcd. for C22H23N3O (345.4): C 76.49, H 6.71, N 12.16; found C 76.02, H 6.70, N 
12.13.  
 
6.9 General Procedure for Synthesis of Enamine 30 
 
A mixture of 50 mmols of 1,3-diketone 28, 50 mmols of amine 29, and catalytical 
amount of p-toluenesulfonic acid (PTSA), in 100 mL dry benzene, were refluxed for 16 hours, 
using the water trap, under inert atmosphere (nitrogen). The reaction mixture was added to 20 
mL of diethyl ether, and after filtration and solvent evaporation the pure enamine was 
isolated. In same cases, the enamines were purified by distillation at low pressure. 
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(Z)-4-(2-(1H-indol-3-yl)ethylamino)pent-3-en-2-one (30a)151 
 
NHO
NH
 
 
According to the GP, 170 mg (70 %) of 30a were isolated. 1H NMR (CDCl3, 300 MHz), δ  
1.83 (s, 3 H), 1.99 (s, 3 H), 3.03 (t, J = 6.0 Hz, 2 H), 3.51 (q, J = 6.0 Hz 2 H), 4.93 (s, 1 H), 
7.07−7.24 (m, 3 H), 7.31 (d, J = 9.0 Hz, 1 H), 7.54 (d, J = 9.0 Hz, 1 H), 8.75 (s, 1 H), 10.90 
(s, 1 H). 13C NMR (CDCl3, 100 MHz), δ 18.9 (CH3), 26.0 (CH2), 28.6 (CH3), 43.4 (CH2), 
95.2 (CH), 111.5 (CH), 111.7 (Cquat.), 118.2 (CH), 119.1 (CH), 121.8 (CH), 123.0 (CH), 127.0 
(Cquat.), 136.5 (Cquat.), 163.2 (Cquat.), 194.6 (Cquat.). HRMS calcd. for C15H18N2O: 242.1419; 
found: 242.1427. 
 
(Z)-4-(butylamino)pent-3-en-2-one (30b)152 
 
NHO
 
 
According to the GP, 152 mg (98 %) of 30b were isolated. 1H NMR (CDCl3, 300 MHz), 
δ 0.88 (t, J = 6.0 Hz, 2 H), 1.33−1.41 (m, 2 H), 1.49−1.56 (m, 2 H), 1.88 (s, 3 H), 1.96 (s, 3 
H), 3.16 (q, J = 6.0 Hz 2 H), 4.91 (s, 1 H),  10.83 (s, 1 H). 13C NMR (CDCl3, 100 MHz), 
δ 13.7 (CH3), 18.7 (CH3), 20.0 (CH2), 28.7 (CH3), 32.1 (CH2), 42.7 (CH2), 94.9 (CH), 163.1 
(Cquat.), 194.6 (Cquat.). HRMS calcd. for C9H17NO: 155.1310; found: 155.1320. 
 
(Z)-4-(4-methoxyphenylamino)pent-3-en-2-one (30c)153 
 
NHO
OMe
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According to the GP, 205 mg (80 %) of 30c were isolated. 1H NMR (CDCl3, 300 MHz), 
δ 1.88 (s, 3 H), 2.06 (s, 3 H), 3.76 (s, 3 H), 5.13 (s, 1 H), 6.82 (d, J = 9.0 Hz, 2 H), 7.0 (d, J = 
9.0 Hz, 2 H), 12.26 (s, 1 H). 13C NMR (CDCl3, 100 MHz), δ 19.3 (CH3), 29.1 (CH3), 55.5 
(CH3), 96.8 (CH), 114.3 (CH),  126.7 (CH), 131.5 (Cquat.), 157.7 (Cquat.), 161.2 (Cquat.), 195.8 
(Cquat.). HRMS calcd. for C12H15NO2: 205.1103; found: 205.1110. 
 
(Z)-3-(butylamino)-N,N-dimethylbut-2-enamide (30d)154 
 
NHO
N
 
 
According to the GP, 169 mg (92 %) of 30d were isolated. 1H NMR (CDCl3, 250 MHz), 
δ 1.34 (t, J = 7.3 Hz, 3 H), 1.37−1.53 (m, 4 H), 1.85 (s, 3 H), 2.86 (s, 6 H), 3.07 (q, J = 6.6 
Hz, 2 H), 4.46 (s, 1 H). HRMS calcd. for C10H20N2O: 184.1576; found 184.1582. 
 
4-(Diethylamino)pent-3-en-2-one (30e)155 
 
NEt2O
 
 
According to the GP, 115 mg (74 %) of 30e were isolated. 1H NMR (CDCl3, 250 MHz), 
δ 1.14 (t, J = 7.14 Hz, 6 H), 2.05−2.07 (m, 3 H), 2.54 (s, 3 H), 3.25 (q, J = 7.14 Hz, 4 H), 5.08 
(s, 1 H). HRMS calcd. for C9H17NO: 155.1310; found 155.1316. 
 
(Z)-4-(Phenylamino)pentan-2-one (30f)156 
 
NHO
 
 
According to the GP, 175 mg (98 %) of 30f were isolated. 1H NMR (CDCl3, 300 MHz), 
δ 0.88 (t, J = 6.0 Hz, 2 H), 1.33−1.41 (m, 2 H), 1.49−1.56 (m, 2 H), 1.88 (s, 3 H), 1.96 (s, 3 
H), 3.16 (q, J = 6.0 Hz 2 H), 4.91 (s, 1 H),  10.83 (s, 1 H). 13C NMR (CDCl3, 100 MHz), 
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δ 18.88 (CH3), 26.0 (CH2), 28.6 (CH3), 43.4 (CH2), 95.2 (CH), 111.5 (CH), 111.7 (Cquat.), 
118.2 (CH), 119.1 (CH), 121.8 (CH), 123.0 (CH), 127.0 (Cquat.), 136.5 (Cquat.), 163.2 (Cquat.), 
194.61 (Cquat.). HRMS calcd. for C13H13NO: 175.0997; found 175.1004. 
 
6.10 General Procedure for the Coupling-Isomerization-Enamine Addition- 
Aldol-Condensation Multicomponent Synthesis of Cyclohexadienes 31 
and Cyclohexenones 32 
 
A magnetically stirred solution of 1.00 mmol of halogen compound 1, 1.05 mmols of 
propargyl alcohol 2, 20 mg (0.02 mmols) of Pd(PPh3)Cl2, and 2 mg (0.01 mmols) of CuI in 
~0.5 mL (505 mg) of degassed triethylamine and 1.5 mL THF under nitrogen, in a sealed 
vessel was heated to 150 ºC, for 10-15 min, under microwave irradiation. After cooling to 
room temperature 3 mmols of enamine 30 and 0.75 mL of CH3COOH were added and the 
reaction mixture was heated to 150 ºC, for another 10−15 min. After cooling to room 
temperature the reaction mixture was poured to 40 mL of ethyl acetate and 40 mL of water 
and stirring was continued for 5 to 10 min. The aqueous layer was extracted with ethyl acetate 
(4x15 mL) and the combined organic phases were dried over magnesium sulfate. After 
filtration the solvents were removed in vacuo and the residue was chromatographed on silica 
gel (hexane/ethyl acetate 4:1 or 1:1) and recrystallized from ethanol or pentane/chloroform 
(1:1) to give the analytically pure cyclohexadienes 30a−k, or cyclohexanones 32a−i. 
 
Table 29 Experimental details of the synthesis of cyclohexadienes 30 and cyclohexanones 32. 
Ar1- Hal  
1 
Propargyl-
alcohol  
2 
Enamine 
 4 
CH3COOH 
 
T1 
(min.) 
T2 
(min.) 
Yield 
 
182 mg 
(1.00 mmol)  
of 1a 
139 mg 
(1.05 mmols) 
of 2a 
726 mg 
(3.00 mmols) 
of 4a 
0.75 mL 15 10 311 mg 
(68 %) of 
31a 
159 mg 
(1.00 mmol)  
of 1b 
139 mg 
(1.05 mmols) 
of 2a 
726 mg 
(3.00 mmols) 
of 4a 
0.75 mL 15 10 321 mg 
(74 %) of 
31b 
158 mg 
(1.00 mmol)  
of 1c 
139 mg 
(1.05 mmols) 
of 2a 
726 mg 
(3.00 mmols) 
of 4a 
0.75 mL 15 10 304 mg 
(70 %) of 
31c 
272 mg 
(1.00 mmol)  
of 1d 
139 mg 
(1.05 mmols) 
of 2a 
339 mg 
(1,40 mmols) 
of 4a 
0.75 mL 20 20 235 mg 
(47 %) of 
31d 
182 mg 
(1.00 mmol)  
of 1a 
145 mg 
(1.05 mmols) 
of 2b 
726 mg 
(3.00 mmols) 
of 4a 
0.75 mL 15 15 250 mg 
(54 %) of 
31e 
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Table 29 continued      
182 mg 
(1.00 mmol)  
of 1a 
145 mg 
(1.05 mmols) 
of 2c 
726 mg 
(3 mmols) of 
4a 
0.75 mL 15 15 297 mg 
(61 %) of 
31f 
158 mg 
(1.00 mmol)  
of 1c 
145 mg 
(1.05 mmols) 
of 2b 
726 mg 
(3 mmols) of 
4a 
0.75 mL 15 15 264 mg 
(60 %) of 
31g 
182 mg 
(1.00 mmol)  
of 1a 
170 mg 
(1.05 mmols) 
of 2f 
726 mg 
(3 mmols) of 
4a 
0.75 mL 15 10 331 mg 
(68 %) of 
31h 
182 mg 
(1.00 mmol)  
of 1a 
139 mg 
(1.05 mmols) 
of 2a 
310 mg 
(2 mmols) 
4b 
0.5 mL 15 20 200 mg 
(54 %) of 
31i 
159 mg 
(1.00 mmol)  
of 1b 
139 mg 
(1.05 mmols) 
of 2a 
465 mg 
(3 mmols) of 
4b 
0.75 mL 15 10 180 mg 
(52 %) of 
31j 
158 mg 
(1.00 mmol)  
of 1c 
139 mg 
(1.05 mmols) 
of 2a 
465 mg 
(3 mmols) of 
4b 
0.75 mL 15 10 180 mg 
(52 %) of 
31k 
182 mg 
(1.00 mmol)  
of 1a 
139 mg 
(1.05 mmols) 
of 2a 
615 mg 
(3 mmols) of 
4c 
1.5 mL 15 10 126 mg 
(30 %) 
31l 
182 mg 
(1.00 mmol)  
of 1a 
139 mg 
(1.05 mmols) 
of 2a 
576 mg 
(3 mmols) of 
4d 
0.75 mL 15 10 227 mg 
(66 %) of 
32a 
159 mg 
(1.00 mmol)  
of 1b 
139 mg 
(1.05 mmols) 
of 2a 
576 mg 
(3 mmols) of 
4d 
0.75 mL 15 10 218 mg 
(68 %) 
32b 
158 mg 
(1.00 mmol)  
of 1c 
139 mg 
(1.05 mmols) 
of 2a 
576 mg 
(3 mmols) of 
4d 
0.75 mL 15 10 154 mg 
(48 %) 
32c 
272 mg 
(1.00 mmol)  
of 1d 
139 mg 
(1.05 mmols) 
of 2a 
576 mg 
(3 mmols) of 
4d 
0.75 mL 15 10 272 mg 
(70 %) of 
32d 
229 mg 
(1.00 mmol)  
of 1e 
139 mg 
(1.05 mmols) 
of 2a 
576 mg 
(3 mmols) of 
4d 
0.75 mL 15 10 186 mg 
(48 %) of 
32e 
182 mg 
(1.00 mmol)  
of 1a 
170 mg 
(1.05 mmols) 
of 2f 
576 mg 
(3 mmols) of 
4d 
0.75 mL 15 10 217 mg 
(58 %) of 
32f 
182 mg 
(1.00 mmol)  
of 1a 
145 mg 
(1.05 mmols) 
of 2b 
576 mg 
(3 mmols) of 
4d 
0.75 mL 15 10 227 mg 
(66 %) of 
32g 
182 mg 
(1.00 mmol)  
of 1a 
145 mg 
(1.05 mmols) 
of 2c 
576 mg 
(3 mmols) of 
4d 
0.75 mL 15 10 217 mg 
(62 %) of 
32h 
158 mg 
(1.00 mmol)  
of 1c 
145 mg 
(1.05 mmols) 
of 2b 
576 mg 
(3 mmols) of 
4d 
0.75 mL 15 10 201 mg 
(62 %) of 
32i 
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4-{2-Acetyl-3-[2-(1H-indol-3-yl)-ethylamino]-5-phenyl-cyclohexa-2,4-dienyl}-
benzonitrile (31a) 
 
N
H
O
NH
CN
 
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1) and 
recrystallization from acetone 311 mg (68 %) of 31a were isolated as yellow crystals. M.p. 
227 °C. 1H NMR (DMSO-D6, 300 MHz), δ 1.80 (s, 3 H), 2.75−2.81 (m, 1 H), 2.94−3.12 (m, 3 
H), 3.68−3.89 (m, 2 H), 4.17 (d, J = 7.0 Hz, 1 H), 6.49 (d, J = 1.9 Hz, 1 H), 7.00−7.05 (m, 
3 H), 7.14 (t, J = 7.4 Hz, 1 H), 7.21−7.29 (m, 4 H), 7.32 (d, J = 8.12 Hz, 2 H), 7.36 (d, J = 
8.12 Hz, 1 H), 7.62 (d, J = 8.12 Hz, 1 H), 7.69 (d, J = 8.12 Hz, 2 H), 10.92 (s, 1 H), 11.72 (t, J 
= 6.0 Hz, 1 H). 13C NMR (CDCl3, 100 MHz), δ 26.6 (CH2), 26.9 (CH3), 34.8 (CH2), 38.2 
(CH), 42.4 (CH2), 97.7 (Cquat.), 108.9 (Cquat.), 110.9 (Cquat.), 111.5 (Cquat.), 115.7 (CH), 118.2 
(Cquat.), 118.5 (CH), 118.9 (CH), 121.0 (CH), 123.7 (CH), 125.5 (CH), 127.0 (Cquat.), 128.3 
(CH), 128.5 (CH), 128.8 (CH), 132.0 (CH), 136.4 (Cquat.), 138.6 (Cquat.), 145.2 (Cquat.), 146.9 
(Cquat.), 151.1 (Cquat.), 156.1 (Cquat.), 192.8 (Cquat.). MS (70 eV, EI): m/z (%): 457.2 (M+, 14), 
414.2 (M+ - CH3CO, 12), 327.2 (M+ - C9H8N, 44), 144.1 (C10H10N, 4), 130.1 (C9H8N+, 100), 
43 (CH3CO+, 18). IR (KBr), ~ν  3060 cm-1, 2219, 1632, 1604, 1576, 1561, 1551, 1463, 1443, 
1429, 1357, 1328, 1308, 1291, 1251, 1240, 1208, 768, 747, 696, 544. UV/vis (CH2Cl2), λmax 
(ε) 282 nm (11200), 290 (10700), 404 (5300). Anal. calcd. for C31H27N3O (457): C 81.40, 
H 5.91, N 9.19; found: C 81.02, H 6.05, N 9.09.  
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1-(2-(2-(1H-Indol-3-yl)ethylamino)-4-phenyl-6-(pyrimidin-2-yl)cyclohexa-1,3-
dienyl)ethanone (30b) 
 
N
H
O NN
NH
 
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1) and 
recrystallization from acetone 321 mg (74 %) of 30b were isolated as yellow crystals.  Mp. 
211 °C. 1H NMR (DMSO-D6, 300 MHz), δ 1.93 (s, 3 H), 2.52−3.05 (m, 4 H), 3.30−3.42 (m, 2 
H), 4.17 (d, J = 7.14 Hz, 1 H), 6.54 (d, J = 2.5 Hz, 1 H), 6.92 (t, J = 4.95 Hz, 1 H), 7.06−7.08 
(m, 1 H), 7.18−7.22 (m, 2 H), 7.23−7.34 (m, 4 H), 7.36−7.41 (m, 2 H), 7.59 (d, J = 7.77 Hz, 1 
H), 8.44 (d, J = 4.74 Hz, 2 H), 10.85 (s, 1 H), 11.74 (t, J = 5.24 Hz, 1 H). 13C NMR (CDCl3, 
100 MHz), δ 26.0 (CH2), 27.4 (CH3), 31.5 (CH2), 41.4 (CH), 42.7 (CH2), 99.1 (Cquat.), 111.0 
(CH), 111.4 (Cquat.), 111.7 (CH), 118.3 (CH), 118.9 (CH), 121.0 (CH), 123.5 (CH), 126.0 
(CH), 127.0 (Cquat.), 128.6 (CH), 128.8 (CH), 136.3 (Cquat.), 139.2 (Cquat.), 147.2 (Cquat.), 155.4 
(Cquat.), 157.0 (CH), 172.2 (Cquat.), 193.6 (Cquat.). MS (70 eV, EI): m/z (%): 434.2 (M+, 18), 
391.2 (M+ - CH3CO, 16), 304.1 (M+ - C9H8N, 60), 130.1 (C9H8N+, 100), 43 (CH3CO+, 22). IR 
(KBr), ~ν  3065 cm-1, 1633, 1562, 1493, 1456, 1440, 1414, 1357, 1325, 1290, 1250, 1233, 
1201, 762, 741, 696, 626, 560. UV/vis (CH2Cl2), λmax (ε) 282 nm (11300), 290 (5000), 404 
(3400). Anal. calcd. for C28H26N4O (434): C 77.39, H 6.03, N12.89; found: C 77.44, H 6.08, 
N 12.93.  
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1-(2-(2-(1H-Indol-3-yl)ethylamino)-4-phenyl-6-(pyridin-2-yl)cyclohexa-1,3-
dienyl)ethanone (31c) 
 
N
H
O N
NH
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1), 304 mg (70 %) 
of 31c were isolated as brown oil. 1H NMR (CDCl3, 300 MHz), δ 2.00 (s, 3 H), 2.58 (ddd, J = 
16.84 Hz, J = 7.87 Hz, J = 2.7 Hz, 1 H), 3.00−3.04 (m, 2 H), 3.19 (dd, J = 16.84 Hz, J = 1.75 
Hz 1 H), 3.56 (m, 2 H), 4.21 (d, J = 6.75 Hz, 1 H), 6.31 (d, J = 2.7 Hz, 1 H), 6.89−7.12 (m, 10 
H), 7.18 (dd, J = 6.75 Hz, , J = 1.7 Hz, 1 H), 7.31 (td, J = 7.7 Hz, , J = 1.75 Hz, 1 H),  7.49  
(d, J = 6.75 Hz 1 H), 8.38-8.40 (m, 1 H), 8.86 (s, 1 H), 11.75 (t, J = 5.5 Hz, 1 H). 13C NMR 
(CDCl3, 100 MHz), δ 26.5 (CH2), 27.1 (CH3), 33.8 (CH2), 41.3 (CH2), 99.4 (CH), 111.4 (CH), 
112.0 (Cquat.),  115.5 (CH), 118.3 (CH), 119.2 (CH), 121.2 (CH), 121.5 (CH), 121.8 (CH), 
123.0 (CH), 125.8 (CH), 127.1 (Cquat.), 128.4 (CH), 128.8 (CH), 136.5 (Cquat.), 139.4 (Cquat.), 
148.1 (Cquat.), 149.1 (CH), 157.0 (Cquat.), 163.8 (Cquat.), 194.6 (Cquat.). MS (70 eV, EI): m/z 
(%): 433.2 (M+, 50), 390.2 (M+ - CH3CO, 70), 303.1 (M+ - C9H8N, 100), 130.1 (C9H8N+, 20), 
43 (CH3CO+, 19). HRMS calcd. for C29H27N3O: 433.2154; found 433.2155. 
 
1-(2-(2-(1H-Indol-3-yl)ethylamino)-4-phenyl-6-(4-(trifluoromethyl)phenyl)cyclohexa-1,3-
dienyl)ethanone (31d) 
 
N
H
O
CF3
NH
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According to the GP after chromatography on silica gel (hexane/acetone 2:1) and 
recrystallization from acetone 235 mg (47 %) of 31d were isolated as yellow crystals. M.p. 
230 °C. 1H NMR (DMSO-D6, 300 MHz), δ 1.81 (s, 3 H), 2.79 (d, J = 15.75 Hz, 1 H), 
2.94−3.14 (m, 3 H), 3.68−3.84 (m, 2 H),  4.18 (d, J = 7.75 Hz, 1 H), 6.55 (d, J = 2.5 Hz, 1 H), 
6.90 (t, J = 6.9 Hz, 1 H), 7.09−7.39 (m, 10 H), 7.59−7.62 (m, 3 H), 10.93 (s, 1 H), 11.70 (t, J 
= 5.75 Hz, 1 H). 13C NMR (CDCl3, 100 MHz), δ 26.5 (CH2), 26.9 (CH3), 34.9 (CH2), 37.9 
(CH), 42.5 (CH2), 98.0 (Cquat.), 110.9 (Cquat.), 111.4 (CH), 115.7 (CH), 118.2 (CH), 118.3 
(CH), 121.0 (CH), 123.6 (CH), 124.9 (CH), 125.0 (CH), 125.5 (CH), 127.0 (Cquat.), 128.0 
(CH), 128.5 (CH), 128.7 (CH), 136.3 (Cquat.), 138.7 (Cquat.), 145.2 (Cquat.), 149.9 (Cquat.), 155.9 
(Cquat.), 192.9 (Cquat.). MS (70 eV, EI): m/z (%): 500.1 (M+, 18), 457.2 (M+ - CH3CO, 8), 370.1 
(M+ - C9H8N, 75), 130.1 (C9H8N+, 100), 43 (CH3CO+, 20). IR (KBr), ~ν  3045 cm-1, 1633, 
1563, 1544, 1459, 1441, 1358, 1326, 1292, 1245, 1210, 1163, 1122, 1112, 1068, 767, 745, 
695, 626, 534. UV/vis (CH2Cl2), λmax (ε) 282 nm (16700), 290 (15600), 404 (8300). Anal. 
calcd. for C31H27F3N2O (500): C 74.38, H 5.44, N 5.6; found : C 74.47, H 5.56, N 5.69. 
 
4-(3-(2-(1H-Indol-3-yl)ethylamino)-2-acetyl-5-(thiophen-2-yl)cyclohexa-2,4-
dienyl)benzonitrile (31e) 
 
N
H
O
NH
CN
S
 
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1), 250 mg (54 %) 
of 31e were isolated as brown oil. 1H NMR (DMSO-D6, 300 MHz), δ 1.78 (s, 3 H), 2.86–3.07 
(m, 4 H), 3.66−3.85 (m, 2 H), 4.15 (d, J = 5.25 Hz, 1 H), 6.59 (s, 1 H), 6.99 (t, J = 6.0 Hz, 1 
H), 7.07–7.12 (m, 2 H), 7.25–7.26 (m, 1 H), 7.30 (d, , J = 7.0 Hz, 2 H),  7.35 (s, 1 H), 
7.44−7.46 (m, 1H), 7.55–7.56 (m, 1H), 7.61 (d, J = 6.25 Hz, 1 H), 7.67 (d, J = 7.0 Hz, 2 H),  
10.88 (s, 1 H), 11.69 (t, J = 4.75 Hz, 1 H). 13C NMR (DMSO-D6, 100 MHz), δ 26.4 (CH2), 
26.8 (CH3), 34.4 (CH2), 38.0 (CH), 42.5 (CH2), 97.8 (Cquat.), 108.8 (CH), 110.9 (Cquat.),  111.4 
(CH), 114.0 (Cquat.),   118.3 (CH), 118.9 (Cquat.), 120.9 (CH), 123.5 (CH), 125.2 (CH), 126.9 
(CH), 127.0 (CH), 132.0 (CH), 136.3 (Cquat.), 140.2 (Cquat.), 140.6 (Cquat.), 150.4 (Cquat.), 156.3 
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(Cquat.), 192.4 (Cquat.). MS (70 eV, EI): m/z (%): 463.4 (M+, 100), 458.3 (M+ - CH3, 18), 420 
(M+ - CH3CO, 22), 130.1 (C9H8N+, 100), 43 (CH3CO+, 20). IR (KBr), ~ν  3425 cm-1, 2230, 
1628, 1604, 1559, 1458, 1427, 1354, 1320, 1280, 1245, 1209, 941, 785, 742, 668, 617, 547, 
499, 462. UV/vis (CH2Cl2), λmax (ε) 276 nm (15800), 284 (16800), 292 (17000), 406 (8800). 
Anal. calcd. for C29H25N3OS (463): C 75.13, H 5.44, N 9.06, S 6.92; found: C 75.38, H 5.36, 
N 8.85, S 6.88. 
 
4-(3-(2-(1H-Indol-3-yl)ethylamino)-2-acetyl-5-(thiophen-3-yl)cyclohexa-2,4-
dienyl)benzonitrile (31f) 
 
N
H
O
NH
CN
S
 
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1), 296 mg (64 %) 
of 31f were isolated as brown oil. 1H NMR (DMSO-D6, 300 MHz), δ 1.78 (s, 3 H), 2.86–2.92 
(d, J = 15.75 Hz,1 H), 2.95–3.06 (m, 3 H), 3.65−3.80 (m, 2 H), 4.16 (d, J = 5.75 Hz, 1 H), 
6.60 (s, 1 H), 6.98–7.03 (m, 2 H), 7.06 (t, J = 6.25 Hz, 1 H), 7.18–7.19 (m, 1 H), 7.25 (s, 1 H), 
7.32–7.35 (m, 3 H), 7.55–7.56 (d, J = 4.0 Hz, 1 H), 7.60 (d, J = 6.5 Hz, 1 H), 7.67 (d, J = 6.25 
Hz, 2 H), 10.88 (s, 1 H), 11.63 (t, J = 4.75 Hz, 1 H). 13C NMR (DMSO-D6, 100 MHz), δ 26.3 
(CH2), 26.8 (CH3), 35.1 (CH2), 38.1 (CH), 42.7 (CH2), 98.0 (Cquat.), 108.9 (Cquat.), 110.9 
(Cquat.),  11.4 (CH), 112.9 (CH), 118.2 (CH), 118.3 (CH), 118.8 (Cquat.), 128.1 (CH), 128.3 
(CH), 128.4 (CH), 132.0 (CH), 136.3 (Cquat.), 139.0 (Cquat.), 142.7 (Cquat.), 150.8 (Cquat.), 155.8 
(Cquat.), 192.5 (Cquat.). ). MS (70 eV, EI): m/z (%): 464.4 (M+ + H+, 70), 463.4 (M+, 60), 458.3 
(M+ - CH3, 100), 420 (M+ - CH3CO, 27), 130.1 (C9H8N+, 100), 43 (CH3CO+, 15). IR (KBr), ~ν  
3423 cm-1, 2920, 2227, 1623, 1559, 1500, 1458, 1423, 1384, 1352, 1325, 1284, 1244, 1209, 
1152, 944, 847, 741, 707, 549. UV/vis (CH2Cl2), λmax (ε) 282 nm (13000), 290 (11500), 326 
(11700), 424 (8800). HRMS calcd. for C29H25N3OS: 463.1745; found 463.1718. 
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1-(2-(2-(1H-Indol-3-yl)ethylamino)-6-(pyridin-2-yl)-4-(thiophen-2-yl)cyclohexa-1,3-
dienyl)ethanone (31g) 
 
N
H
O N
NH
S
 
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1) and 
recrystallization from acetone 264 mg (60 %) of 31g were isolated as yellow oil. 1H NMR 
(DMSO-D6, 300 MHz), δ 1.90 (s, 3 H), 2.95 (dd, J = 2.25 Hz, J = 6.25 Hz, 1 H), 3.09−3.14 
(m, 2 H), 3.37 (dd, J = 1.5 Hz, J = 13.5 Hz, 1 H), 3.72−3.85 (m,  2 H), 4.13 (dd, J = 1.25 Hz, 
J = 6.5 Hz, 1 H), 6.64 (d, J = 2.25 Hz, 1 H) 6.98−7.13 (m, 5 H), 7.15-7.16 (m, 1 H), 7.31 (d, J 
= 1.75 Hz, 1 H), 7.35 (d, J = 6.75 Hz, 1 H), 7.42 (dd, J = 1.0 Hz, J = 4.0 Hz, 1 H), 7.54 (td, J 
= 1.0 Hz, J = 6.25 Hz, 1 H), 7.66 (d, J = 6.75 Hz, 1 H), 8.47−8.49 (m, 1 H),  10.11 (s, 1 H), 
11.85 (t, J = 4.5 Hz, 1 H). 13C NMR (CDCl3, 100 MHz), δ 27.2 (CH3), 27.6 (CH2), 34.4 
(CH2), 42.0 (CH), 44.1 (CH2), 55.3 (CH3), 112.2 (CH), 112.7 (Cquat), 119.1 (CH), 119.53 
(CH), 121.8 (CH), 122.0 (CH), 124.1 (CH), 126.9 (Cquat.), 127.9 (CH), 128.4 (CH), 128.9 
(CH), 137.7 (CH), 141.0 (Cquat.), 144.4 (Cquat.), 149.9 (Cquat),  156.9 (Cquat.), 164.9 (Cquat),  
194.2 (Cquat.). MS (70 eV, EI): m/z (%): 439.1 (M+, 55), 396.1 (M+ - CH3CO, 65), 309.1 (M+ - 
C9H8N, 100), 43 (CH3CO+, 25). IR (KBr), ~ν  3416 cm-1, 3102, 3055, 2919, 1622, 1559, 1458, 
1424, 1383, 1352, 1323, 1285, 1242, 1204, 1185, 1148, 943, 768, 741, 702. UV/vis (CH2Cl2), 
λmax (ε) 272 nm (16200), 290 (13900), 326 (13100), 420 (10000). HRMS calcd. for 
C27H25N3OS: 439.1718; found 439.1736. 
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4-(3-(2-(1H-Indol-3-yl)ethylamino)-2-acetyl-5-(4-methoxyphenyl)cyclohexa-2,4-
dienyl)benzonitrile (31h) 
 
N
H
O
NH
CN
O
 
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1) and 
recrystallization from acetone 331 mg (68 %) of 31h were isolated as yellow crystals. M.p. 
227 °C. 1H NMR (DMSO-D6, 300 MHz), δ 1.78 (s, 3 H), 2.75 (d, J = 16.75 Hz, 1 H), 
2.89−3.11 (m, 3 H), 3.64−3.88 (m, 2 H), 3.72 (s, 3 H), 4.14 (d, J = 7.75 Hz, 1 H), 6.44 (s, 1 H) 
6.77 (d, J = 9.0 Hz, 2 H), 6.99–7.07 (m, 3 H), 7.13 (t, J = 7.75 Hz, 1 H), 7.25−7.38 (m, 4 H), 
7.61 (d, J = 7.75 Hz, 1 H), 7.67 (d, J = 7.75 Hz, 2 H), 10.89 (s, 1 H), 11.74 (t, J = 6.0 Hz, 
1 H). 13C NMR (CDCl3, 100 MHz), δ 26.6 (CH2), 26.9 (CH3), 34.7 (CH2), 38.3 (CH), 42.5 
(CH2), 55.3 (CH3), 97.5 (Cquat) 108.9 (Cquat.), 110.9 (Cquat.), 111.0 (Cquat.), 111.5 (CH), 118.3 
(CH), 118.5 (CH), 119.0 (Cquat),  121.1 (CH), 123.7 (CH), 127.2 (CH), 128.4 (CH), 130.9 
(Cquat.), 132.6 (CH), 136.4 (Cquat),  145.0 (Cquat.), 151.3 (CH) 156.5 (Cquat.), 159.9 (Cquat.), 
192.4(Cquat.). MS (70 eV, EI): m/z (%): 487.1 (M+, 13), 444.1 (M+ - CH3CO, 10), 357.1 (M+ - 
C9H8N, 80), 130.1 (C9H8N+, 100), 43 (CH3CO+, 18). IR (KBr), ~ν  3406 cm-1, 3050, 2227, 
1629, 1604, 1559, 1512, 1458, 1357, 1331, 1295, 1257, 1232, 1210, 1180, 1030, 828, 745, 
560. UV/vis (CH2Cl2), λmax (ε) 284 nm (41100), 292 (42600), 312 (41100), 404 (40000), 312 
(51800). Anal. calcd. for C32H29N3O2 (487): C 78.82, H 5.99, N 8.62; found: C 78.84, H 6.01, 
N 8.60. 
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4-(2-Acetyl-3-(butylamino)-5-phenylcyclohexa-2,4-dienyl)benzonitrile (31i) 
 
N
H
O
nBu
CN
 
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1), 200 mg (54 %) 
of 31i were isolated as brown oil. 1H NMR (CDCl3, 300 MHz), δ 0.91 (t, J = 7.25 Hz,  3 H), 
1.38−1.52 (m, 2 H), 1.60−1.69 (m, 2 H), 1.88 (s, 3 H), 2.98 (dd, J = 16.75 Hz,  J = 2.0 Hz, 1 
H),  3.17 (ddd, J = 16.75 Hz, J = 7.75 Hz, J = 2.5 Hz, 1 H), 3.47−3.58 (m, 2 H), 4.30 (dd, J = 
7.75 Hz, J = 1.75 Hz, 1 H), 6.89 (d, J = 2.75 Hz, 1 H), 7.29−7.33 (m, 3 H), 7.41-7.45 (m, 2 
H), 7.46  (d, J = 8.0 Hz, 2 H), 7.59 (d, J = 8.0 Hz, 2 H), 11.74 (s, 1 H). 13C NMR (CDCl3, 100 
MHz), δ 14.0 (CH3), 20.6 (CH2), 27.1 (CH), 33.1 (CH2), 36.1 (CH2), 39.7 (CH), 42.8 (CH2), 
99.0 (Cquat.),  110.5 (Cquat.), 116.7 (CH), 119.4 (Cquat.), 126.6 (CH), 129.1 (CH), 129.4 (CH), 
129.6 (CH), 129.8 (CH), 132.7 (CH), 140.1 (Cquat.), 147.4 (Cquat.), 151.9 (Cquat.), 157.4 (Cquat.), 
194.6 (Cquat.), 207.3 (Cquat.). MS (70 eV, EI): m/z (%): 370.2 (M+, 70), 327.2 (M+ - CH3CO, 
100), 268.2 (M+ - C7H4N, 50), 43 (CH3CO+, 28). IR (KBr), ~ν  2958 cm-1, 2931, 2872, 2227, 
1713, 1634, 1604, 1578, 1558, 1498, 1460, 1443, 1357, 1328, 1291, 1247, 1222, 830, 768, 
696. UV/vis (CH2Cl2), λmax (ε) 286 nm (14000), 402 (6200). HRMS calcd. for C25H26N2O: 
370.2045; found 370.2049. 
 
1-(2-(butylamino)-4-phenyl-6-(pyrimidin-2-yl)cyclohexa-1,3-dienyl)ethanone (31j) 
 
N
H
O
nBu
NN
 
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1), 180 mg (52 %) 
of 31j were isolated as brown oil. 1H NMR (CDCl3, 300 MHz), δ 0.90 (t, J = 7.3 Hz,  3 H), 
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1.39−1.49 (m, 2 H), 1.57−1.67 (m, 2 H), 2.14 (s, 3 H), 3.02 (ddd, J = 16.8 Hz, J = 7.6 Hz, J = 
2.85 Hz, 1 H), 3.32−3.40 (m, 2 H), 3.51 (dd, J = 16.8 Hz, J = 1.75 Hz, 1 H), 4.32 (d, J = 5.9 
Hz, 1 H),   6.54 (d, J = 2.79 Hz, 1 H), 6.99 (t, J = 4.83 Hz, 1 H), 7.29-7.60 (m, 5 H), 8.57 (d, J 
= 4.83 Hz, 2 H), 11.75 (s, 1 H). 13C NMR (CDCl3, 100 MHz), δ 13.6 (CH3), 19.9 (CH2), 27.2 
(CH), 32.0 (CH2), 32.3 (CH2), 42.1 (CH), 42.3 (CH2), 98.8 (Cquat.), 115.7 (CH), 117.8 (CH), 
125.9 (CH), 126.1 (CH), 128.3 (CH), 128.5 (CH), 139.8 (Cquat.), 148.0 (Cquat.), 155.8 (Cquat.), 
156.3 (CH), 172.6 (Cquat.), 194.5 (Cquat.). MS (70 eV, EI): m/z (%): 347.2 (M+, 45), 304.2 (M+ - 
CH3CO, 100), 268.1 (M+ - C4H3N2, 40), 43 (CH3CO+, 26). IR (KBr), ~ν  3034 cm-1, 2958, 
2930, 2872, 1792, 1634, 1562, 1466, 1416, 1295, 1164, 1129, 1079, 938, 762, 697. UV/vis 
(CH2Cl2), λmax (ε) 250 nm (10100), 282 (13300), 402 (5100).  HRMS calcd. for C22H25N3O: 
347.1998; found 347.1992. 
 
1-(2-(Butylamino)-4-phenyl-6-(pyridin-2-yl)cyclohexa-1,3-dienyl)ethanone (31k) 
 
N
H
O
nBu
N
 
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1), 180 mg (52 %) 
of 31k were isolated as brown oil. 1H NMR (DMSO-D6, 300 MHz), δ 0.90 (t, J = 7.25 Hz,  
3 H), 1.31−1.43 (m, 2 H), 1.52−1.64 (m, 2 H), 1.92 (s, 3 H), 3.02 (ddd, J = 16.75 Hz, J = 8.0 
Hz, J = 2.75 Hz, 1 H), 3.31−3.36 (m, 2 H), 4.15 (d, J = 8.0 Hz, 1 H),   6.52 (d, J = 2.75 Hz, 1 
H), 6.90−6.95 (m, 1 H), 7.04 (d, J = 7.75 Hz, 1 H), 7.18-7.28 (m, 5 H), 7.35 (td, J = 7.75 Hz, 
J = 1.75 Hz, 1 H), 8.42 (d, J = 4.75 Hz, 1 H),   11.70 (t, J = 5.25 Hz,  1 H). 13C NMR (CDCl3, 
100 MHz), δ 13.8 (CH3), 19.8 (CH2), 26.8 (CH), 31.4 (CH2), 33.6 (CH2), 41.1 (CH), 42.3 
(CH2), 98.1 (Cquat.), 115.2 (CH), 120.9 (CH), 121.1 (CH), 125.8 (CH), 128.2 (CH), 128.4 
(CH), 135.9 (CH), 148.2 (Cquat.), 148.8 (CH), 156.5 (Cquat.), 163.6 (Cquat.), 194.2 (Cquat.). MS 
(70 eV, EI): m/z (%): 346.2 (M+, 15), 303.2 (M+ - CH3CO, 100), 268.1 (M+ - C5H4N, 40), 43 
(CH3CO+, 22). IR (KBr), ~ν  3392 cm-1, 3057, 2957, 2929, 2872, 1724, 1635, 1560, 1465, 
1433, 1355, 1290, 1244, 1120, 964, 938, 763, 697, 542. UV/vis (CH2Cl2), λmax (ε) 272 nm 
(13300), 402 (5000).  HRMS calcd. for C23H26N2O: 346.2045; found 346.2059. 
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4-(2-Acetyl-3-(4-methoxyphenylamino)-5-phenylcyclohexa-2,4-dienyl)benzonitrile (31l) 
 
 
N
H
O
MeO
CN
 
 
According to the GP after chromatography on silica gel (hexane/acetone 2:1), 126 mg (30 %) 
of 31l were isolated as brown oil. 1H NMR (CDCl3, 300 MHz), δ 2.02 (s, 3 H), 2.93 (d, J = 
16.5 Hz, 1 H), 3.25−3.34 (m, 1 H), 3.81 (s, 3 H),  4.25 (d, J = 7.3 Hz, 1 H), 6.57 (d, J = 2.73 
Hz, 1 H), 6.89 (dd, J = 6.81 Hz, J = 2.13 Hz, 2 H), 7.10 (d, J = 6.81 Hz,  2 H), 7.13−7.26 (m, 
5 H), 7.35 (d, J = 8.25 Hz, 2 H), 7.51 (d, J = 8.25 Hz, 1 H), 12.60 (s, 1 H). 13C NMR (CDCl3, 
100 MHz), δ 27.4 (CH3), 35.3 (CH2), 39.3 (CH), 55.4 (CH3), 100.5 (Cquat.), 110.3 (Cquat.), 
114.3 (CH), 117.5 (CH), 118.8 (Cquat.), 125.6 (CH), 126.2 (CH), 127.5 (CH), 127.8 (CH), 
128.3 (CH), 130.8 (Cquat.), 131.9 (CH), 139.0 (Cquat.), 145.2 (Cquat.), 149.9 (Cquat.), 154.2 
(Cquat.), 157.5 (Cquat.), 195.8 (Cquat.). MS (70 eV, EI): m/z (%): 420.1 (M+, 70), 405.2 (M+ - 
CH3, 5), 377.2 (M+ - CH3CO, 60), 318.2 (M+ - C7H4N, 18), 43 (CH3CO+, 17). IR (KBr), ~ν  
2962 cm-1, 2930, 2227, 1606, 1511, 1245, 1033, 824, 697. UV/vis (CH2Cl2), λmax (ε) 270 nm 
(16500), 350 (5100), 386 (5000).  HRMS calcd. for C28H24N2O2: 420.1838; found 420.1841. 
 
6-(4-Cyanophenyl)-N,N-dimethyl-2-oxo-4-phenylcyclohex-3-enecarboxamide (32a) 
 
O
O
Me2N
CN
 
 
According to the GP after chromatography on silica gel (toluene/acetone 3:1) and 
recrystallization from acetone 227 mg (66 %) of 32a were isolated as light yellow crystals. 
M.p. 164 °C. 1H NMR (CDCl3, 300 MHz), δ 2.79 (s, 3 H), 2.96 (s, 3 H), 2.99−3.01 (m, 2 H), 
3.97 (ddd, J = 6.0 Hz, J = 12.0 Hz, J = 12.0 Hz, 1 H), 4.08 (d, J = 12.0 Hz, 1 H), 6.45 (s, 1 H), 
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7.31−7.50 (m, 7 H), 7.53 (d, J = 8.16 Hz, 2 H). 13C NMR (CDCl3, 100 MHz), δ 35.3 (CH2), 
35.5 (CH3), 37.4 (CH3), 43.6 (CH), 54.7 (CH), 110.6 (Cquat.), 118.5 (Cquat.), 124.2 (CH), 125.5 
(CH), 128.1 (CH), 128.7 (CH), 130.4 (CH), 132.7 (CH), 137.3 (Cquat.), 147.6 (Cquat.), 158.1 
(Cquat.), 168.3 (Cquat.), 194.8 (Cquat.). MS (70 eV, EI): m/z (%): 344.1 (M+, 30), 300.1 (M+ - 
C2H6N+, 7), 272.1 (M+ - C2H6NCO, 100), 244.1 (M+ - C2H6NCO, - CO, 6), 72 (C2H6NCO+, 
23). IR (KBr), ~ν  3870 cm-1, 3854, 3822, 3816, 3802, 3752, 3745, 3736, 3712, 3676, 3651, 
3629, 3432, 3056, 2932, 2227, 1644, 1608, 1574, 1507, 1447, 1414, 1399, 1369, 1285, 1249, 
1170, 1136, 1116, 1042, 1002, 970, 944, 914, 884, 864, 835, 762, 694, 609, 581, 509. UV/vis 
(CH2Cl2), λmax (ε) 240 nm (20600), 288 (22600). Anal. calcd. for C22H20N2O2 (344): C 76.72, 
H 5.85, N 8.13; found : C 76.96, H 5.89, N 8.15. 
 
N,N-Dimethyl-2-oxo-4-phenyl-6-(pyrimidin-2-yl)cyclohex-3-enecarboxamide (32b) 
 
NN
O
O
Me2N
 
 
According to the GP after chromatography on silica gel (toluene/acetone 1:1) and 
recrystallization from acetone 218 mg (68 %) of   32b were isolated as light brown crystals. 
M.p. 163 °C. 1H NMR (CDCl3, 250 MHz), δ 1.35−1.41 (m, 1 H), 2.71 (s, 3 H), 2.98 (s, 3 H), 
3.14 (dd, J = 18.0 Hz, J = 4.5 Hz,  1 H), 4.09 (ddd, J = 4.5 Hz, J = 11.5 Hz, J = 11.8 Hz, 1 H), 
4.29 (d, J = 11.8 Hz, 1 H), 6.29 (d, J = 2.0 Hz, 1 H), 7.41 (t, J = 2.0 Hz,  1 H), 7.23−7.46 (m, 
5 H), 8.43 (d, J = 4.75 Hz, 2 H). 13C NMR (CDCl3, 100 MHz), δ 33.9 (CH2), 35.6 (CH3), 37.6 
(CH3), 46.0 (CH), 52.6 (CH), 119.0 (CH), 125.5 (CH), 124.5 (CH), 126.0 (CH), 128.4 (CH), 
128.6 (CH), 130.1 (CH), 131.5 (CH), 131.9 (CH), 137.6 (Cquat.), 157.0 (CH), 157.9 (Cquat.), 
169.5 (Cquat.), 170.3 (Cquat.), 195.1 (Cquat.). MS (70 eV, EI): m/z (%): 321.2 (M+, 5), 277.1 (M+ 
- C2H6N, 100), 249.1 (M+ - C2H6NCO, 9), 72 (C2H6NCO+, 17). IR (KBr), ~ν  3342 cm-1, 3052, 
2930, 1645, 1569, 1563, 1494, 1493, 1423, 1396, 1369, 1265, 1120, 760, 721, 696, 542. 
UV/vis (CH2Cl2), λmax (ε) 286 nm (30000). HRMS calcd. for C19H19N3O2: 321.1477; found: 
321.1476. 
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N,N-Dimethyl-2-oxo-4-phenyl-6-(pyridin-2-yl)cyclohex-3-enecarboxamide (32c) 
 
N
O
O
Me2N
 
 
According to the GP after chromatography on silica gel (toluene/acetone 3:1) and 
recrystallization from acetone 154 mg (48 %) of 32c were isolated as light brown crystals. 
M.p. 151 °C. 1H NMR (CDCl3, 300 MHz), δ 2.68 (s, 3 H), 2.87−3.18 (m, 5 H), 3.93 (ddd, J = 
5.5 Hz, J = 12.0 Hz, J = 12.3 Hz, 1 H), 4.35 (d, J = 12.3 Hz, 1 H), 6.34 (d, J = 2.0 Hz, 1 H), 
6.96−6.99 (m, 1 H), 7.10 (d, J = 7.25 Hz, 1 H), 7.22−7,24 (m, 2 H), 7.35−7.48 (m, 4 H), 8.36 
(d, J = 4.75 Hz, 1 H). 13C NMR (CDCl3, 100 MHz), δ 34.6 (CH2), 35.6 (CH3), 37.6 (CH3), 
45.5 (CH), 53.9 (CH), 122.1 (CH), 123.8 (CH), 124.5 (CH), 126.1 (CH), 128.4 (CH), 
130.2(CH), 136.8 (CH), 138.1  (Cquat.), 149.0 (CH), 158.3 (Cquat.), 161.0 (Cquat.), 169.5 (Cquat.), 
195.5 (Cquat.). MS (70 eV, EI): m/z (%): 320.2 (M+, 18), 276.1 (M+ - N(CH3)2, 42), 249.1 (M+ - 
C2H6NCO, 100), 72 (C2H6NCO+, 22). IR (KBr), ~ν  3440 cm-1, 3055, 2931, 1645, 1591, 1571, 
1496, 1473, 1439, 1398, 1352, 1292, 1163, 1141, 760, 691, 524. UV/vis (CH2Cl2), λmax (ε) 
264 nm (14100), 272 (16500), 288 (18900). Anal. calcd. for C20H20N2O2 (320): C 75.00, H 
6.25, N 8.75; found: C 74.51, H 6.41, N 8.60. 
 
N,N-Dimethyl-2-oxo-4-phenyl-6-(4-(trifluoromethyl)phenyl)cyclohex-3-enecarboxamide 
(32d) 
 
O
O
Me2N
CF3
 
 
According to the GP after chromatography on silica gel (toluene/acetone 1:1) and 
recrystallization from acetone 218 mg (68 %) of 32d were isolated as light brown crystals. 
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M.p. 177 °C. 1H NMR (CDCl3, 300 MHz), δ 2,79 (s, 3 H), 2.90 (s, 3 H), 3.05−3.13 (dd, J = 
17.5 Hz, J = 5.4 Hz, 2 H), 4.01−4.12 (m, 2 H), 6.59 (d, J = 2.0 Hz, 1 H), 7.29−7.65 (m, 9 H). 
13C NMR (CDCl3, 100 MHz), δ 35.3 (CH2), 35.5 (CH3), 37.4 (CH3), 43.2 (CH), 54.8 (CH), 
124.4 (CH), 125.5 (CH), 126.0 (CH), 127.5 (CH), 130.3 (CH), 146.2 (Cquat.), 158.1 (Cquat.), 
168.3 (Cquat.), 194.2 (Cquat.). MS (70 eV, EI): m/z (%): 387.1 (M+, 10), 315.1 (M+ - C4H10N, 
100), 72 (C2H6NCO+, 9). IR (KBr), ~ν  3440 cm-1, 3058, 2934, 1644, 1620, 1575, 1497, 1447, 
1421, 1400, 1370, 1327, 1226, 1166, 1115, 1069, 1019, 837, 762, 694, 611, 520. UV/vis 
(CH2Cl2), λmax (ε) 288 nm (18200). HRMS calcd. for C22H20F3NO2: 387.1446; found: 
387.1439. 
 
Ethyl 4-(6-(dimethylcarbamoyl)-5-oxo-3-phenylcyclohex-3-enyl)benzoate (32e) 
 
O
O
Me2N
CO2Et
 
 
According to the GP after chromatography on silica gel (toluene/acetone 4:1) and 
recrystallization from acetone 186 mg (48 %) of  32e were isolated as light brown oil. 1H 
NMR (CDCl3, 250 MHz), δ 1.18 (t, J = 7.25 Hz, 3 H), 2.66 (s, 3 H), 2.81 (s, 3 H), 2.85−2.98 
(m, 2 H), 3.82−3.99 (m, 2 H), 4.14 (q, J = 7.25 Hz, 2 H),  6.35 (s, 1 H), 7.20−7.38 (m, 7 H), 
7.82 (d, J = 8.5 Hz, 2 H). 13C NMR (CDCl3, 100 MHz), δ 14.1 (CH3), 35.1 (CH2), 35.5 (CH3), 
35.1 (CH2), 35.5 (CH3), 37.4 (CH3),  43.4 (CH), 54.9 (CH), 60.7 (CH2),  124.4 (CH), 126.0 
(CH), 127.1 (CH), 128.7 (CH), 129.3 (Cquat.), 129.9 (CH), 130.3 (CH), 137.6 (Cquat.),  147.1 
(Cquat.), 158.3 (Cquat.), 166.1 (Cquat.), 168.5 (Cquat.), 194.4 (Cquat.). MS (70 eV, EI): m/z (%) : 
391.2 (M+, 11), 346.1 (M+ - C2H6N+, 6), 319.1 (M+ - C2H6NCO+, 100), 72 (C2H6NCO+, 7). IR 
(KBr), ~ν  3325 cm-1, 3059, 2958, 2933, 2246, 1714, 1643, 1611, 1575, 1447, 1366, 1279, 
1183, 1106, 1021, 971, 774, 760, 732, 707. UV/vis (CH2Cl2), λmax (ε) 240 nm (12700), 286 
(12300), 382 (23600).  HRMS calcd. for C24H25NO4: 391.1783; found: 391.1760. 
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6-(4-Cyanophenyl)-4-(4-methoxyphenyl)-N,N-dimethyl-2-oxocyclohex-3-
enecarboxamide (32f) 
 
O
O
Me2N
CN
O
 
 
According to the GP after chromatography on silica gel (toluene/acetone 3:1), 217 mg (58 %) 
of 32f were isolated as light yellow oil. 1H NMR (CDCl3, 300 MHz), δ 2.75 (s, 3 H), 3.04 (s, 
3 H), 3.06–3.09 (m, 2 H), 3.38 (s, 3 H), 3.92–4.02 (m, 1 H), 4.49 (d, J = 10.8 Hz, 1 H), 6.43 
(s, 1 H), 7.00 (d, J = 7.75 Hz, 2 H), 7.63–7.72 (m, 6 H). 13C NMR (CDCl3, 100 MHz), δ  35.3 
(CH3), 35.6 (CH2), 37.5 (CH3), 44.8 (CH), 55.4 (CH), 55.7 (CH3), 111.2 (Cquat.),  115.0 (CH), 
119.3 (Cquat.),  122.9 (CH), 128.8 (CH), 129.6 (CH), 130.6 (Cquat.),   132.9 (CH), 149.8 (Cquat.), 
158.5 (Cquat.), 162.5 (Cquat.), 169.5 (Cquat.), 195.1 (Cquat.). MS (70 eV, EI): m/z (%): 374.1 (M+, 
7), 302.1 (M+ - C2H6NCO+, 100), 72 (C2H6NCO+, 11). IR (KBr), ~ν  3441 cm-1, 2934, 2227, 
1641, 1600, 1570, 1513, 1463, 1421, 1400, 1370, 1276, 1245, 1184, 1138, 1030, 827, 582, 
569, 551. UV/vis (CH2Cl2), λmax (ε) 318 nm (17100). HRMS calcd. for C23H22N2O3: 
374.1630; found 374.1645. 
 
6-(4-Cyanophenyl)-N,N-dimethyl-2-oxo-4-(thiophen-2-yl)cyclohex-3-enecarboxamide 
(32g) 
 
O
O
Me2N
CN
S
 
 
According to the GP after chromatography on silica gel (toluene/acetone 3:1) and 
recrystallization from acetone 231 mg (66 %) of 32g were isolated as light yellow crystals. 
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M.p. 176−177 °C. 1H NMR (DMSO-D6, 300 MHz), δ 2.67 (s, 3 H), 3.03 (s, 3 H), 3.10–3.15 
(m, 1 H), 3.17 (dd, J = 6.0 Hz, J = 20.0 Hz, 1 H),  3.80 (ddd, J = 6.0 Hz, J = 14.4 Hz, J = 15.0 
Hz, 1 H), 4.62 (d, J = 15.0 Hz  1 H), 6.43 (s, 1 H), 7.17 (t, J = 4.5 Hz, 1 H), 7.59 (d, J = 7.5 
Hz , 2 H), 7.69 (d, J = 2.5 Hz , 1 H), 7.77–7.82 (m, 3 H). 13C NMR (DMSO-D6, 100 MHz), 
δ 34.87 (CH2), 34.92 (CH3), 37.1 (CH3), 43.2 (CH), 53.7 (CH), 109.6 (Cquat.), 118.9 (Cquat.), 
120.7 (CH), 128.8 (CH), 129.1 (CH), 129.5 (CH), 130.7 (CH), 132.4 (CH), 141.1 (Cquat.), 
148.6 (Cquat.), 151.9 (Cquat.), 168.5 (Cquat.), 194.6 (Cquat.). MS (70 eV, EI): m/z (%): 350.1 (M+, 
11), 278.1 (M+ - C2H6NCO+, 100), 72 (C2H6NCO+, 18). IR (KBr), ~ν  3434 cm-1, 2227, 1638, 
1597, 1504, 1418, 1399, 1378, 1285, 1249, 1172, 1137, 828, 724, 610, 574, 554, 508, 474. 
UV/vis (CH2Cl2), λmax (ε) 282 nm (7000), 326 (20000). Anal. calcd. for C20H18N2O2S (350): 
C 68.55, H: 5.18, N 7.99, S 9.15; found: C 68.41, H 5.11, N 8.24, S 9.14. 
 
6-(4-Cyanophenyl)-N,N-dimethyl-2-oxo-4-(thiophen-3-yl)cyclohex-3-enecarboxamide 
(32h) 
 
O
O
Me2N
CN
S
 
 
According to the GP after chromatography on silica gel (toluene/acetone 3:1) and 
recrystallization from acetone 217 mg (62 %) of 32h were isolated as light yellow oil. 1H 
NMR (C3H6O-D6, 300 MHz), δ 2.75 (s, 3 H), 3.04 (s, 3 H), 3.05−3.09 (m, 1 H),  (dd, J = 6.0 
Hz, J = 18.0 Hz, 1 H), 3.93 (ddd, J = 6.0 Hz, J = 12.0 Hz, J = 12.0 Hz, 1 H),  4.49 (d, J = 12.0 
Hz, 1 H), 6.50 (d, J = 2.0 Hz, 1 H),  7.56–7.61 (m, 2 H), 7.64 (d, J = 7.0 Hz, 2 H), 7.73 (d, J = 
7.0 Hz, 2 H), 7.99 (m, 1 H). 13C NMR (C3H6O-D6, 100 MHz), δ 35.2 (CH3), 35.6 (CH2), 37.4 
(CH3), 44.5 (CH), 55.2 (CH), 111.2 (Cquat.), 119.3 (Cquat.), 123.3 (CH), 126.1 (CH), 127.3 
(CH), 127.9 (CH), 129.6 (CH), 132.9 (CH), 140.7 (Cquat.), 149.7 (Cquat.), 153.2 (Cquat.), 169.3 
(Cquat.), 195.4 (Cquat.). MS (70 eV, EI): m/z (%): 350.1 (M+, 38), 278.1 (M+ - C2H6NCO+, 100), 
72 (C2H6NCO+, 22). IR (KBr), ~ν  3439 cm-1, 3854, 2226, 1641, 1607, 1506, 1416, 1399, 
1285, 1248, 1175, 1140, 837, 791, 708, 634, 607, 579, 556, 503, 475. UV/vis (CH2Cl2), λmax 
(ε) 300 nm (22900). HRMS calcd. for C20H18N2O2S: 350.1089; found 350.1095. 
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N,N-Dimethyl-2-oxo-6-(pyridin-2-yl)-4-(thiophen-2-yl)cyclohex-3-enecarboxamide (32i) 
 
N
O
O
Me2N
S
 
 
According to the GP after chromatography on silica gel (toluene/acetone 3:1) 201 mg (62 %) 
of 32i were isolated as brown oil. 1H NMR (C3D6O, 300 MHz), δ 2.74 (s, 3 H), 3.05 (s, 3 H), 
3.07–3.12 (m, 1 H), 3.16 (dd,  J = 3.0 Hz, , J = 18.0 Hz, 1 H), 4.03 (ddd, J = 7.5 Hz, J = 7.5 
Hz, J = 12.0 Hz, 1 H),  4.56 (d, J = 12.0 Hz, 1 H), 6.39 (d, J = 3.0 Hz,  1 H), 7.16–7.24 (m, 2 
H), 7.34 (d, J = 7.0 Hz, 1 H), 7.61 (d, J = 3.0 Hz , 1 H), 7.67–7.75 (m, 2 H),  8.53 (d, J = 4.0 
Hz , 1 H). 13C NMR (C3D6O, 300 MHz), δ 34.7 (CH2), 34.9 (CH3), 37.2 (CH3), 45.7 (CH), 
54.0 (CH), 121.9 (CH), 122.5 (CH), 124.1 (CH), 129.0 (CH), 129.9 (CH), 137.0 (CH), 142.0 
(Cquat.), 149.5 (CH), 151.6 (Cquat.), 161.5 (Cquat.), 164.5 (Cquat.), 195.5 (Cquat.). MS (70 eV, EI): 
m/z (%): 326.2 (M+, 10), 254.1 (M+ - C2H6NCO+, 100), 72 (C2H6NCO+, 33). IR (KBr), ~ν  
3500 cm-1, 2932, 1641, 1592, 1570, 1474, 1438, 1422, 1397, 1287, 1254, 1140, 826, 787, 750, 
715, 609, 570, 547, 521, 473. UV/vis (CH2Cl2), λmax (ε) 266 nm (8100), 270 (8100), 292 
(18100). HRMS calcd. for C18H18N2O2S: 326.1089; found 326.1079. 
 
6.11 General Procedure for the Coupling-Isomerization/Coupling of 
o-Amino Aryl Halides 1 with Propargylic Alcohols 2 
 
A magnetically stirred solution of 1.00 mmol of halogen compound 1, 1.05 mmols of 
propargyl alcohols 2, 20 mg (0.02 mmols) of (PPh3)2PdCl2, and 2 mg (0.01 mmols) of CuI in 
2 mmols of degassed DBU and 1.5 mL THF under nitrogen was stirred under nitrogen in a 
heavy-walled SmithCreator process vial at the temperature and time indicated, (for 
experimental details see Table 30) in the microwave cavity. After cooling to room 
temperature 40 mL of ethyl acetate and 40 mL of water were added and stirring was 
continued for 5 to 10 min. The aqueous layer was extracted with ethyl acetate (4 × 15 mL) 
and the combined organic phases were dried over magnesium sulfate. After filtration the 
solvents were removed in vacuo and the residue was chromatographed on silica gel 
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(hexane/ethyl acetate 4:1 or 1:1) and recrystallized from ethanol or pentane/chloroform (1:1) 
to give the analytically pure alkyne 38 and respectively the quinoline 41. 
 
Table 30 Experimental details of the synthesis of alkyne 38 and quinoline 40. 
Ar1- Hal  
1 
Propargyl-alcohol  
2 
Temperature / 
Time  
Yield 
 
219 mg 
(1.00 mmol) of 
1m 
101 mg 
(1.05 mmols) of 
2g 
120 °C 
30 min 
83 mg 
(44 %) of 
38 
219 mg 
(1.00 mmol) of 
1m 
139 mg 
(1.05 mmols) of 
2a 
120 °C 
30 min 
166 mg 
(81 %) of 
41a 
219 mg 
(1.00 mmol) of 
1m 
145 mg 
(1.05 mmols) of 
2b 
120 °C 
30 min 
156 mg 
(74 %) of 
41b 
244 mg 
(1.00 mmol) of 
1n 
139 mg 
(1.05 mmols) of 
2a 
120 °C 
30 min 
160 mg 
(70 %) of 
41c 
244 mg 
(1.00 mmol) of 
1n 
170 mg 
(1.05 mmols) of 
2f 
120 °C 
30 min 
148 mg 
(57 %) of 
41d 
287 mg 
(1.00 mmol) of 
1o 
139 mg 
(1.05 mmols) of 
2a 
120 °C 
30 min 
251 mg 
(92 %) of 
41e 
219 mg 
(1.00 mmol) of 
1m 
101 mg 
(1.05 mmols) of 
2g 
150 °C 
30 min 
68 mg 
(40 %) of 
41f 
234 mg 
(1.00 mmol) of 
1p 
139 mg 
(1.05 mmols) of 
2a 
150 °C 
30 min 
174 mg 
(79 %) of 
41g 
220 mg 
(1.00 mmol) of 
1q 
139 mg 
(1.05 mmols) of 
2a 
150 °C 
30 min 
161 mg 
(78 %) of 
41h 
360 mg 
(1.00 mmol) of 
1r 
139 mg 
(1.05 mmols) of 
2a 
150 °C 
30 min 
212 mg 
(64 %) of 
41i 
 
(E)-1-(2-Aminophenyl)hex-4-en-1-yn-3-ol (38) 
 
NH2
OH
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 5:1), 83 mg (44 
%) of 38 were isolated as brown oil. 1H NMR (CDCl3, 300 MHz), δ 1.69  (d, J = 6.3 Hz, 3 H), 
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2.64 (s, 1 H), 4.06 (s, 2 H), 5.03 (d, J = 6.3 Hz, 1 H), 8.02 (dd, J = 6.0 Hz, J = 15.0 Hz, 1 H), 
5.84−5.96 (m, 1 H), 6.6−6.65 (m, 2 H), 7.07 (t, J = 6.3 Hz, 1 H), 7.21 (d, J = 7.5 Hz,  1 H). 
13C NMR (CDCl3, 100 MHz), δ 17.5 (CH3), 63.4 (CH), 82.5 (Cquat.), 94.1 (Cquat.), 107.3 
(Cquat.), 114.5 (CH), 117.9 (CH), 128.9 (CH), 129.8 (CH), 130.4 (CH), 132.3 (CH), 147.9 
(Cquat.). (70 eV, EI): m/z (%): 187.1 (M+, 70), 168.1 (M+ - H3O+, 100), 154 (M+ - H2O, - CH3, 
20 ), 144 (M+ - C2H3O, 15), 117 (M+ - C4H7O, 35). HRMS calcd. for C12H13NO): 187.0997; 
found 187.1000. 
 
2-Phenylquinoline (41a)157 
 
N
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 5:1), 166 mg 
(81 %) of 41a were isolated as white crystals. M.p. 82 °C (lit. 82-83 °C).157 
1H NMR (CDCl3, 300 MHz), δ 7.47–7.58 (m, 4 H), 7.75 (t, J = 7.73 Hz, 1 H), 7.89 (d, J = 8.3 
Hz, 1 H), 8.02 (d, J = 10.0 Hz, 1 H), 8.11 (d, J = 7.8 Hz, 1 H), 8.29–8.35 (m, 3 H). 13C NMR 
(C3D6O, 100 MHz), δ 119.3 (CH), 127.1 (CH), 128.1 (CH), 128.5 (CH), 129.4 (Cquat.), 129.5 
(CH), 130.2 (CH), 130.3 (CH),   130.4 (CH), 137.7 (CH), 140.1 (Cquat.), 149.0 (Cquat.), 157.3 
(Cquat.). (70 eV, EI): m/z (%): 205.1 (M+, 100), 162.0 (M+ - C2H5N, 12), 76 (C6H4+, 7). (KBr), 
~ν  3446 cm-1, 3057, 1616, 1597, 1555, 1508, 1491, 1446, 1423, 1319, 1283, 1242, 1126, 
1025, 831, 793, 773, 692, 677, 624, 551. UV/vis (CH2Cl2), λmax (ε) 274 nm (57600), 308 
(24400), 320 (28800), 334 (36100), 350 (35100). HRMS calcd. for C15H11N): calcd. 
205.0891; found 205.0881. 
 
2-(Thiophen-2-yl)quinoline (41b)158 
 
N
S
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 156 mg 
(74 %) of 41b were isolated as light-yellow crystals. M.p. 133 °C (lit. 131-133 °C).158 1H 
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NMR (CDCl3, 300 MHz), δ 7.16 (t, J = 4.0 Hz, 1 H), 7.48 (t, J = 6.8 Hz, 1 H), 7.61 (d, J = 5 
Hz, 1 H), 7.69–7.76 (m, 1 H), 7.88–8.01 (m, 4 H), 8.27 (d, J = 8.0 Hz, 1 H). 13C NMR 
(C3D6O, 100 MHz), δ 119.3 (CH), 127.1 (CH), 128.1 (Cquat.), 128.6 (CH), 129.6 (CH), 129.8 
(CH), 130.2 (CH), 130.7 (CH),   137.6 (CH), 144.9 (Cquat.), 148.8 (Cquat.), 153.2 (Cquat.). (70 
eV, EI): m/z (%): 211 (M+, 100), 178 (M+ - HS, 10), 128 (M+ - C4H3S, 10), 83.5 (C4H4S+, 7). 
(KBr), ~ν  3441 cm-1, 3101, 3060, 1614, 1595, 1554, 1500, 1427, 1317, 1242, 1228, 1122, 
1057, 933, 858, 841, 826, 787, 759, 711, 619. UV/vis (CH2Cl2), λmax (ε) 258 nm (14100). 
HRMS calcd. for (C13H9NS): 211.0455; found 211.0444. 
 
2-Phenylquinoline-6-carbonitrile (41c)159 
 
N
NC
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 5:1), 160 mg 
(70 %) of 41c were isolated as white crystals. M.p. 144 °C (lit. 142-143 °C).159 1H NMR 
(CDCl3, 300 MHz), δ 7.46–7.56 (m, 3 H), 7.79 (dd, J = 9.0 Hz, J = 3.0 Hz, 1 H), 7.93 (d, J = 
9.0 Hz, 1 H), 8.14–8.22 (m, 5 H). 13C NMR (C3D6O, 100 MHz), δ 109.7 (Cquat.), 118.8 (Cquat.), 
120.4 (CH), 126.4 (Cquat.), 127.8 (CH), 129.0 (CH), 130.3 (CH), 130.4 (CH), 131.1 (CH), 
133.7 (CH),   137.0 (CH), 138.5 (Cquat.), 149.2 (Cquat.), 160.0 (Cquat.). (70 eV, EI): m/z (%): 
230.1 (M+, 100), 203.1 (M+ - HCN, 9). (KBr), ~ν  3444 cm-1, 2225, 1621, 1597, 1557, 1489, 
1448, 1395, 1340, 1326, 1284, 898, 839, 786, 753, 687, 669, 594. UV/vis (CH2Cl2), λmax 
(ε):262 nm (22400), 298 (11500), 328 (8100), 342 (6400). Anal calcd. for C16H10N2 (230): C 
83.46, H 4.38, N 12.17; found: C 83.40, H 4.44, N 12.10. 
 
2-(4-Methoxyphenyl)quinoline-6-carbonitrile (41d) 
 
N
O
NC
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According to the GP after chromatography on silica gel (hexane/ethyl acetate 5:1), 148 mg 
(57 %) of 41d were isolated as white crystals. M..p. 191 °C. 1H NMR (CDCl3, 300 MHz), δ 
3.89 (s, 3 H), 7.04 (d, J = 9.0 Hz, 2 H), 7.81 (dd, J = 9.0 Hz, J = 1.5 Hz, 1 H), 7.93 (d, J = 8.4 
Hz, 1H), 8.16 – 8.22 (m, 5 H). 13C NMR (CDCl3, 100 MHz), δ 55.5 (CH3), 109.2 (Cquat.), 
114.4 (CH), 118.9 (Cquat.), 120.0 (CH), 126.2 (Cquat.), 129.2 (CH), 130.3 (CH), 130.9 (CH), 
131.1 (Cquat.), 133.7 (CH), 136.8 (CH), 149.4 (Cquat.), 159.5 (Cquat.), 161.6 (Cquat.). (70 eV, EI): 
m/z (%): 260.07 (M+, 100), 245.05 (M+ - CH3, 20), 217.06 (M+ - CH3CO, 35). HRMS 
(C17H12N2O): calcd. 260.0949; found 260.0930. (KBr), ~ν  3437 cm-1, 3023, 2966, 2934, 2840, 
2225, 1963, 1920, 1878, 1807, 1598, 1579, 1517, 1489, 1464, 1440, 1422, 1337, 1307, 1284, 
1254, 1183, 1020, 906, 852, 835, 824, 592. UV/vis (CH2Cl2), λmax (ε) 272 nm (18500), 310 
(19900), 328 (8100), 320 (20500). Anal. calcd. for C17H12N2O (260): C 78.44, H 4.65, N 
10.76, O: 6.15; found: C 78.10, H 4.67, N 10.66. 
 
2-Phenyl-6-(trifluoromethyl)quinoline (41e) 
 
N
F3C
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 5:1), 251 mg 
(92 %) of 41e were isolated as white crystals. M.p. 114 °C. 1H NMR (CDCl3, 300 MHz), δ 
7.52–7.59 (m, 3 H), 7.95 (dd, J = 7.8 Hz, J = 1.5 Hz, 1 H), 8.19 (d, J = 7.8 Hz, 1 H), 8.25 (d, J 
= 7.5 Hz, 1H), 8.31–8.38 (m, 3 H), 8.54 (d, J = 8.0 Hz, 1 H). 13C NMR (CDCl3, 100 MHz), δ 
120.8 (CH), 123.5 (Cquat.), 125.8 (CH), 126.9 (CH), 128.5 (CH), 129.4 (CH), 130.9 (CH), 
131.8 (CH), 134.3 (Cquat.), 134.6 (Cquat.), 138.9 (CH), 139.5 (Cquat.), 150.1 (Cquat.), 159.8 
(Cquat.). (70 eV, EI): m/z (%): 273.1 (M+, 100), 204.2 (M+ - CF3, 36), 126.6 (M+ - CF3, - C6H6, 
12). HRMS (C16H10F3N): calcd. 273.0765; found 273.0763. (KBr), ~ν  3434 cm-1, 1630, 1603, 
1474, 1449, 1355, 1332, 1304, 1281, 1244, 1199, 1166, 1122, 1065, 906, 894, 844, 763, 700, 
692. UV/vis (CH2Cl2), λmax (ε) 260 nm (74100), 286 (25300), 322 (18000), 336 (14500). Anal 
calcd. for C16H10F3N (273): C 70.33, H 3.66, N 5.13; found: C 70.58, H 3.80, N 5.10. 
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(E)-2-(Prop-1-enyl)quinoline (41f)160 
 
N
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 68 mg 
(40 %) of 41f were isolated as brown oil. 1H NMR (CDCl3, 300 MHz), δ 2.1 (d, J = 6.9 Hz, 3 
H), 6.72 (d, J = 619.5 Hz, 1 H), 6.83−6.87 (m, 1 H), 7.36−7.52 (m, 2 H), 7.66−7.78 (m, 2 H), 
8.04−8.08 (m, 2 H). 13C NMR (C3D6O, 100 MHz), δ 18.6 (CH3), 118.7 (CH), 125.8 (CH), 
127.1 (Cquat.), 127.4 (CH), 129.7 (CH), 129.5 (CH), 132.3 (CH), 132.7 (CH), 136.2 (CH), 
156.4 (Cquat.), 173.2 (Cquat.). (70 eV, EI): m/z (%): 169.1 (M+, 80), 168.1 (M+ - H, 100), 51 
(C4H3+, 10). HRMS calcd. for C12H11N: 169.0891; found 169.0887. 
 
6-Methyl-2-phenyl-1,8-naphthyridine (41g) 
 
N N
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 5:1), 174 mg 
(79 %) of 41g were isolated as light yellow crystals. M.p. 142 °C. 1H NMR (CDCl3, 300 
MHz), δ 2.54 (s, 3 H), 7.44–7.54 (m, 3 H), 7.91 (d, J = 1.5 Hz, 1 H), 7.94 (d, J = 8.3 Hz, 1H), 
8.13 (d, J = 8.3 Hz, 1H),  8.28 (dd, J = 8.3 Hz, J = 1.5 Hz, 2 H), 8.96 (d, J = 2.1 Hz, 1 H). 13C 
NMR (CDCl3, 100 MHz), δ 18.6 (CH3), 119.6 (CH), 121.3 (Cquat.), 127.8 (CH), 128.8 (CH), 
129.9 (CH), 131.5 (Cquat.), 135.2 (CH), 137.1 (CH), 138.7 (Cquat.), 154.8 (Cquat.), 155.8 (CH), 
159.3 (Cquat.). (70 eV, EI): m/z (%): 220.1 (M+, 100), 205.1 (M+ - CH3, 10), 77 (C6H5+, 12). 
HRMS (C15H12N2): calcd. 220.1000; found 220.1000. (KBr), ~ν  3420 cm-1, 3027, 1604, 1581, 
1546, 1503, 1481, 1458, 1434, 1321, 1278, 1140, 1025, 898, 814, 766, 739, 703, 678, 568. 
UV/vis (CH2Cl2), λmax (ε) 256 nm (27200), 272 (11300), 332 (14000), 344 (11300). Anal. 
calcd. for C15H12N2 (220): C 81.79, H 5.49, N 12.72; found: C 81.71, H 5.38, N 12.79.  
 
 
 
6 Experimental Part  195 
  
2-Phenyl-1,6-naphthyridine (41h)161 
 
N
N
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 5:1), 161 mg 
(78 %) of 41h were isolated as light yellow crystals. M.p. 98 °C (lit. 97-98 °C).161 1H NMR 
(CDCl3, 300 MHz), δ 7.24–7.49 (m, 3 H), 7.83–7.89 (m, 2 H), 8.07–8.10 (m, 2 H), 8.16 (d, J 
= 9.0 Hz, 1 H), 8.69 (s, 1 H), 9.16 (s, 1 H).13C NMR (CDCl3, 100 MHz), δ 120.3 (CH), 122.3 
(CH), 127.9 (CH), 128.7 (CH), 130.3 (CH), 136.3 (CH), 138.6 (Cquat.), 147.2 (CH), 150.5 
(Cquat.), 152.5 (CH), 161.4 (Cquat.). (70 eV, EI): m/z (%): 206.1 (M+, 100), 77 (C6H5+, 8). 
(KBr), ~ν  3422 cm-1, 3059, 1615, 1592, 1551, 1481, 1460, 1447, 1400, 1367, 1318, 1258, 
1024, 945, 845, 760, 689, 639, 573, 554. UV/vis (CH2Cl2), λmax (ε) 256 nm (12700). HRMS 
calcd. for  C14H10N2: 206.0844; found 206.0831. 
 
Pyrido[3,2-g]quinoline, 2,8-diphenyl- (41i) 162 
 
N N
 
 
According to the GP after chromatography on silica gel (hexane/ethyl acetate 4:1), 212 mg 
(64 %) of 41i were isolated as yellow crystals. M.p. 216 °C (lit. 217-218 °C).162  
1H NMR (C3H6O, 300 MHz), δ 7.40–7.52 (m, 6 H), 8.04 (d, J = 9.0 Hz, 2 H), 8.29–8.32 (m, 4 
H), 8.50–8.53 (m, 3 H), 8.77 (s, 1 H). 13C NMR (C3D6O, 100 MHz), δ 119.2 (CH), 125.9 
(Cquat.), 126.3 (CH), 127.8 (CH), 128.4 (CH), 128.9 (CH), 129.0 (CH), 129.9 (CH), 134.2 
(CH), 136.9 (CH), 139.4 (Cquat.), 147.3 (Cquat.), 158.6 (Cquat.). (70 eV, EI): m/z (%): 332.1 (M+, 
100), 305.1 (M+ - HCN, 6), 77 (C6H5+, 10). (KBr), ~ν  3442, 2226, 1621, 1574, 1545, 1490, 
1466, 1453, 1430, 1338, 1307, 1253, 1205, 1181, 1020, 884, 818, 755, 695, 625, 595. UV/vis 
(CH2Cl2), λmax (ε) 254 nm (34100), 290 (58100), 296 (57200), 376 (14800), 390 (15700). 
HRMS calcd. for C24H16N2: 332.1313; found 332.1304. 
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Table 31 Data and Structure Refinement for (E)-1-Phenyl-3-pyrimidinprop-2-en-1-one, 4b. 
Empirical Formula C13H10N2O 
Formula Weight 210.23 
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Orthorombic 
Space group Pna2 (1)  
Unit cell dimensions a = 22.813(5) Å        α = 90 °.  
 b = 3.8386(9) Å      β = 90 °.  
 c = 11.683(4) Å       γ = 90 °.  
Volume 1023.1(4) Å3  
Z 4  
Density (calculated) 1.36 g/cm3  
Absorption coefficient 0.089 mm-1  
Crystal size 0.34 x 0.32 x 0.23 mm  
θmin / θmax 1.79 to 28.31 °.  
Reflections collected 6859 
Independent reflections 2450 [R(int) = 0.0391]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 2450/ 0 /185 
Goodness-of-fit on F2 1.03  
Final R indices (I>2σ(I)) R1 = 0.036 and R2 = 0.096  
(∆ρ)max und (∆ρ)min 0.27 and -0.21 eA-3  
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Table 32 Data and Structure Refinement for 4-(8a-morpholino-2-phenyl-4a,5,6,7,8,8a-
hexahydro-4H-chromen-4-yl)benzonitrile, 6. 
Empirical Formula C26H28N2O2 
Formula Weight 400.50 
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 10.080(1) Å        α = 90 °.  
 b = 11.664(1) Å      β = 103.976(2) °.  
 c = 18.265(2) Å       γ = 90 °.  
Volume 2083.9(4) Å3  
Z 4  
Density (calculated) 1.277 g/cm3  
Absorption coefficient 0.081 mm-1  
Crystal size 0.30 x 0.26 x 0.20 mm  
θmin / θmax 2.7 to 28.28 °.  
Reflections collected 20678 
Independent reflections 5103 [R(int) = 0.0321]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 5103/ 0 /383  
Goodness-of-fit on F2 1.05 
Final R indices (I>2σ(I)) R1 = 0.049 and R2 = 0.114  
(∆ρ)max und (∆ρ)min 0.44 and -0.20 eA-3  
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Table 33 Data and Structure Refinement for 4-(4-Cyano-phenyl)-2-phenyl-7,8-dihydro-5H-
[1,6]naphthyridine-6-carboxylic acid ethyl ester, 10a. 
Empirical Formula C24H21N3O2 
Formula Weight 383.44 
Temperature 373(2) K  
Wavelength 0.71073 Å  
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 12.194(2) Å        α = 90 °.  
 b = 8.973(2) Å      β = 96.684(4) °.  
 c = 17.515(3) Å       γ = 90 °.  
Volume 1903.5(6) Å3  
Z 4  
Density (calculated) 1.338 g/cm3  
Absorption coefficient 0.087 mm-1  
Crystal size 0.26 x 0.23 x 0.12 mm  
θmin / θmax 2.55 to 24.71 °.  
Reflections collected 13721  
Independent reflections 3236 [R(int) = 0.0612]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 3236/ 0 /346  
Goodness-of-fit on F2 1.04 
Final R indices (I>2σ(I)) R1 = 0.043 and R2 = 0.086 
(∆ρ)max und (∆ρ)min 0.20 and -0.19 eA-3  
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Table 34 Data and Structure Refinement for 2-Phenyl-4-pyridin-2-yl-6,7-dihydro-5H-
[1]pyrindine, 10f. 
Empirical Formula C19H16N2 
Formula Weight 272.34 
Temperature 100 K  
Wavelength 0.71073 Å  
Crystal system Orthorhombic 
Space group P212121 
Unit cell dimensions a = 5.295(1) Å        α = 90 °.  
 b = 9.989(2) Å      β = 90 °.  
 c = 25.956(6) Å       γ = 90 °.  
Volume 1372.8(5) Å3  
Z 4  
Density (calculated) 1.32 g/cm3  
Absorption coefficient 0.078 mm-1  
Crystal size 0.42 x 0.15 x 0.12 mm  
θmin / θmax 2.18 to 28.28 °.  
Reflections collected 10186 
Independent reflections 3389 [R(int) = 0.033]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 3389/ 0 /254  
Goodness-of-fit on F2 1.05  
Final R indices (I>2σ(I)) R1 = 0.036 and R2 = 0.092 
(∆ρ)max und (∆ρ)min 0.31 and -0.20 eA-3  
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Table 35 Data and Structure Refinement for 2-Phenyl-4-(4-trifluoromethyl-phenyl)-6,7-
dihydro-5H-[1]pyrindine, 10g. 
Empirical Formula C21H16F3N 
Formula Weight 339.35 
Temperature 100 K  
Wavelength 0.71073 Å  
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 9.3792(9) Å        α = 112.508(2) °.  
 b = 9.6624(9) Å      β = 92.435(2) °.  
 c = 9.7227(9) Å       γ = 102.162(2) °.  
Volume 788.3(1) Å3  
Z 2  
Density (calculated) 1.43 g/cm3  
Absorption coefficient 0.11 mm-1  
Crystal size 0.30 x 0.26 x 0.19 mm  
θmin / θmax 2.24 to 28.29 °.  
Reflections collected 5866 
Independent reflections 3857 [R(int) = 0.018]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 3857/ 0 /290  
Goodness-of-fit on F2 1.07  
Final R indices (I>2σ(I)) R1 = 0.041 and R2 = 0.110 
(∆ρ)max und (∆ρ)min 0.37 and -0.32 eA-3  
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Table 36 Data and Structure Refinement for 2-Phenyl-4-pyrimidin-2-yl-5,6,7,8-tetrahydro-
quinoline, 10j. 
Empirical Formula C19H17N3 
Formula Weight 287.36 
Temperature 100 K  
Wavelength 0.71073 Å  
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 7.2677(8) Å        α = 82.238(2) °.  
 b = 9.452(1) Å      β = 82.509(2) °.  
 c = 10.920(1) Å       γ = 75.802(2) °.  
Volume 716.9(1) Å3  
Z 2  
Density (calculated) 1.33 g/cm3  
Absorption coefficient 0.08 mm-1  
Crystal size 0.37 x 0.30 x 0.20 mm  
θmin / θmax 2.77 to 28.33 °.  
Reflections collected 5359 
Independent reflections 3537 [R(int) = 0.036]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 3537/ 0 /267  
Goodness-of-fit on F2 1.06  
Final R indices (I>2σ(I)) R1 = 0.041 and R2 = 0.119 
(∆ρ)max und (∆ρ)min 0.43 and -0.27 eA-3  
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Table 37 Data and Structure Refinement for 2-Phenyl-4-pyridin-2-yl-5,6,7,8-tetrahydro-
quinoline, 10k. 
Empirical Formula C20H18N2 
Formula Weight 286.3 
Temperature 100 K  
Wavelength 0.71073 Å  
Crystal system Monoclinic 
Space group C2/c 
Unit cell dimensions a = 20.269(2) Å        α = 90 °.  
 b = 9.4071(9) Å      β = 107.228(2) °.  
 c = 16.413(1) Å       γ = 90 °.  
Volume 2989.2(5) Å3  
Z 8  
Density (calculated) 1.27 g/cm3  
Absorption coefficient 0.075 mm-1  
Crystal size 0.33 x 0.25 x 0.25 mm  
θmin / θmax 2.58 to 28.32 °.  
Reflections collected 10773 
Independent reflections 3701 [R(int) = 0.023]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 3701/ 0 /271  
Goodness-of-fit on F2 1.04  
Final R indices (I>2σ(I)) R1 = 0.041 and R2 = 0.110 
(∆ρ)max und (∆ρ)min 0.39 and -0.21 eA-3  
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Table 38 Data and Structure Refinement for 2-(2,6-Diphenyl-pyridin-4-yl)-pyrimidine, 10n. 
Empirical Formula C21H15N3 
Formula Weight 309.36 
Temperature 100 K  
Wavelength 0.71073 Å  
Crystal system Orthorhombic 
Space group Pbcn 
Unit cell dimensions a = 16.225(1) Å        α = 90 °.  
 b = 11.3707(7) Å      β = 90 °.  
 c = 8.0467(5) Å       γ = 90 °.  
Volume 1484.5(2) Å3  
Z 4  
Density (calculated) 1.38 g/cm3  
Absorption coefficient 0.083 mm-1  
Crystal size 0.25 x 0.20 x 0.14 mm  
θmin / θmax 2.19 to 28.28 °.  
Reflections collected 14072 
Independent reflections 1852 [R(int) = 0.045]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 1852/ 0 /141  
Goodness-of-fit on F2 1.05  
Final R indices (I>2σ(I)) R1 = 0.043 and R2 = 0.119 
(∆ρ)max und (∆ρ)min 0.39 and -0.36 eA-3  
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Table 39 Data and Structure Refinement for 4-(4-Cyano-phenyl)-2-methyl-6-phenyl-nicotinic 
acid ethyl ester, 13a. 
Empirical Formula C22H18N2O2 
Formula Weight 342.38 
Temperature 100 K  
Wavelength 0.71073 Å  
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 8.111(3) Å        α = 100.097(7) °.  
 b = 9.880(3) Å      β = 96.569(7) °.  
 c = 11.128(4) Å       γ = 94.605(7) °.  
Volume 874.9(5) Å3  
Z 2  
Density (calculated) 1.30 g/cm3  
Absorption coefficient 0.084 mm-1  
Crystal size 0.28 x 0.23 x 0.15 mm  
θmin / θmax 2.10 to 28.45 °.  
Reflections collected 6550  
Independent reflections 3823 [R(int) = 0.026]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 3823/ 0 /307  
Goodness-of-fit on F2 1.04 
Final R indices (I>2σ(I)) R1 = 0.041 and R2 = 0.114 
(∆ρ)max und (∆ρ)min 0.38 and -0.22 eA-3  
 
 
 
 
 
8 Crystal Data  214 
  
 
 
 
Table 40 Data and Structure Refinement for 2-Methyl-6-phenyl-4-pyrimidin-2-yl-nicotinic 
acid ethyl ester, 13b. 
Empirical Formula C19H17N3O2 
Formula Weight 319.36 
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Orthorhombic 
Space group Pca21 
Unit cell dimensions a = 10.4549(8) Å        α = 90 °  
 b = 19.132(1) Å      β = 90 ° 
 c = 7.6580(6) Å       γ = 90 °  
Volume 1531.8(2) Å3  
Z 4 
Density (calculated) 1.38 g/cm3  
Absorption coefficient 0.09 mm-1  
Crystal size 0.37 x 0.37 x 0.23 mm  
θmin / θmax 2.13 to 28.35 °.  
Reflections collected 10986 
Independent reflections 3677 [R(int) = 0.030]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 3677/ 0 /285 
Goodness-of-fit on F2 1.06 
Final R indices (I>2σ(I)) R1 = 0.032 and wR2 = 0.0875 
(∆ρ)max und (∆ρ)min 0.36 and -0.26 eA-3  
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Table 41 Data and Structure Refinement for Etyl 2-methyl-6-phenyl-4-(thiazol-2-
yl)nicotinate, 13c. 
Empirical Formula C19H16N2O2S 
Formula Weight 324.39 
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Monoclinic 
Space group P21/c  
Unit cell dimensions a = 10.776(3) Å        α = 90 °  
 b = 7.141(2) Å      β = 92.832(5) ° 
 c = 20.236(3) Å       γ = 90 °  
Volume 1555.4(6) Å3  
Z 4 
Density (calculated) 1.38 g/cm3  
Absorption coefficient 0.219 mm-1  
Crystal size 0.33 x 0.15 x 0.07 mm  
θmin / θmax 2.7 to 28.32 °.  
Reflections collected 11156 
Independent reflections 3863 [R(int) = 0.028]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 3863/ 0 /272 
Goodness-of-fit on F2 0.99 
Final R indices (I>2σ(I)) R1 = 0.033 and wR2 = 0.087  
(∆ρ)max und (∆ρ)min 0.37 and -0.25 eA-3  
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Table 42 Data and Structure Refinement for 4-[2-Ethoxy-6-(4-methoxyphenyl)-pyridin-4-yl]-
benzoic acid ethyl ester, 21e. 
Empirical Formula C23H23NO4 
Formula Weight 377.42 
Temperature 200(2) K  
Wavelength 0.71073 Å  
Crystal system Orthorombic 
Space group P212121  
Unit cell dimensions a = 13.9831(4) Å        α = 90 °  
 b = 23.5154(7) Å      β = 90 ° 
 c = 23.8147(7) Å       γ = 90 °  
Volume 7830.74(5) Å3  
Z 16 
Density (calculated) 1.28 g/cm3  
Absorption coefficient 0.09mm-1  
Crystal size 0.40 x 0.30 x 0.08 mm  
θmin / θmax 1.7 to 22.0 °.  
Reflections collected 51474 
Independent reflections 9569 [R(int) = 0.0846]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 9569/ 0 /1009  
Goodness-of-fit on F2 1.06 
Final R indices (I>2σ(I)) R1 = 0.048 and wR2 = 0.098  
(∆ρ)max und (∆ρ)min 0.18 and -0.20 eA-3  
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Table 43 Data and Structure Refinement for 4-[6-(4-Methoxy-phenyl)-1-methyl-2,3-dihydro-
1H-pyrrolo[2,3-b]pyridin-4-yl]-benzonitrile, 27a. 
Empirical Formula C22H19N3O 
Formula Weight 341.40 
Temperature 571(2) K  
Wavelength 0.71073 Å  
Crystal system monoclinic 
Space group P21/n  
Unit cell dimensions a = 11.4985(2) Å        α = 90 °.  
 b = 8.2319(1) Å      β = 95.956(1) °.  
 c = 19.1003(3) Å       γ = 90 °.  
Volume 1798.17(5) Å3  
Z 4  
Density (calculated) 1.261 g/cm3  
Absorption coefficient 0.079 mm-1  
Crystal size 0.40 x 0.34 x 0.24 mm  
θmin / θmax 2.14 to 23.26 °.  
Reflections collected 12652 
Independent reflections 2583 [R(int) = 0.0266]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 2583/ 0 /311 
Goodness-of-fit on F2 1.07 
Final R indices (I>2σ(I)) R1 = 0.032 and R2 = 0.081  
(∆ρ)max und (∆ρ)min 0.10 and -0.13 eA-3  
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Table 44 Data and Structure Refinement for 6-(4-Methoxy-phenyl)-1-methyl-4-pyrimidin-2-
yl-2,3-1H-pyrrolo[2,3-b]pyrimidine, 27b. 
Empirical Formula C19H18N4O 
Formula Weight 318.37 
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Orthorhombic 
Space group P212121 
Unit cell dimensions a = 6.9223(4) Å        α = 90 °.  
 b = 11.9648(7) Å      β = 90 °.  
 c = 18.529(1) Å       γ = 90 °.  
Volume 1534.6(2) Å3  
Z 4  
Density (calculated) 1.378 g/cm3  
Absorption coefficient 0.089 mm-1  
Crystal size 0.25 x 0.15 x 0.14 mm  
θmin / θmax 2.20 to 28.27 °.  
Reflections collected 15822  
Independent reflections 3805 [R(int) = 0.0251]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 3805/ 0 /289  
Goodness-of-fit on F2 1.05 
Final R indices (I>2σ(I)) R1 = 0.038 and R2 = 0.100 
(∆ρ)max und (∆ρ)min 0.39 and -0.28 eA-3  
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Table 45 Data and Structure Refinement for 4-[2-(4-Phenoxy-phenyl)-8-methyl-5,6,7,8-
tetrahydro-[1,8]naphthyridin-4-yl]-benzonitrile, 27e. 
Empirical Formula C28H23N3O 
Formula Weight 417.49 
Temperature 200(2) K  
Wavelength 0.71073 Å  
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 11.415(3) Å        α = 90 °.  
 b = 10.313(3) Å      β = 93.896(7) °.  
 c = 18.660(5) Å       γ = 90 °.  
Volume 2191.6(11) Å3  
Z 4  
Density (calculated) 1.265 g/cm3  
Absorption coefficient 0.078 mm-1  
Crystal size 0.30 x 0.27 x 0.08 mm  
θmin / θmax 2.19 to 21.97 °.  
Reflections collected 12766 
Independent reflections 2643 [R(int) = 0.0447]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 2643/ 0 /381  
Goodness-of-fit on F2 1.02 
Final R indices (I>2σ(I)) R1 = 0.039 and R2 = 0.094 
(∆ρ)max und (∆ρ)min 0.22 and -0.14 eA-3  
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Table 46 Data and Structure Refinement for 4-[9-Methyl-2-(4-phenoxy-phenyl)-6,7,8,9-
tetrahydro-5H-pyrido[2,3-b]azepin-4-yl]-benzonitrile, 27h. 
Empirical Formula C29H25N3O 
Formula Weight 431.52 
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Monoclinic 
Space group Pc 
Unit cell dimensions a = 11.253(1) Å        α = 90 °.  
 b = 39.851(6) Å      β = 94.469(3) °.  
 c = 20.366(3) Å       γ = 90 °.  
Volume 9105(2) Å3  
Z 16  
Density (calculated) 1.259 g/cm3  
Absorption coefficient 0.077 mm-1  
Crystal size 0.25 x 0.15 x 0.14 mm  
θmin / θmax 1.43 to 28.39 °.  
Reflections collected 95629  
Independent reflections 44574 [R(int) = 0.0927]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 44574/ 2 /2385  
Goodness-of-fit on F2 0.98 
Final R indices (I>2σ(I)) R1 = 0.073 and R2 = 0.136 
(∆ρ)max und (∆ρ)min 0.60 and -0.44 eA-3  
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Table 47 Crystal Data and Structure Refinement for 2-(4-Methoxy-phenyl)-9-methyl-4-
pyridin-2-yl-6,7,8,9-tetrahydro-5H-pyrido[2,3-b]azepine, 27j. 
Empirical Formula C22H23N3O 
Formula Weight 345.43 
Temperature 200(2) K  
Wavelength 0.71073 Å  
Crystal system Triclinic 
Space group P 1 
Unit cell dimensions a = 8.9544(6) Å        α = 66.502(2) °.  
 b = 10.4943(7) Å      β = 71.853(2) °.  
 c = 11.4673(9) Å       γ = 67.098(2) °.  
Volume 894.61(11) Å3  
Z 2 
Density (calculated) 1.282 g/cm3  
Absorption coefficient 0.080 mm-1  
Crystal size 0.34 x 0.32 x 0.22 mm  
θmin / θmax 1.97 to 27.57 °.  
Reflections collected 3467 
Independent reflections 3236 [R(int) = 0.0297]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 3246/ 0 /237  
Goodness-of-fit on F2 1.06 
Final R indices (I>2σ(I)) R1 = 0.040 and R2 = 0.105 
(∆ρ)max und (∆ρ)min 0.26 and -0.18 eA-3  
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Table 48 Crystal Data and Structure Refinement for 4-{2-Acetyl-3-[2-(1H-indol-3-yl)-
ethylamino]-5-phenyl-cyclohexa-2,4-dienyl}-benzonitrile, 31a. 
Empirical Formula C31H27N3O 
Formula Weight 457.56 
Temperature 200(2) K  
Wavelength 0.71073 Å  
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 9.9084(3) Å        α = 62.423(1) °.  
 b = 11.65921(3) Å      β = 70.337(1) °.  
 c = 12.5576(4) Å       γ = 75.469(1) °.  
Volume 1203.02(6) Å3  
Z 2 
Density (calculated) 1.263 g/cm3  
Absorption coefficient 0.077 mm-1  
Crystal size 0.40 x 0.38 x 0.16 mm  
θmin / θmax 1.89 to 27.48 °.  
Reflections collected 12574 
Independent reflections 5473[R(int) = 0.0214]  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 5473 0 /341 
Goodness-of-fit on F2 1.03 
Final R indices (I>2σ(I)) R1 = 0.038 and R2 = 0.094 
(∆ρ)max und (∆ρ)min 0.21 and -0.20 eA-3  
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Table 49 Crystal Data and Structure Refinement for 1-(2-(2-(1H-Indol-3-yl)ethylamino)-6-
(pyridin-2-yl)-4-(thiophen-2-yl)cyclohexa-1,3-dienyl)ethanone, 31g. 
Empirical Formula C35H35N3O3  
Formula Weight 545.66 
Temperature 200(2) K  
Wavelength 0.71073 Å  
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 9.8493(1) Å        α = 104.226(1) °.  
 b = 12.0664(2) Å      β = 109.865(1) °.  
 c = 14.0104(2) Å       γ = 96.537(1) °.  
Volume 1481.98(4) Å3  
Z 2 
Density (calculated) 1.223 g/cm3  
Absorption coefficient 0.078 mm-1  
Crystal size 0.38 x 0.22 x 0.14 mm  
θmin / θmax 1.62 to 24.71 °.  
Reflections collected 12569 
Independent reflections 5053 [R(int) = 0.0241]  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 5053/ 0 /488 
Goodness-of-fit on F2 1.03 
Final R indices (I>2σ(I)) R1 = 0.038 and R2 = 0.093 
(∆ρ)max und (∆ρ)min 0.18 and -0.18 eA-3  
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Table 50 Crystal Data and Structure Refinement for N,N-dimethyl-2-oxo-4-phenyl-6-
(pyrimidin-2-yl)cyclohex-3-enecarboxamide, 32b. 
Empirical Formula C19H19N3O2 
Formula Weight 321.37 
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 17.096(2) Å        α = 90 °.  
 b = 12.0871(17) Å      β = 97.942(3) °.  
 c = 7.9004(11) Å       γ = 90 °.  
Volume 1616.9(4) Å3  
Z 4 
Density (calculated) 1.320 g/cm3  
Absorption coefficient 0.088 mm-1  
Crystal size 0.20 x 0.16 x 0.09 mm  
θmin / θmax 1.20 to 28.31 °.  
Reflections collected 16777 
Independent reflections 4018 [R(int) = 0.0464]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 4018/ 0 /293 
Goodness-of-fit on F2 1.01 
Final R indices (I>2σ(I)) R1 = 0.046 and R2 = 0.105 
(∆ρ)max und (∆ρ)min 0.32 and -0.27 eA-3  
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Table 51 Crystal Data and Structure Refinement for N,N-dimethyl-2-oxo-4-phenyl-6-(4-
(trifluoromethyl)phenyl)cyclohex-3-enecarboxamide, 32d. 
Empirical Formula C22H20F3NO2 
Formula Weight 387.39 
Temperature 200(2) K  
Wavelength 0.71073 Å  
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 10.7411(1) Å        α = 99.400(1) °.  
 b = 13.6656(2) Å      β = 103.720(1) °.  
 c = 14.9311(3) Å       γ = 106.400(1) °.  
Volume 1979.14(5) Å3  
Z 4 
Density (calculated) 1.300 g/cm3  
Absorption coefficient 0.102 mm-1  
Crystal size 0.40 x 0.24 x 0.20 mm  
θmin / θmax 1.45 to 23.26 °.  
Reflections collected 14698 
Independent reflections 5674 [R(int) = 0.0246]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 5674/ 0 /509 
Goodness-of-fit on F2 1.03 
Final R indices (I>2σ(I)) R1 = 0.043 and R2 = 0.1.07 
(∆ρ)max und (∆ρ)min 0.38 and -0.32 eA-3  
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Table 52 Crystal Data and Structure Refinement for 6-(4-cyanophenyl)-N,N-dimethyl-2-oxo-
4-(thiophen-2-yl)cyclohex-3-enecarboxamide, 32g. 
Empirical Formula C20H18N2O2S 
Formula Weight 350.42 
Temperature 100(2) K  
Wavelength 0.71073 Å  
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 9.925(2) Å        α = 68.277(4) °.  
 b = 10.178(2) Å      β = 67.477(4) °.  
 c = 10.300(2) Å       γ = 68.712(4) °.  
Volume 862.7(3) Å3  
Z 2  
Density (calculated) 1.349 g/cm3  
Absorption coefficient 0.203 mm-1  
Crystal size 0.33 x 0.32 x 0.20 mm  
θmin / θmax 2.22 to 28.30 °.  
Reflections collected 9081 
Independent reflections 4232 [R(int) = 0.0179]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 4232/ 8 /313  
Goodness-of-fit on F2 1.02 
Final R indices (I>2σ(I)) R1 = 0.036 and R2 = 0.099 
(∆ρ)max und (∆ρ)min 0.35 and -0.25 eA-3  
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Table 53 Crystal Data and Structure Refinement for 2-phenylquinoline-6-carbonitrile, 40c. 
Empirical Formula C16H10N2 
Formula Weight 230.26 
Temperature 200(2) K  
Wavelength 0.71073 Å  
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 3.8902(2) Å        α = 111.558(1) °.  
 b = 11.7293(7) Å      β = 92.791(1) °.  
 c = 13.4790(8) Å       γ = 90.013 °.  
Volume 571.23(6) Å3  
Z 2  
Density (calculated) 1.339 g/cm3  
Absorption coefficient 0.080 mm-1  
Crystal size 2.20 x 0.24 x 0.10 mm  
θmin / θmax 1.63 to 27.48 °.  
Reflections collected 5862 
Independent reflections 2568 [R(int) = 0.0231]  
Absorption correction semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2  
Data/restraints/parameters 2568/ 0 /203  
Goodness-of-fit on F2 1.03 
Final R indices (I>2σ(I)) R1 = 0.039 and R2 = 0.109 
(∆ρ)max und (∆ρ)min 0.20 and -0.23 eA-3  
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